










“A RAPID FABRICATED DERMAL EQUIVALENT” 
 
Michaël Ananta, M.D. 
 
 
A dissertation submitted in partial fulfilment of the requirements for the degree of 
Doctor of Philosophy in Tissue Engineering 
 











I, Michaël Ananta, confirm that the work presented in this thesis is my own. Where 
information has been derived from other sources, I confirm that this has been indicated 




First and foremost, I would like to express my utmost gratitude to God, the most 
Gracious and most Merciful.   
I am very grateful to my primary supervisor Dr Vivek Mudera, Ph.D. He has 
been a source of practical council and support throughout. He provided me with 
invaluable guidance and inspiration. I am indebted to him for his time and patience. I 
would like to thank Professor Robert A. Brown, my secondary supervisor, for his 
guidance and academic support throughout my project. I am deeply grateful to Erik 
Walbeehm for his referral which provided me with the opportunity to step into the 
world of science. 
During this work I have had the good fortune to collaborate with a great many 
colleagues for whom I have the utmost regard, and I wish to extend my sincerest 
gratitude for their invaluable support, both professionally and personally. From the 
Institute of Orthopaedics: Ektoras (Hector) Hadjipanayi, Umber Cheema, Jennifer 
Verhoekx, Rebecca A. Porter, Sally Brown, Michelle Korda, Hedeer Jawad, Chavaunne 
Thorpe, Kevin Ho, Elena Garcia, Carolina Arevalo, Jasmine Ho, Mariea Brady, Tijna 
Alekseeva, Sorousheh Samizadeh, Alvena Kureshi, Farhad Foroughi, Alla Alovskaya, 
Shweta Aggarwal, Mrs. Anita Onsworth, Mrs. Michele Panaman, Mrs. Julie Cheek, Mr. 
Suhel Miah; from the Eastman Dental Institute: Batool Kazmi, Mrs. Nicky Mordan; 
from the Department of Histopathology (Royal National Orthopaedic Hospital, RNOH): 
Mrs. Margaret Byers, Mr. Steve Crane, Ms. Francesca Maggiani, Mr. Hongtao Ye, Mr. 
Fitim Berisha, Mrs. Thama Kugan, Mrs. Madeline Guntrip; from Northwick Park 
Institute for Medical Research: Lisandra E. de Castro Brás, Mrs. Cathy Gray, Mrs. 
Lindsey C. Fletcher, Neelam Gurav, Dr. Paul Sibbons, Dave; from the 3G-SCAFF 
collaboration: Cecilia Aulin, Jöns Hilborn, Stéphanie Houis, Dilibaier Aibibu, Camilla 
Frederiksson, Lionel Micol and Eva-Maria Engelhardt. Special thanks go out to Tim 
Morris for his statistical advice and I gratefully acknowledge funding from the EU 
Framework VI program (3G-Scaff reference: 013603-3G SCAFF), EPSRC, BBSRC, 
and RNOH Special Trustees. 
Most of all, I wish to extend my endless gratitude and appreciation to my family: 
Mother, Father, Maya, Mira and Paul for their help, inspiration and support. 
 4 
Publications 
(Resulting in part from the work presented in this thesis) 
 
I. Research papers 
 
1. A Rapidly Fabricated Dermal Equivalent 
 
Michaël Ananta, Robert A. Brown, Vivek Mudera (submitted for publication). 
 
2. High Density Collagen Gel Tubes: A matrix for Primary Human Bladder 
Smooth Muscle Cells  
 
Lionel A. Micol, Michaël Ananta, Eva-Maria Engelhardt, Vivek Mudera, Robert 
A. Brown, Jeffrey A. Hubbell, Peter Frey (submitted for publication). 
 
3. Mechanisms of structure generation during plastic compression of nanofibrillar 
collagen hydrogel scaffolds: towards engineering of collagen 
 
Ektoras Hadjipanayi, Michaël Ananta, Marcin Binkowski, Ian Streeter, Zhan 
Feng Cui, Robert A. Brown and Vivek Mudera. Journal of Tissue Engineering 
and Regenerative Medicine (2010) 4. 
 
4. A Poly(Lactic Acid-Co-Caprolactone)-Collagen Hybrid for Tissue Engineering 
Applications 
 
Michaël Ananta, Jöns Hilborn, Dilibaier Aibibu, Robert A. Brown, Vivek 
Mudera. Tissue Engineering Part A (2009) 15, 1667-75. 
 
II. Oral presentations 
 
1. A Co-Culture Dressing with a Rapidly Tissue Engineered Dermal Component 
Tested in Acute Full Thickness Skin Defects: A Lapine Study 
 
Michaël Ananta, Robert A. Brown, Vivek Mudera. TERMIS-eu 2010, Galway, 
Ireland 
 
2. Complex Tissue Engineering with a Novel Poly(Lactic Acid-Co-Caprolactone)-
Collagen Hybrid 
 
Michaël Ananta, Cecilia Aulin, Jöns Hilborn, Stéphanie Houis, Robert A. 
Brown, Vivek Mudera. TERMIS-eu 2008, Porto, Portugal 
 
3. A Novel Poly(L-Lactide-co-e-Caprolactone)-Collagen Hybrid Construct for 
Application in Tissue Engineering 
 
Michaël Ananta, Jöns Hilborn, Dilibaier Aibibu, Robert A. Brown, Vivek 




Cell encapsulation in collagen hydrogels affords the ability to rapidly create living yet 
mechanically weak tissue equivalents. A previously developed compression technique 
that removes the interstitial fluid from these hydrogels allows for a rapid improvement 
of the mechanical strength with adequate cell survival. However, although the UTS of 
the resulting compressed collagen-rich tissue sheets approach those found in vivo, the 
break strength, due to the small size of these sheets, does not allow for appropriate 
handling properties such as suturing. 
 
In the present study it was found that both the thickness and the break strength of the 
compressed sheets could be improved by increasing the (pre-compression) collagen 
hydrogel volume. It was found here, however, that the previously described anisotropic 
increase of the collagen density in the hydrogel at the surface through which the 
interstitial fluid content is removed forms a mass transfer dependent resistance to the 
outflow of fluid through this surface which indicates that there is a limit to the size and 
strength of living tissue that can be achieved with this technique. 
 
It was found here that the suturability of the compressed sheets could also be enhanced 
by the hybridisation with a synthetic degradable mesh without compromising cell 
survival or the speed of construction. 
 
Fibroblast seeded hybrid constructs featuring a near confluent epithelial monolayer and 
with a stratified epithelium, created within 5 hours and 2 weeks respectively, were 
tested in a lapine model of an acute full thickness skin defect to test for their safety and 
efficacy in wound healing. Only constructs with a stratified epidermis showed a 
significant increase in wound closure and neo-vascularisation of the wound bed 
compared to untreated wounds. 
 
Comparison of the present findings with currently available living biological dressings 
for the treatment of chronic wounds suggests the utility and possible cost-effectiveness 
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Cutaneous wounds extend the range of epidermal wounds to full thickness skin defects 
(i.e. those extending through the full thickness of the dermis). In adult humans, full 
thickness dermal wounds close or heal in small part by wound contraction but in most 
part by the formation of a dense collagen type I rich connective (scar) tissue replacing 
the void left by the original tissue architecture (Martin, 1997; Li et al., 2007).  
 
Although, normal scar tissue supports the restoration of the barrier function of the skin 
it lacks normal skin appendages (e.g. hair follicles, sweat glands) and is mechanically 
inferior to normal dermal tissue ultimately regaining only 80% of the original tensile 
strength (Martin, 1997). Additionally, this newly formed connective tissue is prone to 
contracture (Brissett and Sherris, 2001) which depending on the anatomical location and 
severity can lead to cosmetic and functional problems. 
 
The aetiology of wounds spans an array of acute (unintentional and intentional, i.e. 
surgery) insults and chronic conditions. Acute injuries comprise a group of mechanical 
(e.g. blunt or sharp force), thermal (Monstrey et al., 2008), chemical, electrical injuries 
(Choi et al., 2009). Chronic wounds (or ulcers) are those that do not heal within a period 
of time in which normal wound closure can be expected (Stadelmann et al., 1998). The 
vast majority of chronic wounds (or ulcers) develop in the context of chronic venous 
insufficiency, neuropathy and diabetes mellitus, or unrelieved pressure and are in a 
minority of cases caused by peripheral vascular disease. 
 
There are three general techniques of wound treatment (Mulder et al., 2002): (i) primary 
intention (i.e. immediate wound closure through surgical means), (ii) secondary 
intention (i.e. the wound is left open and allowed to close by natural wound healing), or 
(iii) third intention (i.e. delayed surgical wound closure after a period of natural wound 
healing). Of these techniques healing by primary intention is preferred as it is generally 
associated with the least formation of scar tissue when performed with minimal wound 
tension. It involves the immediate closure of the wound by opposing the wound edges 
through some form of fixation (e.g. sutures, staples, or adhesive materials) with or 
without surgical debridement of foreign contaminants or devitalised tissues. 
Chronic wounds generally heal by secondary intention (with the aid of wound 
dressings) with the added attention to the underlying aetiology, although in certain cases 
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these wounds can be excised and converted to a surgical wound with or without the 
transplantation of distant skin tissue or transposition of local skin tissue. 
 




A physical insult of the skin involving the dermis generally results in injury of blood 
vessels with the subsequent leakage of blood into the wound. In the primary hemostasis 
process, activated platelets aggregate and adhere at the site of injury forming a platelet 
plug. A secondary hemostasis process, the coagulation cascade, occurs in parallel and 
involves the thrombin mediated conversion of fibrinogen in fibrin which subsequently 
polymerises, forming a network to which activated platelets adhere (Laurens et al., 
2006). 
 
This plug prevents further blood loss (Figure 1), forms a reservoir of growth factors 
derived from encapsulated cells (e.g. platelet derived growth factor, PDGF; 
transforming growth factor β, TGF-β), plasma protein (fibronectin, vitronectin) and 
cytokines that stimulate wound healing and acts as a temporary scaffold for new tissue 
formation. 
 
1.1.2 Inflammatory phase  
 
Within minutes of injury, blood-borne polymorphonuclear leukocytes (neutrophils, 
PMN) extravasate in venous capillaries (activated by macrophage derived interleukin-
1β, IL-1β; tumor necrosis factor-α, TNF-α; interferon-γ, IFN-γ) and collect at the wound 
site (Figure 1) to debride devitalised tissue and reduce the bacterial load through 
phagocytosis (Eming et al., 2007). 
 
Neutrophil recruitment to the wound site ceases as the stimulus is removed. Chemo-
attractants from platelets encapsulated in the fibrin clot, keratinocytes at the wound 
margins, and fibroblasts attract monocytes from the systemic circulation which 
subsequently become activated and differentiate into mature tissue macrophages adding 




Figure 1 - Illustration of the progression of the normal wound healing response in 
adult humans which following a haemostatic phase is characterised by (1) an 
inflammatory phase, (2) a proliferative phase, and (3) remodelling phase. 
 
 27 
These professional antigen presenting cells not only serve an immunological role but 
are also essential for a normal wound healing response by activating local fibroblasts, 
keratinocytes and endothelial cells through the secretion of growth factors such as TGF-
β, TGF-α, basic fibroblast growth factor (FGF), PDGF and vascular endothelial growth 
factor (VEGF) (Barrientos et al., 2008). 
 
1.1.3 Proliferative phase 
 
The proliferative phase overlaps the end of the inflammatory phase and is characterised 
by angiogenesis and collagen deposition (i.e. granulation or new connective tissue 
formation), re-epithelialisation, and wound contraction (Martin, 1997). 
 
1.1.3.1 Re-epithelialisation  
 
The epidermis, a stratified squamous epithelium, has an important barrier function 
protecting the body against infection and dehydration. Both the epidermis and basement 
membrane can regenerate provided that sufficient dermal tissue remains within the 
wound bed (Suter et al., 2009). 
 
1.1.3.1.1 Normal keratinocyte biology 
 
The epidermis, in uninjured conditions, is renewed by a basal population of progenitor 
cells (i.e. basal cells or transit amplifying cells) through proliferation and differentiation. 
The stem cell population within the hair follicle bulge rarely divide under normal 
circumstances but can reconstitute the epidermis if the basal progenitor population is 
eradicated through injury (Morasso and Tomic-Canic, 2005). 
 
In the normal epidermis, keratinocytes committed to differentiate progressively move 
towards the periphery of the epidermis, from the basal to the suprabasal layers, 
transitioning from basal cells to spinous cells, then to granular cells and ultimately into 
a keratinised (or cornified) anucleated cells (i.e. squame) (Figure 2) (Maja et al., 1997; 





Figure 2 – Illustration highlighting the characteristics of keratinocyte biology 
(Mitev and Miteva, 1997): cell anatomy, differentiation and stratification (see text 
for detailed description). 
 
As spinous cells transform to granular cells, the keratin filaments (a cytoskeletal 
element) are organised and cross-linked into large macrofilaments by filaggrin (stored 
in in keratohyalin granules as profilaggrin) to provide the cells with mechanical 
strength. In the transition zone between the stratum granulosum and stratum corneum, 
precursor proteins such as loricrin and involucrin in the granular cells are cross-linked at 
the inner surface of the cell membrane by transglutaminases forming a cornified 
envelope which replaces the cytoplasmic membrane of the differentiating keratinocyte. 
Additionally, submembranous lamellar bodies within the granular cells secrete lipids 
(e.g. ceramides) into the extracellular space forming intercellular lamellae which make 
up the lipid envelope. 
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Figure 3 - In the acute wound (left) keratinocytes are activated in response to pro-
inflammatory cytokines and growth factors and proliferate and migrate into the 
wound bed. The chronic wound (right) is characterised by mitotically active cells 
located in the suprabasal (differentiated) layers. Furthermore, the corniﬁed layer 
is hyperkeratotic and parakeratotic suggesting a derangement in the completion of 
either activation or differentiation (Morasso and Tomic-Canic, 2005). 
 
Basal keratinocytes during wound healing are activated by growth factors and pro-
inflammatory cytokines (i.e. keratinocyte derived epidermal growth factor, EGF, 
heparin-binding EGF, transforming growth factor-α, TGF-α, and fibroblast derived 
keratinocyte growth factor, KGF or FGF7, TGF-β1), resulting in increased proliferation 
and in migration mediated by the dissolution of cell-cell adhesion molecules, down-
regulation of hemidesmosomes that attach to laminin (present in uninjured basal 
membrane), and up-regulation of those that recognise fibronectin (integrin α5β1), 
vitronectin (integrin αvβ5), collagen (integrin α2β1) of the provisional extracellular 
matrix (ECM) present in the wound bed (Mitev and Miteva, 1997; Werner et al., 2007). 
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Essential for the migrating phenotype are the production of (urokinase-type and tissue-
type) plasminogen activator that can degrade the fibrin barrier by activating plasmin 
within the fibrin clot and the production of matrix metalloproteinases (MMPs) that can 
release keratinocytes from their attachments to the basal lamina (collagen type VII of 
anchoring fibrils and collagen type IV present within the lamina densa of the basement 
membrane) and digest focal adhesion attachments to the dermal substrate (collagens I 
and III) within the wound (Coulombe, 2003). 
 
Basal and suprabasal keratinocytes return to their normal differentiation program once 
the wound surface is covered with a monolayer of keratinocytes resulting in the re-
establishment of a stratified epidermis and underlying basal lamina. 
 
The failure of chronic wounds to epithelialise is characterised by hyperproliferation and 
a hyperkeratotic and parakeratotic (i.e. presence of nuclei) cornified layer, suggesting an 




At day 4 post-injury, new blood vessels (sprouting) from preexisting vessels invade the 
wound clot and it is these capillaries that give the granulation tissue its granular 
appearance and name (Tonnesen et al., 2000; Li et al., 2003a). Basic FGF (also known 
as FGF-2) and vascular endothelial growth factor (VEGF) promote angiogenesis. FGF-2 
is membrane bound in endothelial cells but released when cells are damaged (through 
injury) and is also secreted by macrophages. VEGF is produced by keratinocytes, 
endothelial cells and fibroblasts (Cheema et al., 2008) under hypoxic conditions. 
 
1.1.3.3 Granulation tissue formation 
 
Fibroblasts form a heteregenous group of mesenchymal connective tissue cells 
responsible for ECM synthesis and re-modelling. These cells are recruited to the site of 
injury from proliferating populations within the wound margins and from differentiating 
pericytes/vascular smooth muscle cells associated with the micro-vasculature and 
fibrocytes (i.e. bone marrow derived fibroblast-like leukocytes) (Hinz, 2007). 
After 3 to 4 days post-injury, activated fibroblasts migrate into the fibrin matrix by the 
action of motogens and mitogens (i.e. PDGF and TGF-β) derived from activated 
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platelets, leukocytes and resident cells, where they deposit collagen-rich matrix. Like 
keratinocytes fibroblasts also need to change their integrin profile to migrate, down-
regulating collagen receptors and up-regulating integrins binding fibrin, fibronectin and 
vitronectin. 
 




Figure 4 – Fibroblasts exposed to mechanical stress will differentiate into 
myofibroblasts which feature a contractile microfilamentous apparatus. 
Fibroblasts in vivo are normally stress shielded and their cytoplasmic actin (CA) 
filaments are mainly organised into a cortical network. When exposed to an 
extracellular mechanical load, fibroblasts transition into proto-myofibroblasts 
forming stress fibres initially composed of CA and anchored at sites of focal 
adhesion. Further increases in matrix tension and the action of TGF-β stimulate 
the formation of super-mature FAs and assembly of the contractile apparatus 
hallmarking the differentiation into myofibroblasts. The contractile stress fibres in 
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these cells contain bundles of actin microfilaments associated with α-smooth actin 
(α-SMA) (Tomasek et al., 2002; Gabbiani, 2003). 
 
Exposure to TGF-β1 in the context of a change of in mechanical microenvironment, 
from an intact, stress-shielded, protective environment to the stressed condition in the 
wound bed, results in a proportion of fibroblasts in the acquisition of contractile stress 
fibres composed of β-cytoplasmic actins and focal adhesions hallmarking the proto-
myofibroblast (Figure 4) (Tomasek et al., 2002). 
 
In fibroblasts, cytoplasmic actin filaments are anchored to focal complexes at sites of 
integrin clustering. Upon increase in intra- and/or extracellular tension these focal 




Figure 5 – Illustration of the hypothesis that myofibroblasts contract the matrix in 
a lock-step mechanism (Tomasek et al., 2002; Castella et al., 2010). It has 
previously been shown that the cellular contraction of the collagen network by the 
myofibroblast is eventually stabilised into the matrix. The exact mechanism, 
however, is unknown but it is proposed by Castella et al. (2010) that the 
contraction induced laxity of the collagen network is removed through proteolysis. 
 
Further stimulation (i.e. TGF-β1 and mechanical stress) transforms the proto-
myofibroblasts into differentiated myofibroblasts which feature supermature (i.e. more 
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complex) focal adhesions and the de novo expression of α-smooth muscle actin 
incorporated in preformed β-cytoplasmic actin stress fibres (Figure 4) (Gabbiani, 2003). 
These contractile and secretory myofibroblasts contribute to wound closure through the 
deposition of ECM and through tissue contraction.  
 
The exact mechanism by which the cell mediated contraction is permanently built into 
the matrix is still unclear (Marenzana et al., 2006), but the following hypothesis is 
proposed (Castella et al., 2010). Global cell contraction shortens the bulk ECM network 
generating slack in individual ECM fibrils (Figure 5). These locally relaxed fibrils can 
be tensed by (Ca²+-dependent) subcellular contractions followed by proteolyses and 
subsequent stabilisation of the fibrils through new collagen secretion and/or cross-
linking. The cell then re-spreads and the process is repeated. A further refinement of this 
hypothesis is that the collagen fibrils relaxed by cellular contraction are unilaterally 
cleaved and the freed ends are incorporated into the same or an adjacent fibrils at the 
shortened length (Cheema et al., 2007). 
 
The contractile activity is terminated as α-SMA expression decreases and 
myofibroblasts apoptose when the tissue is repaired and tensional homeostasis is 
restored. 
 
1.1.4.1 Hypertropic scarring, keloids and scar contracture  
 
In pathological wound healing myofibroblast activity persists even after the wound has 
re-epithelialised and healed leading to hypertrophic scars which are characterised by a 
high cell, collagen density and contracture. The development of this long term 
complication is linked to delayed epithelialisation and to mechanical tension exerted on 
the wound (Brissett and Sherris, 2001; Kose and Waseem, 2008). Depending on the 
extent and the anatomical location, scar contracture can lead to debilitating functional 
impairment.  
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1.2 Chronic wound healing 
 
A wound is considered chronic, if it does not heal in an orderly or timely fashion, or if 
the healing process does not result in structural integrity (Stadelmann et al., 1998). 
 
1.2.1 Molecular pathogenesis of chronic wounds 
 
In chronic wounds, healing is compromised by a persistent inflammatory phase 
resulting in high levels of MMPs and ROSs in the wound (Harding et al., 2005). 
 
The MMPs are thought to contribute to the impairment of wound healing by the 
proteolysis and inactivation of growth factors, chemotactic agents and pro-inflammatory 
cytokines. In acute, partial thickness burns in humans increased levels of proteases are 
associated with a decreased angiogenesic  response and epidermal regeneration 
(Caulfield et al., 2008). Further, the excessive proteolytic break-down of the ECM 
negatively affects the balance between tissue synthesis and degradation (Rayment and 
Upton, 2009). 
 
Endogenously produced ROSs might induce premature and telomere-independent (i.e. 
independent of population doublings) senescence of fibroblasts and keratinocytes 
decreasing the expression of pro-inflammatory cytokines and chemokines (Harding et 
al., 2005). The net result is suppression of cell proliferation and migration which leads 
to the reduced accumulation of leukocytes, keratinocytes, fibroblasts and endothelial 
cells at the site of injury. 
 
1.2.2 Venous leg ulcers 
 
Venous skin ulceration (i.e. loss of skin that takes more than 6 weeks to heal) forms one 
end of the spectrum of chronic venous disease consisting of varicose veins, leg edema, 
hyperpigmentation, eczema and lipodermatosclerosis (Schmid-Schonbein et al., 2001; 
Bergan et al., 2006). These ulcers are associated with primary venous hypertension or 
secondary to venous valve dysfunction or venous thrombosis. 
 
Although the exact temporal and causal sequences of events have not yet fully been 
elucidated, the current hypothesis is that venous flow disturbances causes leukocyte 
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pooling in the capillary microcirculation (Raffetto, 2009). The concomitant fluid shear 
stress causes the activation of endothelial cells and leukocytes resulting in the 
extravasation of activated leukocytes and plasma proteins in the extra-vascular 
compartment. 
 
The chronic inflammation is characterised by the accumulation in the dermis of 
macrophages and mast cells which produce TGF-β1, MMPs (Rayment and Upton, 
2009) and reactive oxygen species (ROSs) (Harding et al., 2005). It is thought these 
inflammatory agents underlie the formation of ulcers, dermal fibrosis, and the 
impairment of the normal wound healing capacity. 
 
Venous leg ulcers have been estimated to affect 0.2-1% of the population in developed 
countries (Simka and Majewski, 2003) and, although generally not limb threatening, are 
associated with a loss in quality of life due to pain and functional limitations (Koupidis 
et al., 2008). 
 
1.2.3 Diabetic foot ulcers  
 
The aetiology of diabetic foot ulcers can largely be attributed to the clinical triad of 
peripheral sensory neuropathy, trauma, and ischemia (Falanga, 2005). Peripheral 
sensory neuropathy (often secondary to diabetes) is associated with reduced sensory 
guarding against pressure and heat making diabetic patients more prone to traumatic 
injury. Additionally, neuropathy can cause a maldistribution of blood flow which in 
combination with any associated macro-vascular disease can lead to ischemia and 
ulceration of the skin. 
 
The World Health Organisation estimated that 2.8% of the world population (or 171 
million) was suffering from diabetes in 2000. This number is expected to rise to 4.4% 
(or 366 milion) in 2030 (Wild et al., 2004). Fifteen percent of patients with diabetes will 
develop a foot ulcer in their lifetime. Of those with foot ulcers 15-24% require minor or 
major amputations because of limb or life threatening infections (Cheer et al., 2009). 
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1.3 Tissue Engineering 
 
The treatment of acute and chronic cutaneous wounds and their long term sequelae 
extends a whole range of surgical and non-surgical treatments. An important treatment 
modality is the use of native skin tissue from the patient self (i.e. autologous) or from an 
allogeneic source (Valencia et al., 2000). Full thickness skin grafts are the gold standard 
for acute full thickness skin defects as it is effective in preventing long term 
complications such as scar contracture and associated functional deformities (Frame et 
al., 2004). The use of skin grafting has also been found effective in increasing closure 
of chronic wounds over non-surgical treatments (Jankunas et al., 2007; Mahmoud et al., 
2008). 
 
Limiting factors in the application of this therapeutic option is the restricted supply of 
skin tissue, donor site morbidity after harvest, and acceptor site morbidity due to general 
and/or immunological issues (in the case of allogeneic grafts). An alternative approach 
to repair and reconstruction aiming to meet the requirements of human anatomy and 
physiology is tissue engineering (TE) (Langer and Vacanti, 1993), also known under the 
synonyms “reparative medicine” (Sipe, 2002) and “regenerative medicine” (Suh, 2000). 
 
1.3.1 Basic principles of tissue engineering 
 
TE, as viewed today, is ‘an interdisciplinary field that applies the principles of 
engineering and life sciences toward the development of biological substitutes that 
restore, maintain, or improve tissue function or a whole organ’ (Langer and Vacanti, 
1993).  
 
The basic components of TE are cells, signals and scaffolds (Langer and Vacanti, 1993). 
The first two components are transplanted directly or within a protective (often 
degradable, porous) framework (i.e. scaffold) to induce tissue repair (Figure 6). From 
this three general strategies are employed in TE: 
1. Transplantation of culture-expanded or modified cells or cell substitutes to augment 
the (diseased or normal) local cell population (i.e. cell-based TE) (Fodor, 2003). 
2. Use of tissue-inducing substances for local targeting of cells where new tissue is 
needed (genes and/or local or systemic growth factors) (Bleiziffer et al., 2007; Chen 
et al., 2010). 
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3. Use of matrices, with or without cells placed on or within, to conduct or induce 
tissue formation (Cima et al., 1991). 
 
1.3.2 Cell sources for tissue engineering 
 
Part of the TE strategy for tissue repair is the expansion and engraftment of cells. Tissue 
engineers have experimented with different cell types from different sources over the 





Figure 6 – Illustration of the basic principles of tissue engineering. Cells obtained 
from a tissue biopsy, taken from a patient or a donor, are expanded through serial 
passages. Once a sufficient cell number has been obtained, cells are seeded (1) 
inside or (2) on a polymeric scaffold material, and cultured in vitro in a bioreactor 
or incubator. When the construct is sufficiently matured it can be implanted in or 
applied to an area of interest. 
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Cell sources are either autologous (from the same organism), allogenic (from a different 
organism within the same species) or xenogeneic (from an organism of a different 
species). Potential limitations specific to each of these therapies are: donor site 
morbidity associated with autologous cell therapy, the immunogenicity of allogenic cell 
therapy, the immunogenicity and risk of xenozoonosis (cross-species pathogen 
infectivity) associated with xenotransplantation. 
 
The specific cell types used for transplantation are categorised as follows (Fodor, 2003): 
1. tissue specific differentiated (or primary) cells  
2. postnatal stem or progenitor cells 
3. embryonic stem cells 
 
Primary mature cells are tissue specific differentiated cells released from explanted 
tissue, cultivated for ex vivo expansion to acquire sufficient cell numbers, and then 
implanted. These cells are ideal in that they already express the desired phenotype. 
However, the success of primary cell culture is limited due to, senescence or 
dedifferentiation during in vitro cultivation, expression of inappropriate phenotypes, and 
low proliferation rates. An additional limitation is that harvest of certain phenotypes can 
only be performed on tissues that can sustain surgical harvesting. 
 
Progenitor cells are early descendants of stem cells that still have limited differentiation 
capabilities (i.e. are oligopotent), but have lost the ability for self-renewal like stem 
cells, and thus proliferate indefinitely (Polak and Bishop, 2006). 
 
Adult (or postnatal somatic) stem cells have the ability of self-renew and they can 
differentiate to all the cell types of the tissue they came from (i.e. are multipotent) 
(Young et al., 2004). Stem cells have been found in a variety of tissues including bone 
marrow, liver, skin, central nervous system, muscle, and mammary gland. Stem cells 
vary in their capacity to undergo tissue specific differentiation, and these progenitors are 
therefore subdivided according to their developmental potency. 
 
Embryonic stem cells are derived from the inner cell mass of the developing blastomere. 
An embryonic stem cells cell is self-renewing, totipotent or pluripotent (can become all 
but extra-embryonic tissues), and theoretically immortal. Pluripotent stem cells offer the 
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possibility of an infinitely renewable source of replacement cells (Polak and Bishop, 
2006). 
 
1.3.3 Tissue engineering scaffolds 
 
Scaffolds are often used in TE to carry cells from the lab to the patient. Additionally, 
when implanted, these scaffolds fulfil a passive role, in maintaining a physical space in 
which tissue repair or regeneration can take place, in replacing the structural loss of 
tissue integrity, in concentrating cells or drugs at the site of interest, protecting them 
against shear force, degradation and inflammation (Drury and Mooney, 2003). They 
also serve an active role in providing a physiological environment essential for the 
survival of anchorage dependent cells and their expression of a biologically relevant 
phenotype. 
 
Independent of their specific application scaffolds used for TE purposes need to have 
certain characteristics (Thomson et al., 1995; Hutmacher, 2000): (i) be highly porous 
with an interconnected pore network for cell growth and flow transport of nutrients and 
metabolic waste; (ii) be biocompatible and bioresorbable with controllable degradation 
and resorption rates to match tissue replacement; (iii) have suitable surface chemistry 
for cell attachment, proliferation, and differentiation; and (iv) have mechanical 
properties to match those of the tissues at the site of implantation. 
 
1.3.3.1 Prefabricated scaffolds 
 
A traditional TE strategy involves the seeding of cells onto prefabricated scaffolds. Four 
types of biomaterials generally used for this purpose are (Hutmacher, 2001; Yang and 
El Haj, 2006): (1) Naturally derived organic materials: collagen, fibrin, hyaluronic acid, 
chitosan, alginate (2) naturally derived inorganic materials: coralline hydroxyapatite, (3) 
synthetic organic: aliphatic polyesters, poly(ethylyne) glycol; and (4) synthetic 
inorganic materials: tricalciumphosphate, plaster of Paris, glass ceramics. 
 
The main advantage of using prefabricated scaffolds is that their physical and chemical 
properties can be tailored with great specificity using whatever harsh method as long as 
the final result is cell friendly. However, this strategy is time consuming as it requires 
cell activity to achieve a sufficient cell density and to produce the 3D ECM environment 
 40 
generally within the pores of a porous support structures (Hollister, 2005) through 
migration, proliferation and deposition of ECM proteins (Cooper et al., 1991; Chen et 
al., 2005). 
 
1.3.3.2 Cell encapsulating scaffolds 
 
As opposed to cell seeding of prefabricated scaffolds, encapsulating cells during 
scaffold formation (Nicodemus and Bryant, 2008) afford the ability to provide the site 
of interest with an adequate number of cells in a relevant 3D environment within an 
instant. Cell encapsulation involves mixing a cell suspension with a liquid hydrogel 
precursor solution which is subsequently crosslinked into a network. Only a few 
materials, such as the collagen hydrogels described here, are suitable for cell 
encapsulation as the scaffold fabrication process needs to be cytocompatible and two 
main categories can be distinguished (Nicodemus and Bryant, 2008): (1) biopolymer 
hydrogels (i.e. collagen, fibrin, alginate) (Mansbridge et al., 1998; Hunt and Grover, 
2010) and (2) synthetic based hydrogels (i.e. purely synthetic, i.e. poly(ethylene glycol), 
with or without incorporated biological signals and derivatised biopolymers). 
 
1.4 Collagen as a scaffolding material 
 
Collagen type I is commonly used as a scaffold in TE (Vaissiere et al., 2000; Glowacki 
and Mizuno, 2008) and collagen hydrogels were one of the first materials to be used for 
cell encapsulation (Elsdale and Bard, 1972; Bell et al., 1979). 
 
Collagen is naturally produced by fibroblasts, osteoblasts, and chondroblasts and is 
found in most connective tissues being most abundant in bone, cornea, dermis and 
tendon. For example about 60% of the total protein content comprises collagen in 
dermal tissue (Ahlfors and Billiar, 2007). The use of collagen as a scaffolding material 
to deliver cells (that generally reside in a collagen rich environment) to the site of 
interest is attractive as the material is biocompatible, has low immunogenicity 
(Furthmayr and Timpl, 1976), is conserved across species (Chu et al., 1984), is 
naturally remodelled by cells, and contains critical binding moieties (Ruoslahti and 




Collagen type I is part of a superfamily of more than 20 genetically distinct collagens. 
These major structural proteins make up about a third of the total protein content in 




Figure 7 – A type I collagen fibre is composed of smaller collagen fibrils which 
themselves comprise of microfibrils. These in turn are assembled from 
tropcollagen molecules in a regular staggered array which give rise to their 
striated appearance when viewed under an electron microscope. 
 
All collagens share the same triple helical conformation of three polypeptide chains 
each with glycine (Gly) typically as every third residue in the amino acid sequence (i.e. 
Gly-X-Y repeat) which further contains a high percentage of hydroxyproline and 
proline residues. Collagen type I, a heterotrimer composed of two α1(I) chains and one 
α2(I) chains, is classified as a fibrous collagen (comprising types I, II, III, V and XI) 
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which constitute a group of rod-like triple helical monomers (hetero- and homotrimers) 
which self-assemble in a parallel, quarter staggered arrangement into cross-striated 
(with an axial periodicity of 67 nm; Figure 7) fibrils (Van der Rest and Garrone, 1991). 
Fibrous collagen precursors are synthesised as soluble procollagens which are converted 
into collagens by cleavage of terminal propeptides by MMPs.  
 
1.4.1 ‘In vitro’ self-assembly of collagen fibrils 
 
Collagen can be extracted from native tissues using weak organic acid solutions 
(Jordan-Lloyd and Marriott, 1935). It is interesting to note that the acid soluble collagen 
fraction decreases with age (BANFIELD, 1952) due to the increase in amount and 
changes in the type of (acid stable enzymic and non-enzymic) cross-links between 
collagen molecules and microfibrils (Bailey et al., 1998). 
 
The collagen used in this study is derived from rat tail tendon extracted in acetic acid 
(Wu et al., 2005). By raising the ionic strength (by the addition of sodium chloride) or 
the pH of this acid solubilised monomeric collagen solution to physiological levels the 
collagen molecules self-assemble (i.e. precipitate and aggregate) in vitro (at room 
temperature) (Silver, 1981) within a matter of minutes into a non-crosslinked entangled 
network of polymer chains (i.e. collagen fibrils) with the same striated appearance as 
found in vivo (Francis et al., 1942). 
 
What results is a highly entangled network of collagen polymer chains and due to the 
volume of solutions used in the extraction, purification (by dialysis) and reconstitution 
process the resulting collagen polymer hydrogels contain a high degree of non-structural 
water. 
 
1.4.2 Cell encapsulation in collagen hydrogels 
 
It is interesting to note that the major driving force behind this self-assembly process is 
the increase in entropy associated with the loss of water bound to the monomer as the 
polymerisation occurs (Kadler et al., 1987). The process is mild and allows for the 
encapsulation of cells during the hydrogel formation to form living tissues within the 
space of an hour (Bell et al., 1979; Nakanishi et al., 2003). It was noted early, however, 
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that the collagen hydrogels were unstable due to the high water content (Elsdale and 
Bard, 1972) making them difficult to handle. 
 
1.4.2.1 Mechanical instability of collagen hydrogels 
 
A decrease in the fluid content improves the mechanical properties by increasing the 
collagen density and the frequency and strength of inter-fibre, physical attractive 




It is known that due to its mechanical instability a (unconfined) collagen hydrogel 
seated on a solid (non-porous) surface will over time and under its own weight 
spontaneously expel its interstitial fluid content  (Elsdale and Bard, 1972) (syneresis or 
unconfined self-compression) through part of the gel surface (more than 50% in 2 hours 
(Brown et al., 2005; Neel et al., 2006). 
 
1.4.2.3 Cell-mediated compaction 
 
Additionally, encapsulated fibroblasts can expel the interstitial fluid and condense the 
collagen matrix through the generation of tractional forces from cell locomotion, 
elongation and spreading mediated by the expression of collagen binding integrins 
(mainly α2β1) (Ehrlich and Rittenberg, 2000). Depending on the cell and collagen 
concentration the time it takes for a collagen hydrogel to achieve its maximum 
contraction can vary from several hours to several days (Dallon and Ehrlich, 2008).  
 
1.4.2.4 Mechanical compaction 
 
The fluid expulsion process can be accelerated by placing the gel on a porous 
(absorbent) substructure (Brown et al., 2005; Neel et al., 2006) which provides an 
additional driving force (a negative capillary pressure) and increases the total fluid 
leaving surface. The process could further be accelerated by increasing the gravitational 
stress (from the gel’s mass) by the addition of a compressive load onto (the apical 
surface of) the hydrogel. This process has been termed plastic compression for the 
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plasticity of the deformation (Brown et al., 2005), although at high strain levels an 
elastic recoil can be observed (Neel et al., 2006). 
 
Speed is the greatest advantage of the compression technique over cell contracted or 
self-compacted hydrogels. To illustrate this point it has previously been shown that the 
compression protocol established by this lab can increase in five minutes the break force 
of a (0.7 ml/cm²) collagen hydrogel to twice that of the same volume contracted by 2.0 
x 105 fibroblasts/ml over a one week in vitro culture period (Hu et al., 2010). Apart 
from skin tissue, the collagen hydrogel compression technique has been used to create 
bladder (Engelhardt et al., 2010), corneal (Mi et al., 2010), bone (Bitar et al., 2007; 
Buxton et al., 2008), and neural (East et al., 2010) tissue equivalents.  
 
Although the resulting compressed collagen sheets (Brown et al., 2005) have the 
ultimate tensile properties approaching those of native tissues (Ahlfors and Billiar, 
2007) they do not have the break strength required to hold a suture because of their 
slender thickness (100 µm). 
 
The break force of the compressed collagen sheets was previously improved by 
increasing the thickness through layering the material by rolling (along their long axis) 
the sheets into rod shaped constructs (Brown et al., 2005; Neel et al., 2006). Although, 
in vivo, adequate suture retention was found up to five weeks post-implantation 
(Mudera et al., 2007), the fabrication and therefore the mechanical properties are 
subject to a certain degree of (intra- and inter-operator) variability. 
 
Additionally, the rod shape and spiral structure are not ideal for the construction of large 
flat structures (for example to mimic epithelial tissues). It would be possible to produce 
a flat construct from a stack of multiple compressed collagen sheets. However, the 
resulting construct would be difficult to manage. It would be possible to improve the 
handling of such a construct by cell-mediated integration of the separate sheets into a 
unified material, but this would require an in vitro culture period (Marenzana et al., 
2007). 
 
In the present study an alternative strategy was explored in which the thickness and the 
break strength of the compressed collagen sheets were improved by increasing the pre-
compression volume of the collagen hydrogel. 
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1.5 Thesis overview 
 
The purpose of this study was to test the utility of the collagen hydrogel compression 
process to rapidly fabricate a connective tissue equivalent which could be used as a 
suturable medical device for the delivery of living cells maintained in a physiological, 
or organotypic, organisation. 
 
Two strategies were studied to increase the suturability of compressed collagen 
hydrogels: (1) by increasing of the collagen bulk material and (2) by the hybridisation 
with a suturable, degradable synthetic polymer mesh. 
 
Having identified the inherent physical limitation of the compression of increased 
volume collagen hydrogels, the study focussed on the in vitro characterisation of the 
hybridisation process using a novel and an established, commercially available synthetic 
material. 
 
The hybrid construct based on the commercially available material was seeded with 
keratinocytes and fibroblasts and tested for safety and efficacy in vivo in a lapine model 
of an acute full thickness skin defect. Skin equivalents implanted directly after 
fabrication were compared to those that were matured in vitro over a 2 week period. 
 
1.5.1 Hypothesis under test 
 
“The collagen hydrogel compression process can be used to rapidly engineer a living 
dermal equivalent for use in skin tissue engineering.” 
 
 “The suturability (measured as the break force) of a compressed collagen hydrogel can 
be improved by increasing the pre-compression volume provided that the post-
compression strain level remains the same.” 
 
“A suturable collagen construct can be fabricated by compressing a collagen hydrogel 
hybridised with a suturable synthetic degradable polymer mesh.” 
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1.5.2 Aims and objectives 
 
The aim of this study was to explore in vitro and in vivo two strategies that could 
improve the suturability, or break force, of compressed collagen hydrogels by intrinsic 
and extrinsic means without significantly affecting cell viability and function. 
 
The main objectives were as follows: 
 
1. Quantify the percentage fluid loss over the collagen hydrogel compression 
process as a measure of hydraulic permeability in relation to the change in 
collagen density as indicated by embedded markers. 
2. Quantify the mechanical break force of a collagen hydrogel with an increased 
pre-compression volume compressed to over 99% strain and compare this to that 
of a collagen hydrogel with the ‘standard’ pre-compression volume (Brown et 
al., 2005) compressed to over 99% strain. 
3. Test the feasibility of encapsulating a degradable synthetic polymer mesh during 
the polymerisation of a collagen hydrogel to construct a hybrid construct 
consisting of a mechanical synthetic polymer backbone and a collagen cell 
carrying component. 
4. Determine post-compression viability of cells encapsulated and compressed in 
the presence of the synthetic polymer mesh, directly after compression and after 
a short in vitro culture period, to determine any negative effects of this method. 
5. Spatially layer and culture in vitro different cell lines (i.e. epithelial and 
mesenchymal cells) on and inside the hybrid construct to test the feasibility of 
mimicking a complex tissue. 
6. Test the safety and efficacy of this complex tissue equivalent in vivo in an 
animal wound model. 
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2. Materials and Methods 
 




Note: the size of the collagen hydrogels in these experiments is expressed as the ratio of 
volume (in ml) to fluid leaving surface (FLS) area (in cm²) to allow for comparison 
between setups. For (5 ml; 0.7 ml/cm²) collagen hydrogels (Brown et al., 2005), four 
volumes of sterile, acid-soluble (incubated at 4°C) rat tail derived (type I) monomeric 
collagen solution (2.16 mg/ml or 0.2% w/v protein in 0.6% acetic acid: First Link UK 
Ltd, West Midlands, UK) were mixed with one volume of 10-fold concentrated minimal 
essential medium (MEM; used as a pH indicator) and brought to neutral pH (pH 7.4) by 
titration with 1M sodium hydroxide (NaOH). The collagen solution was cast into one of 
the two pockets (each measuring 33x22x10 mm³) of a custom built stainless steel mould 
(weighing 120 grams) seated on a glass slide and left to polymerise undisturbed at room 





Figure 8 – (a) Neutralised collagen hydrogels (pink) cast in pockets of a stainless 
steel mould (arrow head) which is seated on a glass slide (arrow). (b) Collagen 
hydrogel after a 30 minute setting period transferred onto a standard setup of 
blotting elements (BE). Scale bars are shown at the bottom right corners. 
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2.1.2 Unconfined compression 
 
When the collagen had polymerised after the 30 minute setting period, the resulting 
hydrogel was transferred onto a standardised assembly of blotting elements (Figure 8b), 
consisting of a layer of nylon mesh (mesh size ~50 µm) on top of a stainless steel mesh 
(mesh size ~300 µm) and three sheets of filter paper (Whatman, Grade 1, 240 mm 
diameter). A constant gravitational load (130 gram on a surface area of 7.4 cm²; a stress 
equivalent of 1.8 kN/m²) was immediately applied onto the top surface of the gel (in an 
unconfined configuration) for a period of 5 minutes to remove the interstitial fluid 
content (Figure 9a). After the compression, the resulting collagen sheet was placed into 
a (phosphate) buffered (saline) solution (PBS, catalogue number BR0014G, Oxoid, 




Figure 9 – (a) Illustration of the standard assembly in which the fluid content (grey 
arrow) of collagen hydrogels is removed through the basal surface by the negative 
capillary action exerted by a standard setup of blotting elements (three sheets of 
filtration paper, a metal and a nylon mesh) and the gravitational force from the 
application (in an unconfined configuration and in the direction of the black 
arrow) of a load on the apical surface. (b) The resulting (i) compressed collagen 
sheet (after a 5 minute compression) could be rolled along the long axis (ii) into 
spiralled constructs. 
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2.1.3 Confined compression 
 
To study the compression of larger volume (> 1.95 ml/cm²) hydrogels, the collagen 
solutions were prepared and neutralised as described above and cast into a newly 
developed and custom built chamber (which laterally confined the gel preventing it 
from buckling during compression; measuring 7x22x60 mm³) seated on a glass slide 
(Figure 10). The collagen solution was allowed to polymerise for 30 minutes after 
which time the glass was replaced by the standard setup of blotting elements (nylon and 
metal mesh, and filtration paper sheets; details described above) and a vertical load was 
applied by placing a free gliding (stainless steel) plunger (40 gram on a surface area of 




Figure 10 – (a) Photograph (scale bar shown at bottom right) and (b) cutaway 
illustration of the custom built compression chamber (i, front and, ii, side view) in 
which collagen hydrogels are compressed on the standard setup of blotting 
elements (BE) and through the application of a free gliding stainless steel plunger 
(white and black arrow). 
 
Inference about the loss in fluid content over the compression process from these 
confined compressed collagen hydrogels was made by measuring the change in height 
of the plunger. The position of the plunger was recorded on video with a digital camera 
(12 megapixel, CANON IXUS 960 IS, Canon inc., Tokyo, Japan) and the change in 
height at each time point was measured in each video frame with the software program 
ImageJ (NIH, Bethesda, MD). 
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2.1.4 Compaction assay 
 
To study the regional changes in collagen density over the compression of a collagen 
hydrogel, 10 mg of activated carbon (Aldrich, Cat. No. 16155-1) was mixed with a 
neutralised 5.7 ml/cm² collagen hydrogel to achieve an even distribution of carbon 
particles throughout the gel body. Immediately, the gel was cast in a transparent 
compression chamber and allowed to set for 30 minutes after which time the gel was 
placed on the standardised setup of blotting elements (described above) resulting in the 
(confined) compression of the gel driven by the gels own weight and the negative 
capillary pressure from the blotting elements. The compression was recorded on video 
by digital camera and inference of the change in collagen density was made from the 
change in the relative positions of the carbon particles within the gel body measured in 
each video frame. 
 
2.1.5 Scanning Electron Microscopy 
 
For high resolution images of the FLS the compressed collagen hydrogels were 
immediately immersed in liquid nitrogen for 1 minute, cut transversely, fixed overnight 
in 2.5% gluteraldehyde, freeze dehydrated overnight (Heto Drywinner, Birkerod, 
Denmark), sputter coated with gold palladium a Polaron E5 100 sputter coater (Quorum 
Technologies, East Sussex, UK) and viewed in a scanning electron microscope (SEM; 
JEOL JSM-5500LV, Japan) operated at 15 kV (Wollweber et al., 1981). 
 
2.1.6 Double fluid leaving surface compression 
 
Based on the data obtained from the experiments described above, a regime for the 
compression of a 3.25 ml/cm² (5 ml) collagen hydrogel was decided on. This involved 
the compression of the gel on the basal FLS for 10 minutes and subsequently on the 
apical FLS for another 10 minutes (1.8 kN/m², standard setup of blotting elements). 
 
2.1.6.1 Physical characterisation 
 
The physical properties of the resulting thick compressed collagen constructs were 
compared to those of the previously described spiralled collagen gels (Brown et al., 
2005; Neel et al., 2006). These constructs were prepared by the compression (1.8 
 51 
kN/m²; 5 minutes on a standard setup of blotting elements) of a 0.7 ml/cm² (5 ml) 
collagen hydrogel and spiralling the resulting collagen sheets along their long axis 
(Figure 9b). Weight measurements were recorded using an analytical balance (BDH, 
UK) directly after fabrication of the constructs. 
 
2.1.6.2 Dynamic mechanical analysis 
 
Tensile mechanical analysis was used to compare the tensile mechanical properties of 
spiralled compressed collagen sheets with those of the thick compressed collagen 
construct. These were carried out using a Perkin-Elmer DMA-7e (Perkin Elmer 
Instruments, USA) at room temperature with constant sample hydration maintained by 




Figure 11 – (a) Photograph of spiralled, compressed collagen hydrogel clamped at 
either end with strips of metal mesh reinforced with super glue to facilitate 
gripping. (b) Specimen (insert, c) mounted in the tension clamps of a dynamic 
mechanical analyser. 
 
Specimens were mounted in the tension clamps of the DMA system (Figure 11). The 
samples were clamped at each end using 2 mm strips of metal mesh reinforced by 
cyanoacrylate adhesive to facilitate gripping during testing. The dimensions of each 
specimen were measured with a travelling microscope. The initial applied load was 1 
mN, and the specimen was tested in tension until failure at a loading rate of 200 
mN/min. From the stress–strain curve (Figure 12), Young’s modulus, ultimate tensile 
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strength (UTS), and yield strain were calculated. Samples that did not break mid-




Figure 12 – Typical tensile test stress-strain curve showing the toe and elastic 
region, yield point and ultimate tensile (break) stress. 
 
 
2.2 Hybrid constructs 
 
A second strategy to improve mechanical properties was investigated by hybridising 1.4 
ml/cm² (10 ml) collagen hydrogels with synthetic polymer meshes. Two different 
materials were tested: (1) a commercially available poly-[lactide-co-glycolide] (PLGA; 
Vicryl®, VM95, Ethicon) mesh and (2) a newly synthesised poly-[lactic acid-co-
caprolactone] (PLACL) mesh. 
 
2.2.1 PLACL mesh fabrication 
 
Yarns were prepared from melt spun filaments (25 filaments each) (Figure 13a) with, a 
total finess of 165 dtex (decitex; grams per 10³ meter length), an individual filament 
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linear density of 6.6 dtex, an individual filament diameter of 28.4 µm, a tenacity (i.e. 
breaking load per unit linear density of the unstrained specimen) of 19.5±0.9 cN tex-1 
(centinewton per tex) and an elongation at break of 41.1±2.3%. The yarns were knitted 
into a mesh (Figure 13b) with a weft-pattern (Figure 13c). It should be noted that the 
PLACL co-polymer was synthesised in by Uppsala University (Uppsala, Sweden) and 





Figure 13 – (a) Scanning electron micrograph of the filament structure of the 
PLACL yarn (scale bar is shown at the bottom right corner). (b) Light micrograph 
of the PLACL mesh showing the weft-knit pattern (scale bar shown at bottom 
right). (c) Illustration of a weft knit pattern which consists of a single yarn looped 
horizontally to form a row with each row building on the previous one. 
 
2.2.2 Hybridisation of collagen hydrogels 
 
The PLACL-compressed collagen hydrogel hybrid (PLACL-CCHH) and PLGA-CCHH 
construct were prepared from two neutralised collagen solutions and either the PLACL 
or PLGA mesh. For acellular constructs, a 5 ml collagen solution was neutralised (as 
described above) and cast into a stainless steel mould (33x22x20 mm³) (Figure 14), the 
PLACL or PLGA mesh (30x20 mm²) added on top, and a second (5 ml) neutralised 
collagen volume poured. After the 30 minute setting period, the resulting hybrid 
construct was compressed in the unconfined configuration as previously described 
(Ananta et al., 2009) (Figure 14b). 
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2.2.3 Physical characterisation of compression 
 
To evaluate their influence on the final collagen density of the collagen component of 
the PLGACL-CCHH construct the compression time and load were varied and weight 
measurements were recorded using an analytical balance directly after the compression 
to infer and compare the collagen density between compression regimes. The following 
conditions were tested on the standard set of blotting elements: compression times of 5 




Figure 14 – (a) Photograph showing seated on a glass slide (white arrow) the 
stainless steel mould (arrow head) of increased height in which the two volumes (10 
ml) of collagen are set around a synthetic degradable mesh. Scale bar shown at 
bottom right corner. (b) Illustration of the unconfined compression setup of the set 
collagen hydrogel with encapsulated synthetic degradable mesh. 
 
2.2.4 Cell culture 
 
2.2.4.1 Fibroblast maintenance 
 
Human neonatal foreskin fibroblasts (hNNF) and rabbit dermal ear fibroblasts (rDEF) 
were maintained in a humidiﬁed atmosphere, in 5% CO2 and at 37°C. The growth 
medium was prepared from Dulbecco's Modified Eagle Medium (DMEM; catalogue 
number D6429, SIGMA, Irvine, UK) supplemented with 10% (v/v) fetal calf serum 
(FCS; First Link, West Midlands, UK), 100 U/ml penicillin and 100 µg/ml streptomycin 
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(P/S; 500 µg mL-1 and 500 units mL-1 respectively; catalogue number 5140-122 
Invitrogen/Gibco, UK). Cells were maintained in 35 ml of growth medium (changed 
twice a week) within T-225 (225 cm²) cell culture ﬂasks (catalogue number 431082, 
Corning-Costar Corp., Corning, New York, USA) featuring gas-permeable caps. 
 
2.2.4.2 Passaging of fibroblasts 
 
The growth medium was removed from the culture flasks and the monolayer of cells 
was washed twice with 10 ml of PBS. The cells were then covered with 6 ml of a 0.05% 
(1x) trypsin solution and incubated at 37°C. The trypsinisation progress was monitored 
under an inverted microscope until approximately 90% of the cells were rounded up, 
generally occurring after 4 to 6 minutes. The cells were then released from the culture 
surface by hitting the side of the flask against the palm of the hand the cells were 
detached. If only a few cells would detach the flasks were left for an additional 60 
seconds before further attempts were made. After the cells were released the trypsin was 
neutralised with 12 ml of DMEM/10%FCS solution. The cell suspension was then 
collected in a 10 ml universal tube and centrifuged at 2000 RPM for 5 minutes to pellet 
the cells. The supernatant was then decanted from the tube without disturbing the cell 
pellet and the cells were resuspended in DMEM. 
 
Cells were then counted with the haemocytometer trypan blue dye exclusion method 
(Mishell et al., 1980) as follows (Figure 15). A 10 µl aliquot of the single-cell 
suspension was diluted with a trypan blue solution in a 1:2 dilution ratio. A cover slip 
was placed over the counting surface of the haemocytometer (Figure 14) after which 10 
µl of the cell suspension was introduced into both loading wells with a pasteur pipette. 
The stained (dead) and non-stained (viable) cells were counted in each of the four 
counting areas (1 mm²; volume 10-4 ml) of both chambers (side A and B) under a phase-
contrast microscope (Leica) at 100x (10x objective) magnification. The cell number in 
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Figure 15 – (a) Illustration of a haemocytometer used to count cells suspended in a 
known volume trapped in two counting chambers (with a depth of 0.1 mm) 
underneath a cover slip and over ruled counting areas (b) Cells in either chamber 
were counted in four (i, - iv) ruled (1 mm²) counting areas (insert, c). 
 
2.2.5 Fabrication of living dermal equivalents 
 
For comparative purposes the previously established compression regime (unconfined, 
1.8 kN/m² for 5 minutes on the standard setup of blotting elements) was used in the 
following experiments. For the creation of living dermal tissue equivalents the collagen 
component of the hybrid construct was cell seeded as follows. Eight volumes (4 ml) of 
collagen solution were mixed with one volume of MEM, neutralised (as described 
above), and mixed with one volume growth medium (see below for details) in which 
2x105 cells were suspended. The cytocompatibility of the technique was tested with 
hNNFs (passage 4-6) and rDEFs (passage 2-5). hNNFs were kindly donated by the 
Institute of Orthopaedics and rDEFs were explanted from tissue biopsies obtained from 
rabbit ears (method described below under ‘Fibroblast explant culture’). 
 
2.2.6 Morphometric measurements 
 
The physical dimensions of the hybrid constructs were measured with a travelling 
microscope. Pore size and porosity were determined with ImageJ from digital 
photographs taken with a digital camera (Olympus, Camedia, C-2020 Zoom, Tokyo, 
Japan) attached to a light microscope (Olympus BH-2, Tokyo, Japan). For high 
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resolution images the constructs were viewed with SEM using the methods described 
above. 
 
2.2.7 Alamar Blue reduction assay 
 
The Alamar Blue (AB) reduction assay as an indirect measure for the number of viable 
cells (Nakayama et al., 1997). The AB dye, the non-fluorescent resazurin, is reduced by 
metabolically active (viable) cells to the highly fluorescent and quantifiable dye 
resorufin (O'Brien et al., 2000). To test cell survival after the compression of the 
PLACL- and PLGA-CCHH material the constructs were incubated, directly after 
fabrication, in a 10% AB dye solution in phenol red-free DMEM (Gibco, Paisley, UK) 
for four hours at 37°C and 5% CO2 after which time the amount of fluorescence was 
measured (Fluoroskan Ascent Labsystems International, Helsinki, Finland; 510 nm 
excitation, 590 nm emission). hNNFs were tested with the PLACl-CCHH and rDEFs 
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Figure 16 – AB reduction (expressed as relative fluorescent units, RFU) as a 
function of cell number. (a) Human fibroblasts and (b) rabbit fibroblasts were 
incubated on tissue culture plastic with AB as previously described. For both 
panels, values were deducted from the autofluorescence of AB without cells. For 
rabbit fibroblasts it was found that over 1 million cells the linear relationship 
between the RFU and cell number changed (arrow). 
 
 58 
The fluorescence intensity was expressed as relative fluorescence units (RFU) and for 
each sample the obtained value was subtracted by the value representing the 
autofluorescence of the (non reduced, non-fluorescent) 10% AB solution. The AB 
reduction by collagen compressed cells was compared to that of (non-compressed) cells 
plated onto tissue culture plastic. The assay was repeated after 7 days in static in vitro 
culture after compression to evaluate cell proliferation. In this 7 day period constructs 
were maintained in growth medium (DMEM, 10% FCS, 1% P/S) under 5% CO2 at 
37°C, for 1 week,  the culture medium was replaced every two days. To determine the 
relation between the number of cells and the intensity of fluorescence, standard curves 
were obtained for hNNFs and rDEFs (Figure 16) by quantifying the AB reduction over 
the four hour period by various cell densities plated onto tissue culture plastic (in 10% 
AB solution at 37°C and 5% CO2). 
 
2.2.8 Confocal microscopy 
 
To test the short term biocompatibility of the PLACL mesh the distribution of live and 
dead cells was visualised after a 7 day culture period by confocal microscopy. Cell 
seeded (within the bottom collagen compartment), PLACL-CCHH constructs were 
cultured for 7 days (static culture conditions) and on the last day incubated for 45 
minutes in 20 µM 5-chloromethylfluorescein diacetate (CMFDA, CellTracker Green, 
catalogue number C2925, Invitrogen, Paisley, UK) to stain for life cells, washed in PBS 
and incubated for 45 minutes in 2 mM ethidium homodimer-1 (EH-1, catalogue number 
E1169, Invitrogen, Paisley, UK) to stain for dead cells. On the same day serial images 
were taken throughout the entire thickness of the bottom collagen component at 15 µm 
intervals with a confocal microscope (40x objective). To evaluate the cell distribution 
the cell number in a 45 µm thick region most distal and most proximal to the PLACL 
mesh was manually counted from the obtained digital images. The number of cells 
(both viable and dead) in each region was expressed as a percentage of the total number 
of (viable and dead) cells counted in both regions. Cell viability in these two regions 
was determined by dividing the counted number of viable cells by the total number of 
dead and viable cells. 
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2.3 Skin equivalents 
 
The following in vitro and in vivo experiments were carried out with the PLGA-CCHH 
constructs. To test the utility of a rapidly engineered stable dermal equivalent for the in 
vitro reconstruction of an epidermis, rabbit ear keratinocytes were seeded on the apical 
surface of an rDEF seeded PLGA-CCHH. 
 
2.3.1 Cell culture 
 
2.3.1.1 Keratinocyte isolation 
 
RDKs were isolated (within 24 hours post-mortem) from tissue taken from the ventral 
side of adult male rabbit ear lobes (Figure 17). The top part of the ear lobe was 
harvested, closely shaven with electric animal clippers (Oster Corporation, model 
number A5-00, Milwaukee, Wisconsin, USA), washed in 70% Industrial Methylated 
Spirits (IMS; Genta Medical, York, UK) for 2 minutes and subsequently twice in sterile 




Figure 17 – (a) Photograph showing the harvest of skin (arrow head) from rabbit 
ear lobes ventral to the cartilage (C). (b) Histological section showing the 
difference in number of hair follicles between skin ventral and dorsal to the 
cartilage (dashed line shows the plane of dissection).  
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A skin graft ventral to the ear cartilage of approximately 10 to 15 cm² was taken. The 
graft was divided into smaller pieces of approximately 5x5 mm² which were then 
incubated in 0.25% (5x) trypsin-EDTA (catalogue number 15400-054, 
Invitrogen/Gibco) with 2% P/S for 90 minutes at 37° C. It should be mentioned that 
trypsin causes a separation of the epidermis above the basal lamina (Nielsen and Don, 
1984) often leaving basal keratinocytes still attached to the dermal component. 
 
After incubation, the epidermis and the dermis were separated with forceps in a sterile 
tissue culture dish with PBS+2% P/S solution to prevent dehydration. The epidermal 
surface of the dermal pieces was scraped with a scalpel blade to release any still 
adherent basal keratinocytes. The dermal fragments were kept in PBS+2% P/S solution 
at 4° C until further use and the scraped cell suspension was transferred from the dish to 
a 50 ml Falcon tube. DMEM containing 10% FCS was added to inactivate the trypsin. 
The solution was then filtered through a 70 µm cell strainer (BD Falcon, cat. no. 
352350), centrifuged at 2000 revolutions per miµnute (RPM) for 5 minutes and 
resuspended in keratinocyte growth medium (KGM; CnT-07, CellNTec, Switzerland). 




Figure 18 – (a) Histological section showing the basal keratinocytes (black arrow 
heads) in the epidermis (E) that were separated enzymatically from the dermis (D) 
and mechanically from the stratum corneum (SC). (b) Phase contrast micrograph 
showing the typical cobble stone morphology of basal keratinocytes. Scale bars are 
shown at the bottom right corner. 
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The epidermal fragments were transferred to a beaker with 0.25% trypsin + 2% P/S to 
which a magnetic stirring bar was added and the epidermal fragments were stirred at 
100 RPM on a magnetic stirrer (Stuart, Bibby Sterilin Ltd., Stone, Staffordshire, UK) 
for 30 minutes at room temperature. DMEM/10%FCS was added to inactivate the 
trypsin. The epidermal pieces were rubbed against the wall of the beaker with the tip of 
a 25 ml serological pipette (catalogue number 4251, Corning-Costar Corp., Corning, 
New York, USA) to release any still adherent keratinocytes from the stratum corneum 
(Figure 18a). 
 
The suspension was then filtered through a 70 µm cell strainer to remove the stratum 
corneum and then centrifuged at 2000 RPM for 5 minutes. The cells were resuspended 
in KGM. The cell fractions from the dermal and epidermal fragments were pooled to 
obtain a single keratinocyte suspension and counted with the haemocytometer and 
trypan blue dye exclusion assay and were then seeded in T-225 flasks at 0.5 to 1.0x106 
cells/25 cm². The medium was changed after the first two days to remove the debris and 
dead cells and three times weekly after that. The keratinocytes were passaged for 
expansion only once when the culture became 80% confluent and then used for seeding 
of the constructs when again 80% confluent (Figure 18b). 
 
2.3.1.2 Keratinocyte passage 
 
The growth medium was removed from the culture flasks and the monolayer of cells 
was washed twice with 10 ml of PBS. The cells were then covered with 10 ml of a 
0.25% trypsin + 2% P/S solution. The trypsinisation progress was monitored under an 
inverted microscope until approximately 90% of the cells were rounded up, generally 
occurred after 4 to 6 minutes. The cells were then released from the culture surface by 
hitting the side of the flask against the palm of the hand until most of the cells were 
detached. If only a few cells would detach the flasks were left for an additional 30 
seconds before further attempts were made. After the cells were released the trypsin was 
neutralised with 20 ml of DMEM/10%FCS solution. The cell suspension was then 
transferred to a 50 ml Falcon tube. The flasks were rinsed with 10 ml PBS to remove 
any remaining keratinocytes from the flask and this suspension was then transferred to 
the Falcon tube. The tube was then centrifuged at 2000 RPM for 5 minutes to pellet the 
cells. The supernatant was decanted from the tube without disturbing the cell pellet. The 
 62 
cells were resuspended in KGM and counted with the haemocytometer and trypan blue 
dye exclusion assay.  
 
2.3.1.3 Fibroblast explant culture 
 
The dermal fragments, obtained after separating the epidermis from the dermis (see 
above), were cut into smaller (2x2 mm²) squares and transferred to 6-well plates. Ten to 
fifteen dermal pieces were placed in the centre of each 6-well plate and a glass cover 
slip (glass cover, 22x26 mm², catalogue number 631-0131, VWR Scientific, Media, 
Philadelphia, USA) was placed on top of them and weighed down with a 10 gram 
stainless steel weight to keep the samples physically attached to the well plate (Figure 
19). Then 5 ml DMEM/10%FCS was added to each well and the plate was placed in a 
humidified 37° C, 5% CO2 incubator. The growth medium was changed twice weekly. 






Figure 19 – (a) Illustration of the top view of a skin explant culture showing a glass 
cover slip placed over dermal fragments in a 6-well plate. (b) Side view of skin 
explant culture showing a stainless steel weight on top of the cover slip to 






Figure 20 – (a) Micrograph showing a fibroblast explant culture, day 5, established 
from a dermal fragment (EX) using the skin explant culture system described in 
Figure 19. (b) Fibroblast explant culture, at day 14. Scale bar shown at bottom 
right corner. 
 
2.3.2 Fabrication of living skin equivalents 
 
Fibroblast seeded PLACL-CCHH constructs (dermal equivalents) were fabricated (as 
described above), placed onto metal grids in a well of a 6-well plate and submerged in 
KGM (CnT-07; ~7 ml). 2.3 to 2.6 x106 cells were brought into a 500 µl of KGM and 
this suspension (inoculum) was added to the apical surface of the dermal equivalents 
(Figure 21a) to form a subconfluent monolayer epithelium (Figure 21c). The 
keratinocytes were allowed to attach for 4 hours after which the KGM was topped up to 
8 ml. 
 
The cell seeding efficiency was determined by counting the number of cells that had not 
attached to the dermal equivalents. The KGM with dead, non-adherent keratinocytes) 
was aspirated, the wells (collecting attached, viable keratinocytes) were trypsinised, and 
both cell fractions were pooled in a single cell suspension. Cells from this suspension 
were counted with the haemocytometer and trypan blue dye exclusion assay (Figure 
15). The seeding efficiency was calculated by dividing the number of cells that had 
adhered to the hybrid construct (the number of cells in the inoculum minus the number 





Figure 21 – Illustration of the keratinocyte / fibroblast co-culture setup. (a) 
Keratinocytes were statically seeded on the apical surface of living dermal 
equivalents (i.e. fibroblast seeded PLGA-compressed collagen hybrid constructs) 
(a1) placed on stainless steel meshes in 6-well plates. (a2) The subconfluent 
epidermis was cultured to confluence submerged in growth medium. (b1) At 
confluence the skin equivalents were raised to the air-liquid interface by lowering 
the volume of growth medium to allow for the formation of a (b2) stratified 
epidermis. 
 
The co-culture constructs were kept submerged in KGM for 3 to 5 days to allow the 
keratinocytes to achieve a confluent monolayer. The medium was then diminished so 
that the constructs on the metal grids were located at the air-liquid interface (Figure 
21b). The constructs were cultured for an additional day on KGM and subsequently for 
twelve days on keratinocyte differentiation medium (CnT-02-3D, CellNTec, 
Switzerland) to form a differentiated and stratified epidermis (Figure 21d). 
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2.4 Implantation study 
 
2.4.1 Study design 
 
All experiments were approved by a local ethical review committee and carried out 
under Home Office Project Licence PPL 80/2200 according to the Animals Scientific 
Procedures Act (1986). Fifteen female New Zealand rabbits (kg) with an initial weight 
of 2.9 - 3.5 kg were purchased from B&K Universal (Grimston, Aldbrough, Hull, East 
Yorkshire, UK) and housed in an approved animal facility. On arrival, rabbits were 
placed into individual cages and allowed to acclimatise to their new surroundings for 7 




Figure 22 – Schematic diagram of the experimental design. Six full thickness skin 
defects were created on the dorsum of rabbits which were either left untreated 
(NT) or treated with full thickness skin grafts (FTSG), acellular constructs (AC), 
uncultured (UC) and cultured (CC) cell seeded constructs. Wound healing was 
evaluated in histological sections 1, 3 and 5 weeks after injury. 
 
PLGA-CCHH constructs were tested in standardised full thickness skin defects on the 
dorsum of female adult New Zealand rabbits (see Figure 22 for an overview of the 
experimental design). Healing of wounds treated with two of the following constructs 
was compared. The first group of (male derived, allogeneic) keratinocyte and fibroblast 
 66 
seeded hybrid constructs were fabricated and directly implanted without an in vitro 
culture period (uncultured constructs; UCs). 
 
The second group of constructs were fabricated and cultured in vitro (for 2-3 week) to 
allow the keratinocytes to differentiate into a stratified epithelium (cultured constructs; 
CCs).  The controls were wounds treated with acellular constructs (AC), wounds treated 
with the rabbits own skin or autologous full thickness skin grafts (FTSG) and wounds 
that were left open (no treatment, NT). Wounds were analysed after 1, 3 and 5 weeks 
after implantation. In each rabbit, six wounds were created and all six wounds were 
given one of the five treatments so that each of the 15 rabbits represented one out of five 




On the day of surgery, the rabbits were weighed and pre-medicated by intramuscular 
injection of Hypnorm 0.3 ml/kg (0.095 mg/kg fentanyl citrate and 3 mg/kg fluanisone) 
into the caudal thigh muscle. A period of 5-10 minutes was allowed for the animal to 
become sedated after which the animal was immobilised for intravenous cannulation by 
wrapping the body in a blanket sparing the head. The area over a marginal ear vein was 
depilated and wiped with 70% ethanol after which the vein was cannulated with a 23-
Gauge butterfly cannula which was fixed with tape to the ear and flushed with 0.9% 
normal saline.  
 
The rabbits were anesthetised with Diazepam (5 mg/ml, 0.1 ml/kg, i.v.) after which the 
fur on the dorsal area between the scapulae and the iliac crests was shaved with small 
animal clippers (Oster, Model A5, Milwaukee, USA) (Figure 23a). 
 
To be able to identify individual rabbits a three character code was tattooed inside the 
ear (Figure 23b). An outline of the areas to be excised was measured out with a ruler, 
drawn with a skin-marking pen and subsequently tattooed (Figure 23a). The rabbit was 
then transferred in the supine position onto a synthetic sheepskin rug to prevent 
excessive heat loss and given oxygen at a gas flow rate of 1 L/min through a face mask 
with a rebreathing bag (Figure 23c,d). Supplemental doses of Hypnorm 0.05-0.1 ml/kg 
were given every 20-30 minutes to maintain anaesthesia (Figure 23d). Intra-operative 
fluid loss was compensated with a continuous infusion of 0.9% saline at 10ml/kg of 
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body weight per hour. Heart rate and peripheral oxygen saturation were monitored 
continuously with a pulse oximeter. The rate of respiration was monitored by observing 
the movement of the chest. The surgical anaesthesia was continuously monitored for 
adequate depth and considered sufficient in the absence of an ear pinch reflex and pedal 
withdrawal reflex (pinch on the rear fifth ray distal phalanx). The skin was then 
disinfected with a 70% alcohol solution containing 0.6% chlorhexidine and the 





Figure 23 – (a) Pre-operative preparation of a rabbit subject. Anaesthetics and 
fluids were administered peri-operatively through a cannula inserted in a marginal 
ear vein (black arrow). The dorsum between the scapulae and the iliac crests was 
depilated and squares of 2x2 cm² (white arrows) were marked out with indelible 
ink and tattooed. (b) A three character code was tattooed inside the ear to identify 
the individual animals. (c) Oxygen was supplied during surgery at a flow rate of 1 
L/min through a face mask (white arrow, d) and supplemental doses of anaesthetic 




2.4.3 Surgical procedure 
 
Three 2x2 cm² (Figure 24a) standardised full thickness skin defects (down to, but not 
including the panniculus carnosus; Figure 24b,c,d) spaced 2 cm’s apart were created on 




Figure 24 – Detailed photograph of the surgical procedure. (a) A 2x2 cm² square 
was tattooed and (b) a full thickness defect was created along the inner margins of 
the outline. (c) Constructs were implanted into the defect by the placement of 
corner and midway sutures (arrow heads) and a single central quilting suture 
(arrow). (d) Photograph showing the anatomy of the relevant tissue layers: 
integument (IN), panniculus carnosus (PC) and latissimus dorsi muscle (LD). (e) 
Histological transverse cross-section showing the intact integument (IN) and the 
skin equivalent (SE) implanted in the defect over the panniculus carnosus (PC). (f) 
After implantation the wounds were covered with an adhesive occlusive dressing. 
 
Haemostasis of the exposed wound bed was obtained with a disposable cautery pen to 
avoid bleeding under the hybrid construct. Constructs were washed in 0.9% saline to 
remove cell culture media components that might cause an adverse antigenic response. 
The hybrid construct was placed on the wound bed and air pockets were expelled before 
it was fixed into place with eight interrupted stitches (3-0 Vicryl, W9507T, Ethicon) 
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along the edges (four in the corners and four midway along the sides) and one central 
quilting suture (through the panniculus carnosus) (Figure 24c). The hybrid constructs 
were kept humid using 0.9% normal saline throughout the surgery. 
 
The operating time did not exceed 3 hours. Postoperative analgesia was provided by 
two subcutaneous injections of 2.2mg/kg Rimadyl (carprofen, Pfiser Ltd., Sandwich, 
UK) once every 12 hours in the scruff of the neck. The wounds were covered with 
semipermeable adhesive film (Op-Site, Smith and Nephew, Largo; Figure 24f) which 
was secured around the four edges with surgical tape. Rabbits were individually caged 
(Figure 25a) and plastic cone collars were required for the entire length of the study for 
all rabbits to prevent the wounds from being disturbed during grooming (Figure 25b). 
Animals and wounds were inspected daily to ensure that the dressings were intact. 
Dressings were only left on for two days after which they were removed because of the 




Figure 25  – (a) Rabbits were individually caged and had free access to water and 
food. (b) Post-surgery rabbits were fitted with a plastic cone collar (arrow) for the 
further duration of the study to prevent interference of the wounds by grooming. 
 
2.4.4 Tissue harvest and handling 
 
At the end of the study period, the animals were sedated, immobilised, and euthanised 
with an overdose of sodium pentobarbitone (Lethabarb, 2.5 ml, 324 mg/ml, Arnolds, 
Reading, UK) administered intravenously through a marginal ear vein. The wounds 
were excised with a margin of normal skin and the samples were immediately fixed in 
10% (v/v) neutral-buffered formol saline (Genta Medical, York, UK) for 12-24 hours. 
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The fixed tissue was bisected, one half kept for storage for future analysis, and the other 
half again cut in two. The two resulting samples were placed into cassettes processed 




2.4.5.1 Hematoxylin & eosin 
 
Five-micrometer tissue sections were cut and mounted on SuperFrost/Plus slides, air 
dried for 10 minutes and heated in an oven at 60 °C for 30 to 60 minutes. The sections 
were deparaffinised in through three changes of Xylene (for 3 minutes each) and 
rehydrated with 3 minute incubations in a series of decreasing concentrations of IMS 
solutions (100%, 100%, and 70%) and finally tap water. The sections were stained for 
6-8 minutes in Harris’ haematoxylin (nuclear stain), washed in running tap water for 5 
minutes, decolourised/differentiated for 3 seconds in 1% acid IMS, washed in running 
tap water (5 minutes), stained in eosin (ECM stain) for 2-5 minutes, washed in running 
tap water (5 minutes). Sections were then dehydrated through increasing concentrations 
of IMS solutions (70%, 100%, and 100%) and cleared through three changes of Xylene, 
each change for 10 seconds. Cover slips were mounted onto the slides over the tissue 
sections with Depex mounting media. 
 
2.4.5.1.1 Epidermal regeneration 
 
The epidermis has an important function in preventing infection and dehydration, so the 
effect of the various treatment methods on epidermal regeneration was tested. The 
percentage wound coverage by newly formed epithelium was determined by the extent 
of the new epithelial layer divided by the length of the wound, as measured from the 
H&E stained tissue sections. Because of the depth of the wound, no hair growth 
occurred in the newly laid down tissue and thus the wound length was measured as the 
distance between hair follicles (Figure 26). 
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2.4.5.1.2 Wound contraction 
 
To study the influence of the hybrid material on wound contraction the distance 
between the hair follicles in the healed tissue was measured and divided by the original 
wound length (Figure 26). 
 
2.4.5.1.3 Wound composition 
 
The changes in cross sectional area and thickness of newly deposited connective tissue, 
the original wound bed and panniculus carnosus were determined from H&E stained 




Figure 26 – Illustration of the histomorphometric evaluation of the excised wound. 
See text for details (D, dermis; WL, wound length; GT, granulation tissue; PC, 
panniculus carnosus; ER, epidermal regenerate). 
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The outline of each tissue was traced with the in-built function in ImageJ and number of 
pixels representing the cross sectional area was determined by the measure function. 
This value could then be converted to a metric scale using a calibrated image featuring a 
scale bar and taken at the same magnification as the sample image. The thickness of 
each tissue was determined by dividing the cross sectional area by the length of the 
measured area. 
 
2.4.5.2 Collagen birefringence 
 
Collagen maturation is important for the strength of the wound so to study this, the 
change in birefringence of the collagen content was visualised and quantified as it 
matures by picrosirius red staining, polarised light microscopy and image analysis. 
Various types (I, II and III, etc.) of collagen have a natural birefringence which can be 
enhanced by Sirius red staining when viewed in a polarised light microscope. Sirius 
Red, a strong anionic dye, stains collagen by reacting, via its sulphonic acid groups, 
with basic groups present in the collagen molecule. The elongated dye molecules are 
attached to the collagen fibre in such a way that their long axes are parallel. This 
parallel relationship between dye and collagen results in a 5-6 times increase in optical 
retardations (birefringence) of the collagen bundles. 
 
2.4.5.2.1 Picrosirius red staining 
 
A 0.1% Sirius red F3B in saturated aqueous solution of picric acid was made by firstly 
adding approximately 15 gram of wet picric acid to 500 ml distilled water. The solution 
was stirred overnight with a magnetic stirrer. To ensure saturation picric acid was added 
until no more crystals could be dissolved. The final picrosirius  red solution was made 
by dissolving 0.5 gram of Sirius red F3B (C.I. 35782) in the saturated picric acid 
solution.  
 
Five-micrometer tissue sections were cut and mounted, deparaffinised and rehydrated to 
water as described above. The tissue sections were then incubated in the picrosirius red 
solution for one hour at room temperature, washed in two changes of acidified water 
(0.5% acetic acid in distilled water), for three minutes each, washed for 5 minutes in 
running tap water, counterstained with Harris’s haematoxylin for 1 minute, 
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differentiated in 1% acid ethanol for 3 seconds and washed in water for another 5 
minutes. Sections were dehydrated, cleared and mounted as described above. 
 
 2.4.5.2.2 Polarised light microscopy 
 
After picrosirius red staining the birefringence of the collagen in the tissue sections 
were visualised under a polarising microscope equipped with two polarisers (Figure 27). 
A linear polarising filter (polariser; Olympus, Tokyo, Japan) was placed on the 
microscope’s field iris diaphragm ring, below the sample, to provide for the linearly 
polarised illumination of the samples. The analyser (also a linear polarising filter) was 
fitted above the sample (within the intermediate module). The transmission axis of the 
(lower) polariser was rotated such that it was at right angles with that of the analyser. 
This could be determined when the linearly polarised light was completely extinguished 




Figure 27 – Illustration of the principal behind polarised light microscopy. (a) 
Natural light is polarised by a linearly polarising filter (i.e. polariser) parallel to 
the transmission axis. (b) This linearly polarised light beam is then transmitted 
through the specimen (Sirius red stained collagen) and is refracted in an ordinary 
and an extra-ordinary ray which move out of phase depending on the degree of 
birefringence and the thickness of the specimen. As they pass through the second 
polariser (i.e. analyser) they interfere either destructively or constructively 
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depending on the phase difference and an image is created resulting from the 
unequal transmission of the components of the polychromatic light. 
 
To enable an objective quantitative assessment, slides were captured with a digital 
camera (2.11 megapixel, 1600x1200-pixel, Olympus C-2020 Zoom, Japan) mounted on 
the microscope. Up to ten fields were captured from each slide under 20x objective, and 
all slides were photographed on the same day to avoid any variability associated with 
the light source. 
 
2.4.5.2.3 Image analysis 
 
Picrosirius red stained collagen fibres viewed under polarised light show different 
polarisation colours (or hues) depending on the thickness and packing of the collagen 
fibrils. As the fibre thickness increases, the colour changes from green to yellow to 
orange to red. To evaluate collagen maturation in tissue samples, their interference 
colour patterns were recorded as 24-bit digital RGB (red, green, and blue) photographs. 
These images were converted to the an 8-bit colour space using the build in “HSB 
Stack” command in the image analysis tool ImageJ (NIH, USA). This command 
transforms the image into a stack of 3 channels, each channel representing one of the 
three perceptual colour attributes: hue, saturation and brightness (HSB). 
 
The analyses were performed on the hue channel as this contained the pure colour 
information and the latter two channels were discarded. The transformation from the 
RGB to the HSB colour space reduces the colour palette from 16.7 million (24-bit) to 
256 (8-bit) values (Figure 28a). Using the threshold function in ImageJ the minimum 
and maximum values of each colour range of interest still perceive as that particular 
colour were defined (Figure 28a): 2-9 and 230-256 for red, 10-38 for orange, 39-51 for 
yellow and 52-128 for green. The hue ranges 1-2 and 129-229 consisted of non-
birefringent tissue elements. 
 
The number of pixels within each colour range was determined by the in-built measure 
function (Figure 28b-d). The red and orange hues represent the thicker collagen fibrils 
whereas the yellow and green hues represent the thinner collagen fibrils. Collagen 
maturation was expressed as the ratio between the amounts of thick fibrils to thin fibrils. 
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The collagen content was determined by the total number of pixels representing an 




Figure 28 – Analysis of birefringence within tissue samples using image analysis 
software. (a, b) The RGB (red, green, and blue) colour space (16.7 million colours) 
in which the micrographs were photographed was converted into a (a, c) HSB 
(hue, saturation and brightness) colour space (8-bit; 256 colours). The 
(birefringent) colours of interest (i.e. red, orange, green and yellow) were 
numerically defined (see ‘a’) and measured in the HSB channel (d, an example is 
given for the colour green). 
 




Tissue sections were stained with a mixture of mouse monoclonal anti-human (with 
cross reactivity to rabbit antigens) (catalogue number NB120-11213, Novus 
Biologicals, Cambridge, UK) antibodies (immunoglobulin G, IgG) directed against 
cytokeratins (1, 4, 5, 6, 8, 10, 13, 18, and 19) expressed in the cytoplasm of epithelial 
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cells. The labelling of antigens by the antibodies was visualised with a polyclonal goat 
anti-mouse IgG conjugated to the fluorescent marker fluorescein isothiocyanate (FITC) 
(catalogue number F-4018, Sigma-Aldrich Co. Ltd., Dorset, UK). See Figure 29 for an 




Figure 29 – Illustration showing the main principle behind immunofluorescence 
(IF) and immunohistochemistry (IHC). In both IF and IHC a primary antibody 
(monoclonal) attaches to an antigen of interest after which a secondary antibody 
(polyclonal) conjugated with a visualising system is attached to the primary 
antibody to visualise the location of the antigen. In IF the secondary antibody is 
conjugated to a fluorescent molecule whereas in IHC it is conjugated with biotin 
which binds to a preformed biotinylated avidin-horseradish peroxidase (HRP) 
complex which converts the colourless substrate into a coloured reaction product. 
As avidin binds to four biotin molecules the reaction is enhanced by the localised 
complexion of an accumulated ‘cloud’ of HRP enzyme. 
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Five-micrometer tissue sections were cut and mounted, deparaffinised and rehydrated to 
water as described above. To prevent non-specific binding of the antibodies non-target 
proteins on the samples were blocked by incubation at room temperature for 30 minutes 
in 1.5% normal goat serum diluted in washing buffer (i.e. PBS) after which time the 
sections were washed with PBS three times. The samples were incubated with primary 
antibody diluted in washing buffer (100 µl) at a concentration of 1:100 (v/v) for 30 
minutes at room temperature. Samples were then washed and incubated with the FITC 
conjugated secondary antibody at a concentration of 1:200 for 30 minutes at room 
temperature in the dark followed by a further three washes in PBS. The specimens were 
then mounted using Vectashield® with 4',6-diamidino-2-phenylindole (DAPI, catalogue 
number H-1500, Vector Laboratories, Peterborough, UK). Rabbit skin was used as a 
positive control and rabbit skin with the primary antibody omitted was used as a 
negative control. Specimens were stored in the dark prior to examination using a 
fluorescence microscope (Olympus). Images at 200x magnification (20x objective; 




Tissue sections were stained with a mouse monoclonal anti-rabbit CD31 (Abcam, 
catalogue number ab9498, Cambridge, UK) antibody (IgG) directed against the platelet 
endothelial cell adhesion molecule (PECAM-1) expressed on the surface of endothelial 
cells, and with a mouse monoclonal anti-rabbit CD45 (catalogue number MCA808G, 
Serotec, Oxford, UK) antibody (IgG) directed against the pan leukocyte marker protein 
tyrosine phosphatase, receptor type, C expressed on the surface of all hematopoietic 
cells (except for erythrocytes and platelets). The labelling of antigens by the antibodies 
was visualised with the VECTASTAIN Elite ABC Kit (catalogue number PK-6102, 
Vector Laboratories, Peterborough, UK). See Figure 29 for an overview of the 
immunohistochemistry technique. 
 
Five-micrometer tissue sections were cut and mounted, deparaffinised and rehydrated to 
water as described above. It was then necessary to perform an antigen retrieval step for 
both antibodies. This was achieved by incubating the specimens in a sodium citrate 
buffer (0.01M Sodium Citrate, 0.05% Tween-20, pH 6.0) in a steamer; 40 and 20 
minutes for CD31 and CD45 respectively. The samples were allowed to cool in the 
antigen retrieval solution for 10 minutes by removing the steaming to room temperature 
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after which samples were washed for 5 minutes in Tris-buffered saline (TBS) with 
Tween (50 mM Tris Base, 150 mM NaCl, 0.05% Tween-20, pH 7.6) with constant 
agitation. 
 
To prevent non-specific binding of the antibodies non-target proteins on the samples 
were blocked by incubation at room temperature in 1.5% normal horse serum (Vector 
Laboratories, Peterborough, UK) diluted in washing buffer. Samples were washed in 
TBS for 5 minutes with constant agitation. The samples were incubated overnight at 
4°C in primary antibody diluted in washing buffer (100 µl) at a concentration of 1:25 
(v/v) for CD31 and 1:75 (v/v) for CD45. Samples were washed and incubated in 3% 
hydrogen peroxide for 30 minutes at room temperature in the dark to block the 
endogenous peroxidase activity. Samples were washed and incubated for 30 minutes at 
room temperature with a horse anti-mouse polyclonal, biotinylated secondary antibody 
(diluted 1:200 in washing buffer) according to the specifications of the manufacturer. 
Samples were washed and then incubated for 30 minutes with the avidin/biotin complex 
(ABC Reagent, Vector Laboratories, Peterborough, UK). Samples were washed and 
incubated for 10 minutes in the dark at room temperature in 3,3'-diaminobenzidine 
(DAB peroxidase substrate solution, catalogue number PK-4105, Vector Laboratories, 
Peterborough, UK). 
 
Samples were washed and incubated for 6 minutes in a 0.5% (w/v) copper sulphate 
(CuSO4 · 5H2O) in 0.9% (w/v) NaCl to enhance the colour of the DAB-horseradish 
peroxidase reaction product to a dark brown. Samples followed by washing in running 
tap water and counterstained with Harris’s haematoxylin for 1 minute, wash in 1% acid 
ethanol for 3 seconds and wash well with water. Sections were then dehydrated, cleared 
and mounted, as previously described. 
 
Positive and negative controls were included in all staining runs. Negative controls 
constituted samples where the primary antibody incubation step was omitted (and 
replaced with washing buffer) and positive controls were tissue samples where the 
targeted antigen was present; spleen and liver for CD45 and CD31 respectively. 
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2.4.6.3 Image Analysis 
 
2.4.6.3.1 Angiogenic response 
 
ImageJ was used to determine the average number and the size of vessel cross sections 
in each image (20x objective; Figure 30a). The in-built ‘colour deconvolution’ function 
allowed us to separate the brown of the DAB reaction product and the blue of the 
haematoxylin counterstain into separate channels. The DAB channel was then selected 
and automatically thresholded using the “Make Binary” command which uses an 
iterative procedure based on the iso-data algorithm to divide the image into objects and 
background (Figure 30b). These black and white images were visually compared with 
the original RGB images from the digital camera to detect nonspecific selection. The 
lumina of the cross sections were filled using the “fill holes” command and the number 
of cross sections and the average cross sectional area (i.e. luminal area and endothelial 




Figure 30 –Tissue sections stained for CD31 positive endothelial cells (with DAB) 
were (a) photographed and, using image analysis software, the staining was 
converted, in three steps (see text for details), into (b) black areas representing 
blood vessel cross sections comprising an endothelial cell mass and (when present) 
a lumen. (c) The number and the total area of the blood vessel cross sections per 
area were then calculated. 
 
2.4.6.3.2 Inflammatory response 
 
To quantify the inflammatory response the number of nuclei per image and the number 
of DAB stained cells (i.e. CD45 positive leukocytes) were counted using the “cell 
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counter” plugin in ImageJ (Figure 31). The percentage of leukocytes was determined by 




Figure 31 - Figure 30 – (a) Immuno-histochemical detection of CD45-positive 
leukocytes using DAB visualisation. (b) Visual output of the ‘cell counter’ plugin 
showing the stained cells that were manually marked for inclusion in the total 
count. (c) The visual output for haematoxylin stained nuclei. 
 
2.5 Statistical analysis 
 
The data were analyzed using the Statistical Package for the Social Sciences software 
program (SPSS, version 13.0, Chicago, IL, US). For all analyses, statistical significance 
was set at the 0.05 level. 
 
A normal (or t) distribution (with a particular mean and variance) was assumed of the 
(in vitro) variables of interest and parametric tests were used to test the difference 
between two (t-test for independent samples) or more means (analysis of variance; 
ANOVA). When performing the t-test, the Levene's test was used to test the assumption 
of equal variances (or homogeneity of variance) and to correct for and if unequal 
variances were detected. If differences were detected by ANOVA analysis, a Tukey-
HSD (Honestly Significant Difference) or a Bonferroni post hoc test was applied to 
identify those differences. 
 
For the in vivo experiments six repeats of one condition at one time point were tested in 
a single rabbit and, therefore, a two-way (treatment modality and time) multilevel 
repeated measures ANOVA (RM-ANOVA) was used to analyse the data. Significant 
multilevel main effects were followed up with a Bonferroni post hoc test. Significant 
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interaction effects were followed up by testing the simple main effects (i.e. one-way 
ANOVAs for each factor, treatment modality and time, conducted separately at each 




3.1 Collagen hydrogel compression 
 
3.1.1 Compression of large volume hydrogels 
 
Collagen (type I) monomers can be extracted from non-cross-linked fractions of 
collagenous tissues (Bailey et al., 1998) (such as is abundant in the tendon found in tails 
of young rats) by dissolution in dilute acid (such as acetic acid) and reconstituted into 
fibrils (with a structure similar to those found in native tissue) by neutralisation of the 
acid solubilised monomeric collagen solution with sodium hydroxide (Francis et al., 
1942). 
 
This spontaneous fibrillogenesis that occurs at neutral pH results in a collagen hydrogel 
consisting of a loose lattice network of collagen fibrils (held together by non-covalent 
fibril-fibril interactions (Rosenblatt et al., 1994) and physical entanglement) surrounded 
by a high-volume of non-structural water (as a result of the extraction and reconstitution 
process). The interstitial fluid has an inhibitory effect on the formation of these inter-
fibrillar attractive forces resulting in poor mechanical properties of the gel. It has been 
shown that mechanical loading of the collagen hydrogels (Brown et al., 2005) can expel 
the interstitial fluid content thereby, increasing the collagen fibril packing density, 
raising the frequency and strength of inter-fibrillar interactions, and producing 
mechanically strong collagen hydrogels in a matter of minutes. 
 
This technique involves the application of a gravitational load (of 1.8 kN/m²) for a 
predetermined time period (of 5 minutes) on the apical surface of a rectangular, 
unconstrained (not confined at the sides) collagen hydrogel seated on top of (porous) 
blotting elements (a standard setup of nylon and metal mesh, and filtration paper 
sheets). The dual action of the compressive load and the negative capillary pressure 
(exerted by the blotting elements) produces a phase separation that involves the outflow 
of the fluid content (mainly) through the basal surface of the hydrogel (referred to as the 
FLS) and concomitant retention and increase in concentration of collagen fibrils. The 
technique has only been tested on collagen hydrogels with a 3-ml volume and an FLS 
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area of 4.3 cm² (or 0.7 ml per cm² FLS area) which after the compression have a 
thickness of approximately 30 µm. 
 
A preliminary study in (an ex vivo rabbit model of) a full thickness skin defect 
(measuring 3 x 2 cm²) to test the feasibility of the use of the compressed collagen sheet 
as a skin implant showed that the fragile material was easily cut by running a suture (a 
4/0 prolene suture) through and that after implantation the collagen sheet easily pulled 
away from the stitches when only a small strain (of approximately 20%) was applied to 
the wound (Figure 32). Therefore, although the material strength (determined by the 
material breaking load per material cross sectional area) of these compressed collagen 
sheets approaches that of native tissues, they are, because of their thickness, fragile and 




Figure 32 – (a) Rabbit model of a full thickness skin defect. (b) Compressed 
collagen sheet placed onto the defect and sutured in place. (c) Manually applied 
strain of 20% tears the collagen sheet away from the stitches (arrow heads). 
 
From the basic rules of physics, the suture holding capacity or material breaking load 
can be improved, provided that the UTS (determined here by the collagen fibril density) 
remain constant, by simply increasing the thickness (or cross sectional area) of the 
compressed collagen gels, as F,break = UTS × (material cross sectional) Area. The 
increase in thickness has previously been achieved for the (0.7 ml/cm²) compressed 
collagen gel by rolling the collagen sheets (along their short axis) into rods (Brown et 
al., 2005) allowing the collagen material to be sutured and implanted in vivo (Mudera et 
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al., 2007). The rolling of the sheets, however, is not conducive to the creation of 
epithelial like structures. 
 
Now, the hypothesis under test is that the break strength can be improved, provided that 
the UTS (or collagen fibril density) remains constant, by increasing the thickness of the 




3.1.2 Non-linear relationship of hydrogel volume to fluid loss 
 
The hypothesis under test is that the thickness and therefore break strength of a 
compressed collagen hydrogel can be improved by increasing the pre-compression 
volume per FLS area provided that the UTS remain constant. It has previously been 
shown that the UTS of the compressed collagen gel is determined by the collagen fibril 
density which is inversely related to the percentage fluid expulsion (Neel et al., 2006). 
Therefore the time that a constant, gravitational load is applied for on the hydrogel 
(which determines the percentage fluid loss) is an important parameter to control when 
changing the pre-compression volume. To ask the question if a fold increase in the pre-
compression collagen volume requires the same fold increase in compression time to 
result in a pre-determined percentage fluid loss, the compression (under a constant load 
of 1.8 kN/m²) of three incremental volumes (1.95, 2.60 and 3.25 ml/cm²; a fixed 
increment of 0.65 ml/cm²) was studied (over a 25 minute compression period). 
 
In the previously established regime the collagen gels were compressed in an 
unconstrained configuration (Figure 9a). This assumes minimal loss of fluid through the 
very low surface area of the vertical edge surfaces. However, due to the height to base 
ratio of the tested volumes the collagen hydrogels had to be laterally confined over the 
compression process in a custom built chamber to prevent the gel body from buckling 
(Figure 10b). The vertical load was applied by a free gliding plunger while the gels were 
seated on the standard setup of blotting elements (nylon and metal mesh, and filtration 
paper sheets). The vertical displacement (or height loss) of the plunger was used as an 
indirect measure of the percentage (of the initial volume) fluid loss and recorded over 
time.  
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A graphical representation of the percentage fluid loss of the three increased volume 
collagen hydrogels is given in Figure 33. It shows that it required a disproportionally 
larger unit increase in time for every unit increase in collagen volume to result in a set 
percentage of fluid removal. An example of 75% fluid loss is given in Figure 33; 
increasing the volume from 1.95 (by 0.65) to 2.60 ml/cm² increases the compression 
time required for a 75% loss in volume by 55%. An additional increase in volume by 
0.65 ml/cm² (to 3.25 ml/cm²) increases this time by 270%; a 5-fold increase. 
Additionally, a logarithmic relationship was found between the percentage fluid loss 
and compression time. The slope of the curves represents the respective rates (i.e. 
change in percentage fluid loss divided by the time in which this change occurred) at 
which fluid leaves the three hydrogels and it can be observed that every unit volume 
fluid outflow from the collagen hydrogels is accompanied by a unit decrease in the rate 




























Figure 33 – A non-linear increase of compression time (t1-3) of collagen hydrogels is 
required for every unit (here 0.65 ml/cm²) increase in collagen volume (per fluid 
leaving surface area; ml/cm²) to achieve the same percentage (e.g. 75%) fluid loss. 
Values are means ± SD for 3 hydrogels for each volume. 
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The expulsion of the fluid content from a compressed collagen hydrogel can be 
described by the physical concept of volumetric flux (or fluid expulsion rate) which is 
defined as the amount of volume that flows through a unit area (in this case the size of 
the FLS) per unit time; flux = volume / time / area. This model suggests that at a 
constant flux and constant (FLS) area every fold increase in volume requires the same 
fold increase in time to allow for this volume to be expelled. The results here show, 
however, that as the compression progressed the rate of fluid expulsion (or flux) 
reduced and every unit increase in pre-compression volume required a disproportionally 
larger unit increase in compression time to obtain a set percentage of fluid removal.  
The fluid expulsion (flux) from a collagen hydrogel can modelled with Darcy’s law for 
flow through porous media (flux = permeability x pressure / viscosity). From this model 
it can be appreciated that the decreasing fluid expulsion rate over the compression 
process could be the results of a mass-transfer dependent decrease in permeability (of 
the FLS) or pressure (driving fluid expulsion) and/or of a mass-transfer dependent 
increase in viscosity (of the fluid expelled). 
 
 
3.1.3 Fluid saturation of blotting elements and fluid outflow 
 
From Darcy’s law it follows that the mass-transfer dependent decrease in fluid 
expulsion from collagen hydrogels could be caused by a decreasing operating pressure. 
The pressure driving fluid expulsion is generated by the gravitational load (which is 
constant, 1.8 kN/m²) and the negative capillary action exerted by the absorbent 
components of the blotting elements (nylon mesh and filtration paper sheets). The 
gravitational load is constant over the compression process, but fluid saturation of the 
absorbent components could, result in a mass transfer dependent reduction in capillary 
pressure leading to the declining fluid expulsion rate. To ask the question if fluid 
saturation of the absorbent components causes the mass transfer dependent decrease in 
the fluid expulsion rate, the confined compression (1.8 kN/m²) was studied and 
compared to collagen hydrogels (2.67 ml/cm²) seated on; (a) the standard setup of nylon 
and metal mesh and three filtration paper sheets, and (b) a modified setup (as the 
standard setup but without the absorbent components); i.e. only metal mesh. The 
vertical displacement (or height loss) of the plunger (load) was used as an indirect 
measure of the percentage (of the initial volume) fluid loss and recorded over time.  
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A graphical representation of the results (Figure 34) show that when the support on 
which the hydrogels were compressed did not feature the absorbent elements the 
relationship between fluid loss and time shifted to the left- and upward but remained 
logarithmic and did not become linear. The slope of the curves represents the fluid 
expulsion rate (flux) from the collagen hydrogels and the shift indicated a higher flux 
from gels compressed on the modified support than on the standard setup of blotting 
elements. An example is given in Figure 34, showing (a 50%) reduction in the required 
time to achieve a 75% fluid loss when the absorbent components were removed. It was 
noted that in the two studied setups the direct interface through which fluid is expelled 
from the gel was more porous for the modified (metal mesh) than the standard setup 
(nylon mesh); average pore size of 300 vs. 50 µm. It is assumed that this difference 


























Figure 34 – Representative plots of fluid expulsion from collagen hydrogels under 
confined compression on two different types of blotting elements. Fluid saturation 
of the blotting elements does not influence the logarithmic relationship between 
fluid loss and time.  
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These results suggest that the supporting blotting elements do influence (by their 
porosity) the outflow of fluid, but this influence appears to be constant (mass transfer 
independent) over the compression as the removal of these components does not 
prevent the change in the fluid expulsion rate over the compression process excluding 
fluid saturation (and concomitant decrease in capillary pressure) of the blotting elements 
as a cause for this phenomenon. 
 
3.1.4 Anisotropic collagen compaction 
 
Following from Darcy’s law (flux = permeability x pressure / viscosity) the decreasing 
rate in fluid expulsion over the compression process could result from a mass transfer 
dependent decrease in permeability (of the FLS). It is possible that the increase in 














Figure 35 – (a) Photograph of a collagen hydrogel marked with charcoal particles 
(white arrow heads) (FLS, fluid leaving surface) (b) Binarised photographs 
showing the change in distance (δy1,2) between markers trapped inside a collagen 
gel at various time points of confined compression (white arrows show the 
direction of compression). 
 
To determine in a quantitative manner the changes in collagen density over the 
compression process markers (charcoal particles) were incorporated (during the 
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polymerisation process) in a (3.25 ml/cm²) collagen hydrogel cast in a transparent 
(cylindrical) chamber (Figure 35a) and tracked over the confined compression process 
(driven by the gels own weight and the negative capillary pressure from the blotting 
elements) (Hadjipanayi and Ananta, et al., 2010). 
 
A subset of the markers would float to the surface of the gel within the first few minutes 
of the polymerisation process but after the standard 30 minute incubation period no 
spontaneous displacement could be observed suggesting that the markers were fixed 
into the collagen network. Figure 35a shows that at the start of the compression (t0) the 
markers were randomly distributed throughout the gel body. As the compression 
progresses the densification of collagen in and fluid loss from various regions could be 
determined from the decrease in the vertical distance (δy) between arbitrarily chosen 

























Figure 36 – (a) A vertical bar graph. Each bar represents the height of a collagen 
hydrogel at different times during confined compression. The two horizontal lines 
with the bars represent the position of two arbitrarily selected markers within the 
gel. Collagen above these markers does not compact until the markers reach the 
basal fluid leaving surface. 
 
Figure 36a illustrates the example of how two arbitrarily chosen divide the collagen 
hydrogel into three regions and Figure 36b shows that these three regions decreased in 
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height not in parallel to each other but in sequence, contributing sequentially to the total 
amount of fluid loss. For instance, it is not until the bottom region (region 1) has 
reached its maximum compression level that the second region (region 2) will begin to 
decrease in volume. All the while the top region (region 3) remained at its original 
volume until also the second region (region 2) had been completely compacted. 
 
From the change in the pattern of marker positions over the compression process, it was 
found that fluid loss did not occur homogenously throughout the entire height of the 
collagen and two distinct regions with different macroscopic responses could be 
distinguished; the bulk region and a small boundary region at the FLS. The bulk region 
was characterised by its tendency to retain its original height with no change in the 
relative distances between the markers (suggesting little or no compaction occurring in 
this region). In contrast, the FLS region showed a continuous accumulation of markers, 
suggesting that collagen compaction in a compressed collagen gel is highly localised at 




Figure 37 – (a) Scanning electron micrograph of a transverse cross-section of a 
3.25 ml/cm² collagen hydrogel sequentially compressed on its basal and apical 
horizontal surface to achieve a near 100% strain level. Scale bar measures 50 µm. 
(b) At higher magnification the lamellar structure formed by the compression 
process can be observed within the hydrogel. Scale bar measures 10 µm. 
 
The material structure in cross sections of compressed (3.25 ml/cm²) collagen hydrogels 
was visualised by SEM to test if indeed a dense boundary collagen layer had formed at 
the FLS. Figure 37a shows that in cross section two distinct regions could be 
distinguished. In the largest region (compressed region), located at the FLS, lamellar 
A B 
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structures were visible throughout while furthest away from the FLS a more amorphous 
(uncompressed) region could be seen. At higher magnification (Figure 37b) the lamellae 
could be seen becoming denser in the direction of the compression with the densest 
layers forming at the FLS. 
 
It is concluded that the compression of collagen hydrogels does not result in a global 
compaction of the collagen matrix but in one localised to the FLS. Only a fraction of the 
total volume is available for flow. And it is proposed that with every unit fluid expelled 
a unit decrease in hydraulic permeability and fluid outflow rate occurs due to the local 
accumulation of collagen at the basal FLS.  
 
 
3.1.5 Sequential fluid expulsion through two fluid leaving 
surfaces 
 
It was found increasing the pre-compression collagen hydrogel volumes extends the 
required compression time under a constant load in a non-linear fashion due to the 
decrease in hydraulic permeability of the FLS caused by the accumulation of collagen at 
this surface. This could set limitations to the maximum volume that could be 
compressed without applying a load that exceeds the maximum stress that for instance 
cells embedded in the hydrogel could tolerate. As it is not technically possible to 
prevent the formation of the collagen barrier at the FLS, short from not performing the 
compression, increasing the total FLS could prove beneficial to shorten the compression 
time and double the maximum hydrogel volume that can be maximally compressed by a 
given load. 
 
From the previous experiment (Figure 33) it can be seen that for a (laterally confined) 
3.25 ml/cm² collagen hydrogel compressed with a constant load of 1.8 kN/m² it required 
towards 30 minutes to achieve the near complete removal of the fluid content through 
its basal surface, but towards only 10 minutes for the removal of half the content. 
Therefore the hypothesis under test is that it would require only 20 minutes for the near 
complete removal of the fluid content of a 3.33 ml/cm² collagen hydrogel through two 
FLSs as opposed to the 30 minutes in a single FLS configuration. To test this, a constant 
load was applied for exactly 10 minutes on the gel to remove the first half of the fluid 
content through the basal FLS and then turned the gel on its apical surface and 
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continued the compression for an additional 10 minutes to remove the second half. This 
regime resulted in a 98.9 ± (SD) 0.5% weight (fluid) loss (values derived from 20 
samples). 
 
It was found that the time required to achieve a set percentage fluid loss through a 
single FLS of a collagen hydrogel compressed under a constant load was shortened 
when the FLS area was increased by the utilisation of a second FLS. This strategy has 
important practical implications with regards to up-scaling the technique as it would 
theoretically double the maximum volume that could be fully compressed under a given 
load. Additionally, the findings add to the evidence that the decrease in hydraulic 
permeability of the FLS was mass transfer dependent. 
 
 
3.1.6 Characterisation of compressed large volume hydrogels 
 
The hypothesis under test is that the break force of compressed collagen hydrogels can 
be increased by improving the size properties of compressed collagen hydrogels by way 
of raising the pre-compression volume. As the UTS is determined by the break force 
(F,break) per cross sectional area, an increase in break force (F,break = UTS x Area) can 
only be obtained if the cross sectional area can be increased without significantly 
reducing the UTS of the material. 
 
To test this hypothesis 3.33 ml/cm² collagen hydrogels was compressed using the 
regime described above (1.8 kN/m² applied for 10 minutes on the basal and then apical 
FLS) and compared the mechanical properties of the resulting sheets to those of 0.7 
ml/cm² gels that were compressed with the previously established protocol (1.8 kN/m² 
applied for 5 minutes on the basal FLS). The 5-fold increase in pre-compression volume 
resulted in an equal fold increase in thickness of the resulting collagen sheet [489 ± 
(SD) 160 µm vs. 95 ± 15 µm, t (8.9) = 9.48, p < 0.001]. 
 
The ‘thin’ (0.7 ml/cm²) collagen constructs were fragile, difficult to handle and had to 
be spiralled to facilitate comparison of the tensile properties by DMA with the ‘thick’ 
(3.33 ml/cm²) constructs which were more robust. The ‘thin’ collagen constructs (Figure 
38a) had a higher UTS compared to the ‘thick’ constructs (Figure 38b) as measured by 
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the ultimate strength [1.28 ± 0.42 vs. 0.54 ± 0.06 MPa); t (10) = 3.91, p = 0.003] and 










































































Figure 38 – Representative stress-strain curves for (a) compressed 0.7 ml/cm² 
(spiralled) and (b) 3.33 ml/cm² (thick) collagen hydrogel showing the toe region, 
the yield and break point. (c, d) Box and whisker plots showing the spiralled 
collagen gels had better mechanical tensile properties than thick collagen 
constructs. The boxes indicate the 75th and 25th percentiles, the whiskers indicate 
the minimum and maximum values, the lines show the median values. Values are 
derived from 7 samples for spiralled constructs and 5 samples for thick constructs. 
Asterisks above graphs indicate significance level (*, p < 0.05; ** p < 0.01). 
 
Additionally, the ‘thin’ constructs had greater stiffness (resistance to deformation; 
Figure 38c) than ‘thick’ constructs [2.38 ± 0.51 vs. 1.90 ± 0.08 MPa); t (6.5) = 2.42, p = 
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0.049]. The ductility (amount of deformation before failure; Figure 38d) of the ‘thin’ 
constructs was also found to be higher, as measured by ultimate strain [68.9 ± 14.1 % 
vs. 39.3 ± 5.3%); t (8) = 4.39, p = 0.002] and the yield strain [47.9 ± 11.5 % vs. 29.6 ± 
3.5 %); t (4.7) = 3.39, p = 0.021]. Although the rolled ‘thin’ collagen constructs showed 
superior mechanical properties over the ‘thick’ collagen constructs the latter showed 
smaller variations in these properties. 
 
These differences in mechanical properties could be attributed to the difference in 
collagen density. It was found that although the (absolute) pre-compression volumes of 
both ‘thin’ and ‘thick’ constructs were the same [5.15 ± 0.16 ml vs. 5.04 ± 0.44 ml, t 
(23.7) = 1.29, p = 0.21], the percentage fluid loss was higher for the ‘thin’ constructs 
[99.30 ± 0.22% vs. 98.91 ± 0.52%, t (25.9) = 3.09, p = 0.005] resulting in a lower post-
compression weight [43 ± 13 mg vs. 33 ± 5 mg, t (12) = 2.69, p = 0.02] suggesting that 
the ‘thin’ construct had a higher average collagen density. 
 
Summarising, the thickness of compressed collagen gels were increased 5.1-fold by 
raising the pre-compression volume. Although the mechanical strength of these thicker 
collagen constructs was 2.4-fold lower than the ‘thin’ collagen constructs (following 
from F,break = UTS x Area) the implied break force was 2.2-fold higher than the ‘thin’ 
collagen constructs.  
  
The break force of compressed collagen hydrogels were increased by improving the size 
properties of compressed collagen hydrogels by way of raising the pre-compression 
volume. The data underlines the relationship between strength and collagen density and 
the importance of precise control over the percentage fluid removal. 
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3.2 Hybrid constructs 
 
3.2.1 Hybridisation of compressed collagen hydrogels 
 
Fabricating sutureable collagen constructs by way of mechanically compressing large 
volume collagen hydrogels has certain technical limitations. A second strategy was 
therefore investigated that involved the incorporation of degradable synthetic organic 
polymer meshes in compressed collagen hydrogels. The hypothesis under test is that 
synthetic polymer meshes can be embedded in collagen hydrogels and the resulting 
hybrid material can be mechanically compressed to produce constructs that can be 
sutured and implanted.  
 
 
3.2.2 Fluid removal from a PLACL-CCHH 
 
Initially a mesh produced from a newly developed, slow degrading PLACL co-polymer 
was used to test the hypothesis. The co-polymer was made from 3% L-lactide and 97% 
ε-caprolactone, degrades by simple hydrolysis, and based on its composition the 
expected time for it to completely degrade is between 6 to 12 months. 
 
A brief description of the textiles and the fabrication of the mesh is given here. The 
PLACL co-polymer was melt spun into yarns consisting of 25 filaments each. Each 
filament had a linear density of 6.6 dtex (decitex; grams per 10³ meter length), a 
diameter of 28.4 µm, and each yarn had, a total finess of 165 dtex, a tenacity (i.e. 
breaking load per unit linear density of the unstrained specimen) of 19.5 ± (SD) 0.9 
cN/tex (centinewton per tex), and an elongation at break of 41.1 ± 2.3%. The 
multifilament yarns were processed into meshes [thickness 0.63 ± (SD) 0.02 mm] with a 
weft-knit. It should be noted that the PLACL co-polymer was synthesised in by Uppsala 
University (Uppsala, Sweden) and that the co-polymer was melt-spun and weft-knitted 
into the mesh by Aachen University (Aachen, Germany). 
 
The following protocol was used to test for the feasibility of forming a PLACL-CCHH 
material using the compression technique. A 0.7 ml/cm² collagen hydrogel was cast, a 
PLACL mesh was placed on top, and a second 0.7 ml/cm² collagen volume was cast. 
After a 30 minute incubation period the resulting hybrid materials were subjected (in an 
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unconfined configuration) to a 1.8 kN/m² load for 5 minutes to remove the fluid content 
of the collagen components. What resulted was a PLACL-CCHH consisting of the mesh 
coated on both surface with compressed collagen hydrogels (further characterisation 
described below). 
 
Although the collagen density with the incorporation of a synthetic backbone is no 
longer critical for the sutureability of the construct the control of this parameter still has 
important implications with regards for instance to the induction of stiffness specific 
cell phenotypes and the integration strength between collagen and mesh. 
 
Previously it was shown for a collagen hydrogel compressed on blotting elements that 
an increase in compressive load increased the rate of weight loss (Neel et al., 2006). To 
test if the presence of the PLACL mesh prevented the expulsion of fluid and 
compaction of collagen, possibly through some sort of splinting action preventing the 
transmission of the mechanical load onto the hydrogel at high levels of compaction, the 
compression was compared of PLACL-collagen hybrid constructs loaded with a 
constant load of 1.8 and 3.6 kN/m² for a time period of 5 and 10 minutes.  
 
The percentage weight (fluid) loss was recorded and the results were subjected to a two-
way ANOVA having two levels of load (1.8 and 3.6 kN/m²) and two levels of time (5 
and 10 minutes). All effects were statistically significant at the .05 significance level. 
The main effect of time on the post compression weight yielded an F ratio (probability 
information provided by ANOVA) of F (1, 8) = 120, p < 0.001 (Figure 39), such that 
the average percentage weight loss was significantly higher when the construct was 
loaded for 10 minutes (mean, M = 98.9%; standard deviation, SD = 0.1%) then for 5 
minutes (M = 98.3%, SD = 0.1%). There was no significant main effect of load on the 
final weight, F (1, 8) = 0.3, p = 0.580. Additionally, no significant interaction effects 




























Figure 39 – Bar graphs showing the amount of fluid removed from PLACL 
hybridised collagen gels (1.4 ml/cm²) expressed as the percentage weight loss 
resulting from an unconfined compression with a gravitational load of 1.8 or 3.6 
kN/m² for 5 or 10 minutes. Values are means ± SD for 3 samples. Asterisks show a 
significant main effect of time on weight loss (*, p < 0.001). 
 
The data suggested that at a near maximum compaction level of the collagen component 
in the PLACL-CCHH the previously described load dependent removal of the fluid 
content appeared to be inhibited; increasing the load did not result in a higher 
percentage fluid loss unless the compression time was increased. This suggested that 
this level of compaction fluid outflow was governed by the capillary action of the 
blotting elements and no longer by mechanical loading; the compaction had became 
time dependent. 
 
It is concluded that at high levels of collagen compaction (> 98%) fluid loss from the 
gel component of the PLACL-CCHH  was not dependent on the size of the compression 
load (in the range of 1.8 and 3.6 kN/m²) but on the compression duration relying on 




3.2.3 Physical characterisation of PLACL- and PLGA-CCHHs 
 
Compressed collagen hydrogels were also hybridised with a PLGA (Vicryl) co-polymer 
knitted mesh to form a PLGA-CCHH construct to allow for a comparison of the 
suitability of the newly developed PLACL mesh for TE purposes with this well 
characterised and commercially available PLGA mesh. 
 
The PLACL mesh (Table 1, Figure 40a) had a lower porosity (defined as the ratio of the 
area of the voids and the total area) [16 ± 1 (SD) % vs. 46 ± 1 %, t (9) = 62.0, p < 0.001] 
and a smaller average pore size [0.55 ± 0.03 mm² vs. 0.04 ± 0.02 mm², t (54) = 112.0, p 
< 0.001] and a lower thickness [0.63 ± 0.02 mm vs. 0.15 ± 0.01 mm, t (54) = 112.0, p < 
0.001] than the PLGA mesh (Figure 40b). 
 
Mesh properties PLACL PLGA 
Pattern Tricot knit Tricot knit 
Yarn diameter (µm) 270 100 
Pore size (mm²) *** 0.04 ± 0.02 0.55 ± 0.03 
Porosity (%) *** 0.16 ± 0.01 0.46 ± 0.01 
Mesh thickness (mm) *** 0.63 ± 0.02 0.15 ± 0.01 
   
Compressed collagen dimensions PLACL-hybrid PLGA-hybrid 
Thickness apical compartment (mm) 0.09 ± 0.01 0.10 ± 0.02 
Thickness basal compartment (mm) * 0.07 ± 0.01 0.09 ± 0.02 
   
 
Table 1 - Poly-[lactic acid-co-caprolactone] (PACL) and poly-[lactide-co-glycolide] 
(PLGA) meshes and compressed collagen components in respective hybrid 
constructs. Values are means ± SD for 6 samples (*, p < 0.05; ***, p < 0.001). 
 
In a transverse cross section of the PLGA- and PLACL-CCHHs flat collagen sheets 
could be observed on either side of the mesh (Figure 40c, d). As expected from the 
previously observed anisotropic compaction profile of compressed collagen hydrogels, 
the basal collagen sheet, featuring the FLS, was thinner than the apical sheet in both 
constructs, although the difference was only marginally significant in the PLGA-CCHH 
[PLACL, 0.07 ± 0.01 mm vs. 0.09 ± 0.01 mm, t (10) = 2.31, p = 0.044; PLGA, 0.09 ± 
0.02 mm vs. 0.10 ± 0.02 mm, t (12) = 1.97, p = 0.073]. 
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Figure 40 – Scanning electron micrographs of meshes made of (a, c, e) poly-[lactic 
acid-co-caprolactone] (PLACL) and (b, d, f) poly-[lactide-co-glycolide] (PLGA): (a, 
b) Mesh structure. (c, d) Transverse cross sections of collagen hydrogels hybridised 
with either of the meshes. The compressed collagen component (arrow heads) can 
be seen as flat sheets above and below the mesh. (e) In PLACL-collagen hybrid 
constructs the collagen (left from dotted line) does not extend deeply into the pores 
(right from dotted line) and superficial shards (arrow heads) can be seen at the 
interface with the mesh, suggesting that there is no physical contact between the 
apical and basal collagen components. (f) The collagen in the PLGA-collagen gel 
hybrid construct can be seen protruding through the pores and extending towards 
the other side (arrow heads). Scale bars are shown in the bottom right corners. 
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Between constructs only the basal collagen sheet differed in thickness, being thinner in 
the PLACL-CCHH [apical collagen sheet, 0.09 ± 0.02 mm vs. 0.09 ± 0.01 mm, t (11) = 
0.204, p = 0.842; 0.09 ± 0.02 mm vs. 0.07 ± 0.02 mm, t (11) = 2.67, p = 0.022]. This 
could possibly be due to the relatively denser structure of the PLACL mesh. 
 
SEM analysis of the interface between the knitted mesh and the collagen gel showed 
that the top and bottom collagen layer did not physically contact each other through the 
dense structure of the PLACL mesh, but the collagen was able to traverse the larger 
pores of the PLGA mesh (Figure 40e, f).  
 
Collagen hydrogels incorporated with two different degradable synthetic polymer 
meshes were compressed to form integrated material structures consisting of a 
synthetic, degradable polymer mesh coated with compressed collagen sheets. The 
findings showed the potential of the technique to combine compressed collagen 
hydrogels with different types of mesh materials. 
 
 
3.2.4 Post-compression cell viability and proliferation 
 
Previously the compression of a cell seeded 0.7 ml/cm² collagen hydrogel with a 1.4 
kN/m² static load resulted in an 14% reduction in cell viability (determined by 
fluorescence microscopy) (Brown et al., 2005). To study the effects of, an increased 
volume collagen hydrogel (1.4 ml/cm²), the embedding of a mesh, and the mesh 
structure on post-compression cell viability (5x105) fibroblasts were seeded within the 
bottom collagen component of both the PLACL- and PLGA-CCHHs and these 
constructs were then subjected to the standard compression regime (application of a 1.8 
kN/m² static load on the standard setup of blotting elements in an unconfined 
configuration). 
 
The AB reduction assay was used to assess the number of viable cells after the 
compression process. The assay measures the reduction of AB into the highly 
fluorescent dye by (metabolically active) viable cells. As the reagent is non-toxic it was 
possible to monitor cell number on the same samples at different time points.  
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Figure 41 – Photographs of the cell-seeded (a) PLACL- and (b) PLGA-collagen 
hybrid construct after 7 days of static culture. (c) Box-and-whisker plots showing 
the amount of fluorescence (from the Alamar Blue reduction assay expressed as 
relative fluorescence units) produced by 5·105 cells (human and rabbit dermal 
fibroblasts) not exposed to the compression process (non-PC; plated on tissue 
culture plastic) and by the same number of cells directly (PC, day 0) and seven 
days (PC, day 7) after being exposed to the compression process while seeded 
inside the (d) PLACL- and (b) PLGA-collagen hybrid constructs (NS, not 
significant; Tukey’s HSD post hoc analysis; ***, p < 0.001; values are for 6 
samples). 
 
Cell viability was measured directly after compression to determine cell survival and 
after a seven day culture period to evaluate if the construct could support cell growth. 
To determine the percentage cell survival the AB reduction of the cell inoculum 
introduced and compressed in the hybrid construct was divided by the reduction of a 
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same size inoculum added to tissue culture plastic. Cells from two different sources 
were used to test the hybrid constructs; human dermal (foreskin) fibroblasts with the 
PLACL-CCHH and rabbit dermal (ear) fibroblasts with the PLGA-CCHH. 
 
Over the seven day culture period no deformation of either of the hybrid constructs 
could be observed (Figure 41a, b). Further, it can be noted from the standard curve 
(fluorescence from AB reduction versus viable cell number; Figure 16) and the data that 
the fold increase in cell number can directly be derived from the fold increase in 
fluorescence (expressed as RFU).  
 
A one-way ANOVA was used to test differences in viable cell number among the three 
different time points; before, directly after and 7 days after compression. For both the 
PLACL- and PLGA-CCHH the viable cell number differed significantly across the 
three time points; PLACL-CCHH, F (2, 17) = 269.5, p < 0.001; PLGA-CCHH, F (2, 
17) = 47.7, p < 0.001 (Figure 41c, d). 
 
Tukey HSD post hoc comparisons of the three time points showed a reduction in viable 
cell number after compression of 36% for the PLACL-CCHH [from 78.3 ± 2.0 (SD) 
RFU to 49.9 ± 6.1 RFU, p < 0.001] and 8% (not significant) for the PLGA-CCHH 
[from 39.4 ± 6.3 RFU to 31.7 ± 8.0 RFU, p = 0.630]. At day 7, post compression, the 
number of cells cultured inside the compressed hybrid constructs had increased 3-fold 
for both the PLACL (M = 152.6, SD = 12.1, p < 0.001) and PLGA-CCHH (M = 105.2, 
SD = 22.6, p < 0.001). 
 
A cell inoculum introduced and compressed within the basal collagen compartment of 
the PLACL- and PLGA-CCHH, to create living dermal equivalents, showed a reduction 
in cell viability, as measured with the AB reduction assay, which was not significant for 
the PLGA based dermal equivalent (8%) but significant for the PLACL based dermal 
equivalents (36%). In light of the previously found 14% reduction in cell viability for 
non-hybridised compressed collagen hydrogels (Brown et al., 2005) the incorporation 
of dense mesh structure seemed to negatively affect post-compression cell survival with 
a more open mesh structure showing better cell viability retention. Additionally, it was 
found that the decrease in cell number was recovered after a static culture period 
showing the ability of the hybrid constructs to support cell growth 
. 
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3.2.5 In vitro analysis of short term biocompatibility of PLACL 
 
The PLGA (Vicryl) material has previously been well characterised. The characteristics 
of the newly PLACL-material on the other hand are mainly derived from predictions 
made from its polymer composition. PLACL degrades through simple hydrolysis and 
intermediate degradation products are caproic and lactic acid (Pitt et al., 1981) which 
negatively effect cell viability through lowering of the surrounding pH (Sung et al., 
2004). Although the release of these degradation products was expected to be low based 
on the predicted degradation profile, the question was asked if any cytotoxic effects (on 
cell viability and migration) from the mesh embedded within the PLACL based dermal 





Figure 42 – (a) Illustration of a transverse cross section through the PLACL based 
dermal equivalent showing the apical and basal collagen component and the 
PLACL-mesh in between. (b) Detailed illustration of the box shows the proposed 
direction of the release of degradation products (DP). To study possible cytotoxic 
effects regions (45 m thick) proximal and distal to the mesh were studied for 
differences in percentage viable cells and in cell number to establish if cells died 
with the proximal region or moved out of this region. 
 
To test this, live and dead fibroblasts within the basal collagen compartment of the 
PLACL based dermal equivalents were visualised post-compression, after a seven day 
static culture period, with a cytoplasmic fluorescent dye (CMFDA; specific for live 
cells) and counterstained with a nuclear dye (EH-1; specific for dead cells). The 
percentage of viable cells and the total number of cells (live and dead) were determined 
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in two overlapping regions (each 45 µm thick) within the 70-µm thick basal collagen 
compartment; a proximal (closest to the collagen-PLACL interface) and distal (free 
interface) region (Figure 42). Possible cytoxic effects of degradation products released 
by the PLACL material were expected to result in an increase in cell death and/or a 
decrease in total cell number (migration) in the proximal compared to the distal region. 
 
 
Figure 43 - Confocal fluorescence 
micrograph of CMFDA (live cells 
staining in green) and EH-1 (dead cell 
staining in red; white arrow heads) 
stained human dermal (foreskin) 
ﬁbroblasts seeded within the bottom 
collagen component of a PLACL-based 
dermal equivalent. Image obtained 7 
days after fabrication and static culture 
Scale bar is shown at bottom right. 
 
It was found that throughout the collagen gel fibroblasts with a bipolar spindle 
morphology characteristic for cultivation on stiff substrates were found (Figure 43). The 
percentage viable cells did not differ between collagen regions proximal and distal to 
the mesh (Figure 42b) suggesting that there were no (preferential) cytotoxic effects of 
(degradation products from) the PLACL mesh on cells over the 7 day culture period 
[90.0 ± 1.6 (SD) % vs. 90.0 ± 3.4 %, t (10) = 0.209, p = 0.839] (Figure 44a). The 
increase in the percentage of viable cells from 64% (direct post-compression; see above) 
to 90% (after a 7-day culture period) suggests that cells had proliferated. This is in line 
with the AB viability data (described above). 
 
The distal and proximal region studied were 45 µm thick and partially overlapped each 
other (the basal collagen component was 70 µm thick). Therefore to assess the cell 
distribution, the number of live and dead cells in the proximal and distal region was 
standardised by dividing this number by the total combined number of cells counted in 
both regions. It was found that the standardised number of cells in the proximal region 
did not differ significantly from the distal region [48 ± 6.8 % vs. 52 ± 6.8 %, t (10) = 
1.069, p = 0.310] (Figure 44b). This demonstrates that in the time period tested the cells 
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did not migrate away from the PLACL mesh due to toxic effects of the material or due 










































Figure 44 – Box-and-whisker plots. PLACL-collagen hybrid constructs, after seven 
days of static culture, showed no differences in (a) cell viability and (b) cell 
distribution between the collagen region at the collagen-PLACL interface 
(proximal) and the collagen region at the free interface (distal) (NS, not significant; 
values are for 6 samples). 
 
The cell-seeded basal collagen component of a PLACL based dermal equivalent after a 
7-day static culture period showed a uniform distribution of cells (both viable and dead) 
throughout the collagen demonstrating that no (significant levels of) toxic degradation 




3.2.6 Effect of an aqueous medium on the PLACL and PLGA 
mesh 
 
When statically culturing the cell seeded dermal equivalents in standard growth 
medium, it was observed that a subset (~40%) of the PLACL based constructs rolled up 
(Figure 45). Similar observations have previously been made with cell seeded PLGA 
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(Vicryl) meshes (Cooper et al., 1991), but a similar experience was not found in the 
current series of experiments.  
 
 
Figure 45 – Photograph. Contraction 
and rolling of the cell-seeded PLACL-
compressed collagen hybrid construct 
under static in vitro culture conditions. 
Scale bar is shown at the bottom right 
corner. 
 
To test if the deformation was the result of cell activity, the PLACL material (without 
the cell seeded collagen component) was incubated in a PBS buffer solution for 3 hours 
(at 37°C and neutral pH). As was found with the cultured cell seeded, collagen 
embedded meshes the PLACL material curled up (Figure 46a, b) demonstrating that this 
was a cell-independent, aqueous solution mediated effect. 
 
The structure of the PLACL and PLGA material is useful for TE purposes. Its porous 
architecture allows for the diffusion of nutrients from the wound bed to the upper 
surface (before vascularisation occurs). A low porosity can impede diffusion but also 
accelerate polymer degradation (through autocatalytic processes) (Athanasiou et al., 
2007). Also the mesh structure is conducive to the prevention of wound contraction. 
Size retention over its implantation period is therefore essential. 
 
To test if the aqueous solution mediated structural changes involved the size and 
porosity properties of the PLACL- and PLGA-material, measurements and imaging 
(digital photography, light microscopy, SEM; see Figure 46) were performed before and 
after incubation of PLACL and PLGA meshes in a PBS buffer solution for 3 hours (at 





Figure 46 – (a-d) Photographs, (e-h) light micrographs, and (i-l) scanning electron 
micrographs showing the PLACL mesh before (a, e, i, c, g, k) and after (b, f, j, d, h, 
l) 3 hours of incubation in a buffer solution at 37 °C and neutral pH. 
Macroscopically (a, b) contraction and deformation (curling) was observed, and at 
a microscopic level (e, f) a decrease in pore size and a tightening of the fibres was 
found (i, j). 
 
Light microscopy (Figure 46e - h) revealed a 70% decrease in porosity for the PLACL 
mesh (defined as the ratio of the area of the voids and the total area) [from 15.8 ± 1.0 to 
5.3 ± 0.8 (SD) %, t (10) = 20.3, p < 0.001] and no statistically significant difference for 
the PLGA mesh [t (10) = 1.70, p = 0.119] (Figure 47a). SEM analysis revealed a 
longitudinal shrinkage of the filaments in the PLACL mesh (Figure 46i, j) but no 
structural changes for the PLGA mesh (Figure 46k, l). Image analysis of photographs 
taken of the meshes revealed a 60% decrease in mesh surface area for the PLACL 
material [from 2.7 ± 0.2 to 1.1 ± 0.2 (SD) %, t (10) = 14.4, p < 0.001] and none for the 

















































Figure 47 – Box-and-whisker plots. (a) The decrease in porosity and (b) mesh size 
of the PLACL mesh after exposure to an aqueous medium (NS, not significant; 
***, p < 0.001; values are for 6 samples). 
 
Under acellular and static conditions, aqueous media caused a longitudinal shortening 
of the yarns in the dense knit pattern of the PLACL-mesh resulting in rolling of the mesh 
and a 60% decrease in surface area and a 60% decrease in porosity. No significant 
structural changes of the PLGA-mesh were measured in the studied time period. 
 
 
3.2.7 Keratinocyte-fibroblast co-culture in PLGA-CCHHs 
 
To test if the PLGA-CCHH construct could be utilised for the fabrication of skin 
substitutes, rabbit derived keratinocytes and dermal fibroblasts were spatially layered on 
the surface and in the collagen component, respectively (Figure 21). 
 
It was previously shown that (proliferating) keratinocytes positively influence epidermal 
regeneration in a dose dependent manner (Svensjo et al., 2001). The aim was therefore 
to achieve the maximum density of cells on the available surface space in the shortest 
amount of time. The hypothesis under test was that a supernumerary number of cells 
could be seeded to achieve a confluent keratinocytes monolayer. It was previously 
established that it would require approximately 3 to 5 x 105 keratinocytes per cm² to 





Figure 48 - Micrographs of haematoxylin-eosin stained reconstructed skin showing 
the PLGA-compressed collagen gel hybrid constructs with rabbit keratinocytes 
(white arrow heads) seeded on the surface of the apical collagen component (CG) 
(a) directly after cell seeding and (b) after 2 weeks of culture (PG, poly(lactide-co-
glycolide) mesh). The region in the box is magnified (x2) in (c) showing that the 
rabbit dermal keratinocytes form a continuous and stratified epidermis with (1) 
cuboïdal basal cells attached to the apical collagen component, (2) flattened 
suprabasal cells and (3) a stratum corneum. (d) Immunofluorescent staining of 
cytokeratins showing the epithelial origin of the formed epidermal tissue (arrow 
points to the stratum corneum). 
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Therefore an inoculum of 2.6 x 106 cells in 1 ml was statically seeded onto the surface 
of the top collagen compartment of the PLGA-based dermal equivalent (prepared as 
described above). After a 2-hour incubation period, it was determined from the Trypan 
Blue exclusion assay that 82 ± 7 (SD) % of the keratinocytes (values are for 18 samples) 
had attached to the collagen surface. This implied that keratinocytes were seeded at a 
density of 5 ± 0.4 (SD) x 105 cells/cm² and histological observation revealed a near 
confluent distribution (Figure 48a). 
 
To test if the PLGA dermal equivalent (n = 18 constructs) was suitable for maintenance 
and differentiation of keratinocytes at the air liquid interface, the keratinocyte seeded 
constructs were cultured for an additional 2-3 days submerged in growth medium 
(under static conditions) to achieve confluence (Figure 21a). The confluent keratinocyte 
monolayer was then raised to the air liquid interface to stratify the epidermis over a 2 
week period (Figure 21b). The histological appearance of the reconstructed epidermis 
showed cuboïdal basal cells attached to the apical collagen component, flattened 
suprabasal cells and a stratum corneum (Figure 48b, c). Cytokeratins expression could 
be detected in the epidermis layers by immunohistochemical staining showing the 
epithelial origin of the epidermal tissue formed (Figure 48d). 
 
It was possible to achieve a (near) confluent monolayer of keratinocytes by static 
seeding of a supernumerary number of cells allowing for the creation of a living skin 
equivalent with a near confluent epidermal monolayer within three hours and with a 
stratified epidermis within three weeks. The latter finding proved that PLGA-CCHH 
was porous and thin enough to allow nutrient flow through the thickness of the 
construct from the basal to the apical surface. 
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3.3 Implantation study 
 
The safety and efficacy of the skin equivalent (i.e. cell-seeded and acellular PLGA-
CCHH) were tested in (a rabbit model of) an acute (excisional) full thickness (dorsal) 
skin defect. 
 
To test if the wound healing benefit (in terms of improved outcome parameters) of a 
stratified (differentiated) epidermis over a monolayer epidermis warranted the extended 
(2 weeks) in vitro culture period of the skin equivalent, two conditions were tested: the 
skin equivalents were either implanted directly after fabrication without an in vitro 
culture period (i.e. UCs) or after 2 weeks of (in vitro) culture in which period the 
keratinocytes were allowed to differentiate to form a stratified epidermis (i.e. CCs). 
 
Wound healing with the cell seeded skin equivalents was compared with that with ACs 
(PLGA-CCHH without cells) to differentiate between effects that result from the 
physical properties of the scaffold and those from the keratinocytes and fibroblast co-
culture. Wounds that were left untreated (open defects) represented spontaneous wound 
healing and were used as (negative) controls. Lastly, FTSGs, the current gold standard 
for the treatment of full thickness defects, were used as (positive) controls. 
 
The full thickness skin defects were created by excision of the dorsal skin (epidermis 
and dermis) of the rabbit up to (not including) the underlying panniculus carnosus 
muscle and the grafts were sutured in place by interrupted stitches and a single central 
quilting suture (Davenport et al., 1988). The skin equivalents were easy to handle and 
suture; no delamination of the collagen from the PLGA mesh was observed during 
suturing. 
 
It should be noted that (post-operatively) the grafts were covered with an occlusive 
dressing (Opsite) for the first period of implantation (Figure 24f) and that as fluid 
collected over the grafts underneath the Opsite, the dressings were removed after the 
first 3 days post-surgery. Animals were sacrificed and the wounds excised 1, 3 and 5 
weeks after implantation of the skin equivalents. 
 
Wounds were evaluated for the following outcome parameters: wound contraction, graft 
take, rate of epithelialisation, angiogenesis, adverse reactions directed against implanted 
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material (i.e. inflammation), and dermal scarring (or collagen maturation). Female 
rabbits were used as subjects into which male cell seeded skin equivalents were 
implanted to allow the differentiation of host cells from donor cells in tissue specimens. 
Additionally, in the clinical setting the use of allogeneic cells is attractive over 
autologous cells as it prevents a delay in treatment that would otherwise result from an 






Graft take is important if the skin equivalents are to have an extended effect on the 
wound healing process and is usually determined by (i) adherence of the graft to the 
wound bed, (ii) vascularisation and (iii) viability of the graft. 
 
The FTSGs showed ‘graft take’, persisting inside the wound defect over the study 
period with adequate size retention of wounds (Figure 49). The FTSGs, post-
implantation, showed a normal skin colour indicating adequate blood perfusion of the 
graft. Additionally, hair growth on the FTSGs was observed, indicating the hair follicles 
had survived the transplantation process. These findings show that the panniculus 
carnosus muscle provides an adequate wound bed for ‘graft take’ and permanent 
engraftment. 
 
Untreated wounds showed progressive closure of the wound primarily by contraction 
resulting in a scar significantly smaller than the original defects size. No hair growth 
was noted with the newly formed connective tissue (Figure 49).  
 
The skin equivalents showed progressive desiccation over time (Figure 49). Of the skin 
equivalents all the ACs remained in situ over the course of the experiment, whereas 
most of the cell seeded constructs were lost by the end of the experiment; this occurred 
faster with the cultured than with the UCs. Table 2 gives an overview of the number of 




Figure 49 – Weekly, post-operative photographs of full thickness wound defects on 
the dorsum of a rabbit treated with full thickness skin grafts (FTSG), untreated, 
treated with acellular skin equivalents and uncultured and (2 week) cultured (cell 































Table 2 - Number of grafts out of the initial number of grafts that were still found 
in situ at each time point (post-operatively). (FTSG, full thickness skin graft; 
acellular skin equivalents and cell-seeded uncultured and cultured skin 
equivalents). 
 
Microscopic evaluation at low magnification of the H&E stained tissue cross-sections 
(Figure 50) revealed that after one week of implantation the skin equivalents could be 
seen in contact with the newly formed, underlying granulation tissue. At week 3 the 
construct was undermined by the complete regeneration of the epidermis resulting in the 
ejection of the skin equivalents from the wound bed. 
 
At higher magnification (Figure 51) various degrees of integration with the underlying 
granulation could be seen for ACs in the first week after implantation. Minimal areas of 
take were observed in wounds treated with ACs showing incorporation of the basal 
collagen component (Figure 51a) and some instances of the mesh into the underlying 
granulation tissue (Figure 51b) with little inflammatory infiltration (of 
polymorphonuclear leukocytes) was observed. The cell seeded skin equivalents, 
however, showed a more marked inflammatory infiltration with no incorporation of the 
collagen or the mesh into the underlying wound (Figure 51b, c). 
 
Therefore, in the first week there was partial take of the ACs, but all skin equivalents 
showed progressive desiccation with ultimately no permanent engraftment of either the 
AC or cell-seeded skin equivalents. By week 3, grafts were invariably undermined by 






Figure 50 – Micrographs (magnification bar measures 1 mm) of haematoxylin and 
eosin stained tissue cross sections of rabbit, dorsal, full thickness wounds (1, 3 and 
5 week post-injury) treated with full thickness skin grafts (FTSG), untreated, 
treated with acellular skin equivalents and uncultured and (2 week) cultured (cell 
seeded) skin equivalents (IM, implant; PC, panniculus carnosus muscle; NT, newly 




Figure 51 – Micrographs of the interface between the implant and the wound bed 
in full thickness skin defects one week after implantation (staining with CD31 
antibody for endothelial cells and haematoxylin counterstaining). Full thickness 
defect treated with acellular skin equivalents show partial integration of (a) the 
basal collagen component (bc) and (b) PLGA-mesh (PG) (of the PLGA-
compressed collagen hybrid material) into the underlying granulation tissue. The 
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inflammatory infiltration (INF) was more marked in wounds treated with (c) 
uncultured and (d) cultured (cell seeded) skin equivalents than in wounds treated 
with the acellular constructs (ac, apical collagen component; black arrow heads 
point to CD31+ blood vessels; white arrow heads point to the in vitro formed 
epidermal layer on top of the apical collagen component of the skin equivalent). 
 
 
3.3.2 Wound contraction 
 
Although the skin equivalents showed no permanent engraftment the size of the wounds 




Figure 52 – Polarised light micrographs of picrosirius stained tissue sections 
showing the wound length of full thickness skin defects at five weeks after 
implantation of (a) full thickness skin graft (FT; scale bar is shown at the bottom 
right corner), and (b) a skin equivalent (here no longer in situ) and after (c) no 
treatment (white arrow heads point to unwounded skin; NT, newly formed 
connective tissue). 
 
To test if the skin equivalents indeed prevented wound contraction the length of the 
wounds were measured in samples harvested 1, 3 and 5 weeks after implantation and 
compared to the original wound length (measured on the day of surgery). Measurements 
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were taken from histological transverse cross sections as over the experiment the wound 
margins moved underneath the skin equivalents, preventing the direct measurement of 
the wound area. 
 
The percentage size retention of the wound area was determined, as a measure of the 
prevention of wound contraction, by dividing the wound length, measured in tissue 
sections from the wound samples obtained at each time point (Figure 52) by the original 
wound length (obtained directly after implantation on the day of surgery).  
The wound length was measured as the distance between hair follicles as no hair growth 
occurred in the newly formed connective tissue. Results were compared to wounds 
treated with FTSGs, the gold standard, and to wounds left untreated. 
 
A two-way RM-ANOVA was conducted on the percentage retention of wound area. 
The data for the three skin equivalents (AC, UC, and CC) did not differ between them 
and the data were therefore pooled into a single ‘hybrid construct’ group and compared 
to the FTSG and ‘no treatment’ group. The independent variables therefore included 
two between-groups factors, treatment, three levels (‘hybrid construct’, FTSG, NT) and 
time with three levels (1, 3 and 5 weeks). 
 
A significant main effect of graft type on the postoperative wound size was observed, F 
(2, 6) = 9.3, p = 0.014. Post hoc (Tukey HSD) simple effects analysis revealed that 
wounds treated with FTSGs (M = 95.6%, SD = 13.8%) were on average significantly 
larger in size than NT wounds (M = 50.8%, SD = 37.1%) showing better retention of 
the wound area. Wounds treated with the skin equivalents (M = 72.0%, SD = 30.0%) 
showed a marginally significant greater size retention than NT wounds; (p = 0.071) 
(Figure 53). Further, a significant main effect of time on the postoperative wound size 
was found, F (2, 6) = 18, p = 0.003, such that the wound size decreased over time for all 
groups. Simple effects analysis revealed that only the decrease between week 1 (M = 
105.2%, SD = 9.0%) and week 3 (M = 64.2%, SD = 24.1%) was statistically significant 
(p = 0.005). No significant interaction effects were found between treatment and time, F 

























Figure 53 – Box and whisker plots showing the effect of full thickness skin grafts 
(FTSG), (acellular and cell seeded) hybrid constructs (HC) and ‘no treatment’ 
(NT) on post-operative wound size after 1, 3 and 5 weeks (NS, not significant; *, p 
< 0.05). 
 
The gold standard the FTSG results show that wounds contracted despite treatment 
with FTSGs and the PLGA-CCHHs and that FTSGs were able to delay contraction. 
Although there was no permanent engraftment of the skin equivalents the treated 
wounds showed after five weeks 55% wound contraction compared to the 84% of 
untreated wounds and to the 12% of FTSGs grafted wounds. 
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3.3.3 Inflammatory response to allogeneic cell therapy 
 
In the clinical setting, the main advantage of allogeneic over autologous cell therapy is 
that a sufficient number of cells can be made available without delaying treatment. 
However, a disadvantage is that an increased inflammatory response could result, 
leading to graft rejection, although it has previously been shown that allogeneic cells 




Figure 54 – Immunohistochemical detection of CD45+ cells (black arrows) within 
the newly formed connective tissue for the different treatment groups at weeks 1, 3 
and 5 (DAB visualisation and haematoxylin counterstain; magnification bar 
measures 100 µm).  
 
In the first week, an apparently larger inflammatory infiltration was found in wounds 
treated with ACs than in wounds treated with allogeneic cell-seeded skin equivalents. 
This could in part explain that ACs showed integration into the underlying wound bed, 
whereas the cell seeded constructs did not (Figure 51). To quantify the inflammatory 
response to the allogeneic cell-seeded skin equivalents the percentage CD45+ cells (i.e. 
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leukocytes) of the total number of (nucleus containing) cells within the wound bed was 
determined by CD45 antibody staining and haematoxylin (nuclear stain) counterstaining 
(Figure 54). The inflammatory response was determined in tissue sections from wound 
samples taken 1, 3 and 5 weeks after implantation and the results were compared to 
wounds in which no cells were introduced (i.e. NT and AC group). 
 
For the interpretation of the results it should be noted that adult male rabbit 
keratinocytes (second passage) and dermal fibroblasts (third to fifth passage) were used 
and that the skin equivalents were cultured in serum free growth medium and were 





























Figure 55 - Box and whisker plots for the percentage CD45+ cells at each time 
point for each treatment condition. (c) Box and whisker plots for the percentage 
CD45+ cells comparing the effect of the presence (+) or absence (-) of (allogeneic) 
cells in the defects at each time point (***, p < 0.001; *, p < 0.05; NS, not 
significant). 
 
An RM-ANOVA was conducted on the determined percentage CD45+ cells. As there 
was no difference between the UC and CC group and between the AC and NT group the 
data were pooled into a cellular (UC, CC) and ‘no cells’ group (AC, NT). The 
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independent variables therefore included two between-groups variables, treatment, with 
two levels (cells, no cells) and time with three levels (1, 3 and 5 weeks).  
 
A significant main effect of treatment was found, F (1, 6) = 8.0, p = 0.03 such that the 
average leukocyte count was higher in allogeneic cell treated wounds (M = 14.1%, SD 
= 8%) than in wounds where no cells were introduced (M = 12.8%, SD = 5%; Figure 
55). There was a significant main effect of time, F (2, 6) = 75.8, p < 0.001; for both 
groups the percentage of leukocytes decreased with time. A Tukey HSD post hoc 
simple effects analysis of time revealed that the average percentage of CD45+ cells at 
week 1 (M = 21%, SD = 4.4%) was significantly greater than week 3 (M = 13%, SD = 
1.8%; p < 0.001) and at week 3 significantly greater than week 5 (M = 7%, SD = 1.7%; 
p < 0.001). Additionally, a significant interaction effect was found between allogeneic 
cell therapy and time, F (2, 6) = 14.2, p = 0.005, showing that the allogeneic cell-
induced increased immune response was time depended. Simple effects analyses 
showed that only the difference in inflammatory response in the first week between 
wounds treated with allogeneic cells (M = 23%, SD = 4%) and ‘no cells’ (M = 19%, SD 
= 4%) was significant, F (1, 2) = 24.1, p = 0.039. 
 
Wounds treated with the allogeneic cell seeded PLGA based skin equivalents showed a 
higher immunologic reaction in the acute healing phase (week 1) compared to 
untreated defects or treated with ACs. 
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3.3.4 New connective tissue formation 
 
The formation of new connective tissue is important to replace lost tissue and to close 
the wound. The formation of an inadequate amount may result in incomplete wound 
closure or at later stages in wound dehiscence (Irvin and Hunt, 1974). An 
overabundance of granulation tissue on the other hand could give rise to hypertrophic 
scars and scar contracture (Rockwell et al., 1989). To study the effects of the skin 
equivalents on the formation of new connective tissue in the full thickness skin defects, 
the thickness and the cross sectional area of the newly formed connective tissue was 
measured in H&E stained sections (Figure 26) of wound samples obtained 1, 3 and 5 
weeks after implantation of the skin equivalents. 
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Figure 56 – Box and whisker plots for the average thickness of newly formed 
connective tissue in full thickness wounds untreated (open defects, ‘no treatment’) 
and treated with acellular and uncultured and cultured cell seeded skin 
equivalents for three time points post-wounding. 
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A two-way RM-ANOVA was conducted on the average thickness of the newly formed 
connective tissue. The thickness did not differ between the three skin equivalents 
(Figure 56) and the data were therefore pooled into a single ‘skin equivalent’ group and 
compared to the ‘no treatment’ group (Figure 57). The independent variables therefore 
included two between-groups factors, treatment with two levels (no treatment, skin 














































Figure 57 – The effect of wound grafting of full thickness skin defects with the 
PLGA-collagen hybrid construct on (a) the cross sectional area and (b) thickness 
of the newly formed connective tissue compared to open defects or no treatment (*, 
p < 0.05). 
 
A significant main effect of treatment on the average thickness of the newly formed 
connective tissue was found, F (1, 6) = 77, p < 0.001, such that the connective tissue 
was thicker in wounds in the ‘no treatment’ group (M = 1.74, SD = 1.24 mm) than in 
wounds treated with the skin equivalents (M = 0.99, SD = 0.62 mm) (p < 0.001). A 
significant main effect of time on the average thickness was observed, F (2, 6) = 188, p 
< 0.001; the connective tissue increased in thickness with time in all groups. Both the 
increase in thickness from week 1 (M = 0.2, SD = 0.07 mm) to week 3 (M = 1.8, SD = 
0.62 mm) (p < 0.001) and from week 3 to week 5 (M = 2.1, SD = 0.62 mm) (p < 0.001) 
were statistically significant. Additionally, a significant interaction effect was found 
between grafting and time, F (2, 6) = 20.2, p = 0.002, indicating that the effect of 
treatment on connective tissue thickness increased with time. Simple effects analyses 
revealed that the thickness of the connective tissue in untreated wounds (M = 2.77, SD = 
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0.90 mm) was (47%) larger than grafted wounds in week 5 (M = 1.46, SD = 0.28 mm) 
respectively, F (1, 2) = 476, p = 0.002 (Figure 57a). The difference between ungrafted 
(NT; M = 2.23, SD = 0.25 mm) and grafted (M = 1.30, SD = 0.33 mm) wounds in week 
3 was only marginally significant, F (1, 2) = 13.8, p = 0.065. 
 
A two-way RM-ANOVA was conducted on the cross sectional area of the newly 
formed connective tissue. The three skin equivalents were again pooled into a single 
‘skin equivalent’ group and compared to the ‘no treatment’ group. The independent 
variables therefore included two between-groups factors, treatment with two levels (skin 
equivalents, no treatment) and time with three levels (1, 3 and 5 weeks). 
 
No significant main effect of treatment on the total cross sectional area of the newly 
formed connective tissue was found, F (1, 6) = 0.251, p = 0.635, indicating that there 
was no difference in the amount of connective tissue formed in construct treated and 
untreated wounds. No significant main effect of time on the cross sectional area was 
observed, F (2, 6) = 1.082, p = 0.397. Additionally, no significant interaction effect was 
found between grafting and time, F (2, 6) = 1.118, p = 0.387 (Figure 57b). 
 
Although the initial thickness data suggested that less connective tissue was formed in 
construct treated than in untreated wounds the measurements of the cross-sectional 
area showed that this was not the case. The apparent difference seems to be the result of 
the same amount of granulation tissue spread over a different wound length in treated 
wounds and untreated wounds (Figure 52). 
 
 
The connective tissue formed within full thickness wounds not only fills the wound 
defect but is also a source of force generation that helps to approximate the wound 
margins, decreasing the wound area requiring to be reepithelialised. To test the 
relationship between the amount of connective tissue and the wound size in this study a 
correlational analysis was conducted on the thickness of the newly formed connective 
tissue and the wound length (determined in tissue samples obtained at 1, 3 and 5 weeks 
after surgery) of untreated defects and defects treated with the skin equivalents. 
 
It was found that the amount of newly formed connective tissue was significantly 
related to the wound size. The thickness of the newly formed connective tissue showed 
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a strong negative correlation (Pearson correlation coefficient (r) = -0.67, p < 0.001) with 
the size of the wound (Figure 58), such that as the amount of newly formed connective 
increases the wound size decreases. Of the variation in wound size 45% (0.67²) could be 
























Figure 58 – Correlation between cross sectional area of the connective tissue newly 
formed in full-thickness skin defects and the wound size (*, p < 0.002). 
 
There is therefore a significant relationship between the wound size and the amount of 
granulation tissue formation. This data suggest that the reduction in wound size is (at 






3.3.5 Collagen content of the newly formed connective tissue 
 
The ECM of the newly formed connective tissue consists of collagens, proteoglycans 
and glycoproteins. It is primarily believed that the collagen content is directly 
responsible for the wound’s UTS (Doillon et al., 1985a) and a disturbance to the 
balance between collagen deposition, degradation and remodelling may result in 
defective wound healing. To study the maturation of collagen within newly formed 
connective tissue polarised light microscopy was used to analyse the birefringence of 




Figure 59 – Micrograph visualising the birefringence of a picrosirius stained tissue 
section of a full thickness skin defect 3 weeks after injury. Central, the full 
thickness defect (d) can be seen bordered by hair follicles (white arrow heads) and 
extending from the epidermis to the original wound bed (wb) (between white 
arrows). Within the defect a new connective tissue has been deposited in which two 
distinct regions can be seen; an apical region (a) and a basal region (b). (pc, 
panniculus carnosus muscle). 
 
Birefringence is the capacity of a material to change the polarisation state of light. This 
can be visualised as the appearance (state change) and change in colour (determined by 
the induced phase retardation and interference) of polychromatic light transmitted 
through the specimen seated between two polarising filters that have their transmission 
axes set at right angles to each other. It has been found that during wound remodelling 
the birefringence of collagenous tissues changes and this is mainly attributed to a closer 
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packing of the collagen ﬁbrils (Doillon et al., 1985b). To test if the skin equivalents had 
a promoting effect on the increase in collagen content in the connective tissue newly 
formed within the full thickness defects the change in birefringence was quantified in 
picrosirius stained tissue sections. 
 
Tissue sections from 1, 3 and 5 week old wounds were stained with picrosirius red to 
enhance the natural birefringence of the collagen molecules. At microscopic inspection 
a gradient in the amount and in the hues of the birefringent material could be observed 
within the newly formed connective tissue and two distinct regions could be 




Figure 60 – Picrosirius red stained, newly formed connective tissue in full thickness 
wounds viewed under a linearly polarising light microscope showing the change in 
amount of collagen and their interference colours over time and between treatment 
groups. The colour chart indicates the hues for immature to mature collagen 
fibrils, scale bar is shown at the bottom right corner. 
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Per tissue section the amount of birefringent material (as a percentage of the total 
measured tissue area) was quantified in up to ten photographed fields of view (polarised 
light microscope; 20x objective) of randomly selected areas in the apical and basal 
regions of the newly formed connective tissue. To quantify the percentage amount of 
birefringent material within the digital photographs the number of pixels with the (wave 
lengths or) hues associated (Rich and Whittaker, 2005) with birefringence (green, 
yellow, orange and red; Figure 28) were counted and divided by the number of pixels of 
the total tissue area. 
 
























Figure 61 - Box and whisker plot for the collagen content (from the percentage 
birefringent material per tissue area) in the basal region of the newly formed 
connective tissue showing the effect of cell therapy on the amount of collagen in the 
apical regions of the newly formed tissue. 
 
No differences were found in the percentage birefringent material per tissue area 
between UC and CC group and between AC and NT group the data were pooled in 
‘acellular’ (AC, NT) and ‘cellular’ (UC, CC) treatment groups (Figure 60). 
 
A two-way RM-ANOVA was conducted on the percentage birefringent material per 
tissue area in the apical and basal regions of the newly formed connective tissue. The 
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independent variables included two between-groups factors, treatment, two levels 
(‘acellular’ and ‘cellular’ groups) and time with three levels (1, 3 and 5 weeks). 
 
In the basal region of the newly formed connective tissue no significant main effect of 
treatment on the amount of birefringent material was found, F (1, 6) = 1.5, p = 0.266; 
indicating that there were no differences in the collagen content between cellular and 
acellular treatments. There was a significant main effect of time on the amount of 
birefringent material in the newly formed connective tissue, F (2, 6) = 414, p < 0.001; 
the collagen content increased over time for both groups. The collagen content 
increased 9-fold from week 1 (M = 8.3%, SD = 6.4%) to week 3 (M = 73.3%, SD = 
7.4%) (p < 0.001) and did not change from week 3 to week 5 (M = 77. 2%, SD = 4.9%) 
(p = 0.569). Additionally, no significant interaction effect between treatment and time 
was observed, F (2, 6) = 2.37, p = 0.174 (Figure 61). 
 
























Figure 62 - Box and whisker plot for the collagen content (measured by the 
percentage increase of birefringent material per field of view) showing the effect of 




In the apical region of the newly formed connective tissue a marginally significant main 
effect of treatment on the amount of birefringent material was found, F (1, 6) = 4.9, p = 
0.069; the collagen content of wounds was higher in the cellular (M = 31.3%, SD = 20.9 
%) than in the acellular treatment group (M = 24.7%, SD = 15.6%). There was a 
significant main effect of time on the amount of birefringent material in the newly 
formed connective tissue, F (2, 6) = 54.0, p < 0.001. The collagen content increased 
over time for both groups. The collagen content increased 4-fold from week 1 (M = 
8.3%, SD = 6.4%) to week 3 (M = 29.9%, SD = 10.6%) (p = 0.003) and 1.5-fold from 
week 3 to week 5 (M = 45.7%, SD = 13.3%) (p = 0.014) were statistically significant. 
Additionally, no significant interaction effect between treatment and time was observed, 
F (2, 6) = 2.73, p = 0.144 (Figure 62). 
 
Regardless of the wound treatment the birefringent material content as a measure of 
collagen content in the newly formed connective tissue in the skin defects increased 
more rapidly in the (deeper) basal regions where it reached an apparent maximum 
three weeks post-injury whereas the collagen content in the (more superficial) apical 
regions continued to increase up to five weeks (post-injury) at which time it still had not 
yet reached the level measured in the basal regions at week 3. Only a late (week 5) and 
marginally significant increase in collagen content could be found in the apical region 
of wounds treated with UCs and CCs. That this effect occurred only after 5 weeks could 
be due to the apparent lag in the increase in collagen content between the apical and 
basal regions. Also any possible effects of the skin equivalents on the collagen content 
in the basal regions could have been obscured as an apparent maximum had been 
reached by week 3.  
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3.3.6 Collagen maturation 
 
Not only the increase in collagen content but also the increase in fibril diameter that 
occurs with collagen maturation is important for the UTS of the wound (Doillon et al., 
1985a). Collagen maturation can be detected by picrosirius red staining and observation 
under polarised light microscopy. Due to the birefringent properties of the collagen 
molecule, a light beam passing through a collagen fibril will give rise to specific 
interference colours (or hues) depending on the diameter of the fibril (Doillon et al., 
1985b). Thinner (more immature collagen) fibrils will light up in green and yellow hues 
whereas thicker (more mature collagen) fibrils will show orange and red hues (Figure 
60).  
 
It has previously been shown that transplanted autologous fibroblasts improve collagen 
maturation in a dose dependent manner (Lamme et al., 2000). To test if the skin 
equivalents had a promoting effect on collagen maturation in the newly formed 
connective tissue of the full thickness skin defects, the ratio of thick to thin collagen 
fibres was determined in picrosirius red stained tissue sections viewed in a polarised 
light microscope. An increase in the thick to thin ratio would suggest an increase in 
collagen maturation. Per tissue section the area of the individual interference colours (as 
a percentage of the total measured tissue area) was quantified in up to ten photographed 
fields of view (20x objective) of randomly selected areas in the apical and basal regions 
of the newly formed connective tissue. To determine the ratio of thick to thin fibres the 
percentage area taken up by the interference colours (hues) associated with thick fibres 
(orange, red) was divided by the percentage area of the interference colours associated 
with thin fibres (yellow, green). 
 
A two-way RM-ANOVA was conducted on the ratio of thick collagen fibres in the 
apical and basal regions of the newly formed connective tissue. There was no difference 
between the AC and NT group and the data were therefore pooled into one (‘no cells’) 
group. The independent variables included two between-groups factors, treatment, three 
levels (‘no cells’, UCs and CCs) and time with three levels (1, 3 and 5 weeks). 
 
In the basal region of the newly formed connective tissue (Figure 63) a significant main 
effect of treatment on the ratio of thick to thin collagen fibres was found, F (2, 3) = 
165.3, p = 0.001, such that the ratio in wounds treated with UCs (M = 0.74, SD = 0.60) 
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was 2-fold higher than after treatment with no cells (M = 0.37, SD = 0.29) and 3.5-fold 
higher in wounds treated with the CCs (M = 1.31, SD = 1.01) compared to acellular 
treatments. A significant main effect of time on the ratio of thick to thin collagen fibres 
was found, F (2, 3) = 286.7, p < 0.001; the ratio increased with time for all groups. The 
thick to thin fibre ratio increased 4-fold from week 1 (M = 0.18, SD = 0.12) to week 3 
(M = 0.66, SD = 0.46) (p = 0.017) followed by a 2-fold increase from week 3 to week 5 
(M = 1.28, SD = 0.86) (p = 0.007). Additionally, a significant interaction was observed 
between treatment and time on the ratio of thick to thin collagen fibres, F (4, 3) = 39.4, 
p = 0.006; the effect of the treatment time on the ratio increased with time. Simple 
effects analyses revealed a significant main effect of treatment in the fifth week, F (2, 1) 
= 860.4, p = 0.024, such that the thick to thin fibre ratio was 3-fold higher in wounds 
treated with CCs (M = 2.42, SE = 0.73) than wounds in the ‘no cells’ group (M = 0.68, 
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Figure 63 – Collagen maturation in the basal regions of the newly formed 
connective tissue. (a) Post-injury changes (at three time points) in proportion of 
birefringence interference colours of collagen fibres in full thickness wounds 
treated without cells (no cells; groups consist of untreated wounds and those 
treated with acellular skin equivalents) and with uncultured and cultured (cell 
seeded) skin equivalents. (b) Box and whisker plot of the ratio in the proportion of 
thick (represented by red and orange colours) to thin (represented by green and 
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Figure 64 – Collagen maturation in the apical regions of the newly formed 
connective tissue. (a) Post-injury changes (at three time points) in proportion of 
birefringence interference colours of collagen fibres in full thickness wounds 
treated without cells (no cells; groups consist of untreated wounds and those 
treated with acellular skin equivalents) and with uncultured and cultured (cell 
seeded) skin equivalents. (b) Box and whisker plot of the ratio in the proportion of 
thick (represented by red and orange colours) to thin (represented by green and 
yellow colours) collagen fibres as presented in (a) (NS, not significant). 
 
In the apical region of the newly formed connective tissue (Figure 64), a marginally 
significant main effect of treatment on the ratio of thick to thin collagen fibres was 
found, F (2, 3) = 6.46, p = 0.082, such that the ratio was 80% higher in wounds treated 
with the CCs (M = 0.25, SD = 0.17) and 20% higher in wounds treated with the UCs (M 
= 0.17, SD = 0.07) than after treatment with no cells (M = 0.14, SD = 0.10). No 
significant effect of time on the ratio of thick to thin collagen fibres was found, F (2, 3) 
= 0.77, p = 0.537. Additionally, no significant interaction between treatment and time 
could be observed, F (4, 3) = 0.45, p = 0.77. 
 
Although after three weeks the constructs had been ejected from the wounds, at week 5 
collagen maturation (thick to thin fibre ratio) was 3.5-fold higher for wounds treated 
with the CCs and 2-fold higher for wounds treated with UCs than when no cells were 
introduced in the wounds. 
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3.3.7 Panniculus carnosus 
 
The physiology of wound healing in the dorsal skin of rabbits is different from humans 
and this has been attributed to the presence of the subcutaneous panniculus carnosus 
muscle, which enables wounds to heal primarily by contraction relying less on new 
connective tissue formation. The precise role of this muscle in the wound contraction 
process is, however, not yet certain. The relationship between the size of the panniculus 
carnosus muscle and the size of the wound was therefore investigated in this study. 
 
Correlational analysis revealed that the thickness of the underlying panniculus carnosus 
muscle was significantly related to the wound size. However, the size of the underlying 
panniculus carnosus muscle showed only a weak negative correlation (r = -0.37, p = 
0.002) with wound size (Figure 65). Of the variation in wound size only 13% (0.37²) 
could be explained by the size of the panniculus carnosus muscle. 
 
Panniculus Carnosus





















Figure 65 – Correlation between the thickness of the panniculus carnosus muscle 
and the wound length (*, p < 0.002).  
 
To test if splinting the wound with the skin equivalents or the treatment with cells had 
an effect on the size of the panniculus carnosus muscle the cross sectional area of the 
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muscle was measured in H&E stained sections and divided by the wound length to yield 
an average muscle thickness (Figure 66). 
 
A two-way RM-ANOVA was conducted on the average thickness of the panniculus 
carnosus muscle. The independent variables included two between-groups factors, 
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Figure 66 - Box and whisker plots for the average thickness of the subcutaneous 
panniculus carnosus muscle in full thickness wounds untreated (‘no treatment’) 
and treated with acellular and uncultured and cultured cell seeded skin 
equivalents for three time points post-wounding. 
 
No significant main effect of the treatment was found, F (3, 5) = 0.198, p = 0.893. No 
significant main effect of time on the thickness of the panniculus carnosus was found, F 
(2, 5) = 2.3, p = 0.191. It should be noted that in the UC and CC group the rabbits for 
the 5 week time point were younger than those in the other groups. This possibly 
accounts for the increase in thickness of the muscle over time in all except these two 
groups. Additionally, no significant interaction was found between treatment and time. 
Over the five week period the average thickness of the panniculus carnosus muscle 




Neither the implantation of the skin equivalents or the treatment with cells had a 
significant effect on the size of the panniculus carnosus muscle. The increase in 
thickness over time was most probably due to the growth of the animals, as the 
thickness decreased with the use of younger animals. Additionally, only a weak, yet 
significant, correlation with the wound size was found. Both findings suggest that the 
panniculus carnosus muscle most likely only plays a passive role in wound contraction. 
 
 
3.3.8 Epidermal regeneration 
 
The epidermis has the capacity to regenerate after injury and the rate of epidermal 
wound closure and the rate at which it does so can be increased by transplantation of 
cultured keratinocytes and fibroblasts reducing the risk of infection and dehydration. To 
compare the effects of the UCs and CCs on epidermal wound closure the percentage 
wound coverage by epidermal regeneration was determined. The percentage wound 
coverage was determined by measuring the length of the epidermal regenerate divided 




Figure 67 – Micrographs of wound edges, one week after injury, showing the 
difference in the length of epidermal regenerates (ER) in full-thickness skin defects 
receiving (A) no treatment or (B) treatment with cultured (cell seeded) skin 
equivalents (SE). Black arrows indicate the wound bed and white arrow heads 
point to the normal epidermis. Scale bar at the bottom right measures 1 mm. 
 
A two-way RM-ANOVA was conducted on the percentage wound closure by epidermal 
regeneration. There was no difference between the AC and NT group and the data were 
therefore pooled into one (‘no cells’) group. The independent variables included two 
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between-groups factors, treatment, three levels (‘no cells’, UC, CC) and time with three 
levels (1, 3 and 5 weeks). 
 
There was a significant main effect of treatment on the percentage wound closure by 
epidermal regeneration, F (2, 3) = 39.3, p = 0.007. Simple effects analysis revealed that 
compared to treatment without cells (M = 70%, SD = 42.6%) epidermal wound closure 
was higher in wounds treated with the cultured cell seeded skin equivalents (M = 81%, 
SD = 27.8%) (p = 0.009). As expected, there was a significant main effect of time on the 
percentage wound closure by epidermal regeneration, F (2, 3) = 2246.3, p < 0.001, such 
that the percentage wound closure increased from the first week (M = 24.2%, SD = 
15.0%) to the third week (M = 100%) (p < 0.001). In addition a significant interaction 
between treatment and time was found, F (4, 3) = 39.3, p = 0.006. No significant simple 
effects were observed, suggesting that overall, the epidermal wound closure increased 








































Figure 68 – (a) Box and whisker plots for percentage wound coverage of full-
thickness skin defects by epidermal regeneration at week 1 showing that the 
percentage closure increased with the number of cells used to treat the wound. (b) 
The epidermis had completely regenerated in all wounds at weeks 3 and 5 and the 
regenerated epidermis was 4 times thicker than that of normal (unwounded) skin 
(**, p < 0.01). 
 
Analysis revealed that the thickness of the regenerated epidermis (M = 68, SD = 15 µm) 
was almost 4-fold greater than in unwounded skin (M = 18, SD = 4 µm), t (33.4) = 
19.21, p < 0.001. To test if the treatment type had an effect on the thickness of the 
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regenerated epidermis a two-way RM-ANOVA was conducted. The independent 
variables included two between-groups factors, treatment, three levels (no cells, UCs, 
CCs) and time with two levels (3 and 5 weeks). 
 
No significant main effect of treatment, F (2, 2) = 0.174, p = 0.851, and no significant 
main effect of time on the thickness of the epidermal regenerate was found, F (2, 2) = 
6.143, p = 0.140 (Figure 68b). Additionally, no significant interaction was observed 
between treatment and time, F (2, 2) = 1.183, p = 0.458. 
 
The percentage wound closure in the first week by newly formed epithelium was 4 times 
higher in wounds treated with cultured equivalents compared to acellular treatment. 
UCs increased epidermal regeneration 1.5 fold, but this effect was not statistically 
significant. At weeks 3 and 5 the wounds in all groups were closed and at both time 
points the newly formed epidermis was almost 4-fold thicker than that of normal skin. 
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3.3.9 Angiogenic response 
 
The formation of new blood vessels from endothelial cells from pre-existing vessels (or 
angiogenesis) is essential to wound healing. Angiogenesis stimulating factors are 
released by host cells (inflammatory cells, keratinocytes, endothelial cells and dermal 
fibroblasts) in response to the inflammatory wound healing response induced by the 
surgical procedure. Additionally, cells (keratinocytes, fibroblasts) seeded within an 




Figure 69 – Immunohistochemical detection of CD31+ endothelial cells visualising 
aniogenesis at three points in the connective tissue newly formed in healing full 
thickness skin defects, untreated, treated with acellular, uncultured and cultured 
skin equivalents (DAB chromogen, haematoxylin counterstain; scale bar is shown 
at the bottom right corner). 
 
No vascularisation of the dense collagen components (of the skin equivalents) could be 
observed. To test if the UCs and CCs were able to stimulate angiogenesis in the wounds 
the number of blood vessels within the granulation tissue was quantified in histological 
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sections and compared to the acellular (AC, NT) treatments. Tissue sections were 
stained for CD31+ endothelial cells and counter stained with haematoxylin (Figure 69). 
Per tissue section two parameters were measured in up to ten fields of view (light 
microscope; 20x objective) of randomly selected areas throughout the newly formed 
connective tissue: (i) the number of blood vessel cross sections per field of vision and 
(ii) the total area of the blood vessel cross sections (representing endothelial cell and 
luminal area) expressed as percentage of the tissue area (in the field of view). 
 


















Figure 70 - Box and whisker plots for the number of CD31+ blood vessel cross 
sections per area newly formed connective tissue in wounds treated without cells 
(no cells; groups consist of untreated wounds and those treated with acellular skin 
equivalents) and with uncultured and cultured (cell seeded) skin equivalents for 
three time points post-surgery (*, p < 0.05; post hoc analysis for the interaction 
between treatment and time). Values are for 6 samples, except ‘no cells’ = 12 
samples. 
 
Firstly, a two-way RM-ANOVA was conducted on the number of blood vessel cross 
sections per tissue area. There was no difference between the AC and NT group and the 
data were therefore pooled into one (‘no cells’) group. The independent variables 
 142 
included two between-groups factors, treatment, three levels (no cells, UCs, CCs) and 
time with three levels (1, 3 and 5 weeks). 
 
There was a significant main effect of the treatment on the number of blood vessel cross 
sections in the granulation tissue, F (2, 3) = 220, p = 0.001, such that a significantly 
greater number of blood vessels was present in wounds treated with the CCs (M = 94.4, 
SD = 105.7) than in wounds treated without cells (M = 24.8, SD = 8.2) (p = 0.001). A 
significant main effect for time was found, F (2, 3) = 384, p = 0.001; for all groups the 
number of blood vessel cross sections decreased over time. A post hoc (Tukey HSD) 
simple effects analysis of time revealed that only the difference in blood vessels number 
between the first week (M = 88.3, SD = 90.3) and third week (M = 23.4, SD = 6.1) was 
significant (p = 0.001). In addition, a significant interaction effect between treatment 
and time was observed, F (4, 3) = 208, p < 0.001. Main effects analysis revealed a 
significant main of the number of blood vessels in the granulation tissue in the first 
week for wounds treated with the CCs, F (2, 1) = 438.4, p = 0.034. Post hoc (LSD) 
analysis revealed a significant difference between CCs (M = 236.6, SD = 38.3) and 
treatments without cells (M = 24.8, SD = 8.2) (p = 0.022) (Figure 70). 
 
Additionally, a two-way RM-ANOVA was conducted on the percentage tissue area 
occupied by the blood vessel cross sections (luminal and endothelial cell area) (Figure 
30). Again no difference between the AC and NT group was found and the data were 
pooled into one (‘no cells’) group. The independent variables included two between-
groups factors, treatment, three levels (‘no cells’, UCs, CCs) and time with three levels 
(1, 3 and 5 weeks). 
 
A significant main effect of treatment on the total size of the blood vessel cross 
sectional area was found, F (2, 3) = 24, p = 0.014, such that the vascularity was 
significantly higher in wounds treated with the CCs (M = 5.5%, SD = 4.7%) than in 
wounds where no cells were introduced (M = 2.7%, SD = 1.2%) (p = 0.13). The 
difference between UCs (M = 3.1%, SD = 1.8%) and treatment without cells (M = 2.7%, 
SD = 1.2%) was not statistically significant (p = 0.633). 
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Figure 71 - Box and whisker plots for the size percentage of the blood vessel cross 
sectional area per area newly formed connective tissue in wounds treated without 
cells (no cells; groups consist of untreated wounds and those treated with acellular 
skin equivalents) and with uncultured and cultured (cell seeded) skin equivalents 
for three time points post-surgery (*, p < 0.05; post hoc analysis for the interaction 
between treatment and time). Values are for 6 samples, except ‘no cells’ = 12 
samples. 
 
A significant main effect of time was found, F (2, 3) = 84.3, p = 0.002, indicating that 
the total size of the blood vessel cross sectional area decreased over time for all groups. 
A Tukey HSD post hoc analysis revealed that the total size of the blood vessel cross 
sectional area was significantly greater in the first week (M = 7.1%, SD = 3.6%) than in 
the third week (M = 2.2%, SD = 0.8%) (p < 0.004); the difference between the third and 
fifth week was not statistically significant (p = 0.916). Additionally a significant 
interaction between treatment and time was found, F (4, 3) = 19.8, p = 0.017. A 
significant main effect of treatment was found in the first week, F (2, 1) = 756.0, p = 
0.026; the effect of treatment on the size of the total blood vessel cross sectional area 
was time dependent. Simple effects post hoc (Bonferroni) analysis showed that in the 
first week there was only a significant difference in the total blood vessel cross sectional 
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area between CCs (M = 11.8%, SD = 2.2%) and treatment without cells (M = 3.8%, SD 
= 0.9%) (p = 0.05) (Figure 71). 
 
Immunohistological staining for CD31+ cells showed that there was no vascularisation 
of the skin equivalents, however, a positive angiogenic effect (inferred from the number 
and total cross sectional area of blood vessels) of the CCs on the granulation tissue in 
acute full thickness skin wounds could be found in the acute phase of wound healing 
(first week post-implantation). In the first week wounds treated with the CCs showed a 
statistically signifcant 8-fold higher number of blood vessels and a (significant) 3-fold 
greater blood vessel cross sectional area than wounds that were not treated with cell 
seeded implants. UCs, in the first week, showed, respectively, a 2-fold and a 1.4-fold 
greater effect over treatments without cells for these two parameters. The power of this 
study, however, was too small to detect these effect sizes. In weeks 3 and 5 no 
differences between cellular and acellular therapies could be detected and in all groups 
both the number of vessels and the total size of the vessel cross sectional area had 





4.1 Collagen hydrogel compression 
 
In the present study an alternative strategy was explored in which the thickness and the 
break strength of the compressed collagen sheets were improved by increasing the pre-
compression volume (Figure 10) of the collagen hydrogel. The handling properties of 
the compressed collagen sheets have previously been improved through layering of the 
material by rolling (along their long axis; Figure 9b) the sheets into rod shaped 
structures (Brown et al., 2005). Although, in vivo, an adequate suture retention was 
found up to five weeks post-implantation (Mudera et al., 2007), the fabrication and 
therefore the mechanical properties are subject to a certain degree of (intra- and inter-
operator) variability (Figure 38). Additionally, the shape and structure are not ideal for 
the construction of thicker, stronger flat structures. It would be possible to stack 
multiple compressed collagen sheets. However, an additional culture period would be 
required to produce an integrated structure (Marenzana et al., 2007). Compressing 
increased collagen hydrogel volumes to increase the thickness and the break strength of 
the resulting sheets was therefore explored in the present study. 
 
It was found that, improving the mechanical properties of large volume collagen 
hydrogels by the expulsion of the interstitial fluid (i.e. hydraulic permeability) through 
the gel membrane is hampered by the anisotropic and mass transfer dependent increase 
in collagen fibril density at the FLS.  
 
A collagen hydrogel can be described as a poro-elastic, biphasic material consisting of a 
(phase separated) highly entangled network of collagen polymer chains (fibrils; solid 
phase) with a typical pore volume fraction of more than 0.9 which is saturated with (an 
incompressible) fluid (liquid phase). Qualitative analysis showed that in the solid phase, 
away from the FLS, fluid flow and network collapse (or collagen compaction) during 
compression is prevented by the incompressibility of the interstitial fluid (Figure 36), 
whereas at the FLS fluid flow is allowed to occur, and it is here that the collagen 
network previously supported by expelled fluid volume collapses into dense collagen 
lamellae (Figure 37). 
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This anisotropic change of collagen density in a collagen hydrogel compressed to 50% 
strain in a confined configuration has previously been demonstrated with the use of 
entrapped markers, similar to the charcoal assay (Figure 35) described here (Girton et 
al., 2002; Chandran and Barocas, 2004). The compression induced anisotropy was also 
demonstrated with polarised light microscopy in collagen hydrogels compressed in an 
unconfined configuration up to 99% strain (Brown et al., 2005). To my knowledge, 
however, the present study is the first to consider the physical implications of these 
compression-induced structural changes for the creation of thicker collagen constructs 
through the compression of larger volume collagen hydrogels. 
 
The condensation of the normal ECM architecture with concomitant decrease in 
hydraulic permeability through the application of an external load, has previously been 
described for biological tissues such as glomerular basement membrane (Robinson and 
Walton, 1989), articular cartilage (Oloyede and Broom, 1994) and collateral ligament 
(Weiss and Maakestad, 2006). The relationship between compression and hydraulic 
permeability found in glomerular basement membranes (Leung and Robinson, 1990) 
has previously modelled with poly(glyceryl methacrylate) hydrogels showing that the 
permeability could be accurately predicted by mathematically representing the hydrogel 
and the basement membrane as a continuum-like distribution of fibres. 
 
To elaborate, this continuum theory regards the randomly arrayed fibres as elements 
within the fluid that cannot be displaced and that hinder an otherwise straight outflow of 
fluid. This process is described by the Carman-Kozeny equation which mathematically 
relates permeability to specific network properties such as fractional void volume (i.e. 
porosity, the fractional volume of the matrix not occupied by solid components), mean 
hydraulic radius of the pores, pore size (determined by fibre spacing and diameter) 
(Swartz and Fleury, 2007). A modification of this equation known as the Happel model 
(John, 1959) also accounts for the contribution of fibrillar orientation to flow resistance 
(with perpendicular oriented fibres providing larger resistance to fluid flow than parallel 
fibres), making it more suitable for highly porous (fibrous) media (with a porosity 
greater than 0.5), such as collagen hydrogels (typical porosity of more than 0.9). 
 
Present and previous experimental findings indeed validate that the predicted 
mechanism of change in hydraulic permeability in the compressed collagen hydrogel 
system is contributed by changes in porosity (Figure 36), (presumably) average 
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effective pore size, and fibril orientation relative to flow (Girton et al., 2002; Chandran 
and Barocas, 2004; Brown et al., 2005). The last has been quantified with polarised 
light microscopy measuring increased retardation values as the collagen fibrils closer to 
the FLS change from a random to an orientation perpendicular to the direction of fluid 
flow (Girton et al., 2002). 
 
It is proposed here that collagen hydrogel compaction is a self-limiting process due to 
the mass transfer dependent decrease in hydraulic permeability whether through, the 
application of a gravitational load (Figure 33) or negative capillary action (Figure 36). It 
could be speculated that given enough time a collagen hydrogel could through cell 
contraction obtain a mechanical strength superior to that of a compressed collagen 
hydrogel, however, cell mediated gel contraction has also been shown to be limited as a 
direct function of collagen fibrillar density (Serpooshan et al., 2010). Additionally, it is 
speculated here that mechanical compression can introduce a collagen density that lies 
passed the physiological range that can be obtained through cell mediated contraction. 
 
Referring back to D’Arcy’s equation, the implication for the mechanical compression of 
collagen hydrogels is that when the hydraulic permeability has sufficiently decreased to 
match the driving force (i.e. gravitational load) fluid flow will cease and further removal 
of the fluid content can then be established by introducing a second (uncompressed) 
FLS (Section 2.1.6) or by increasing the gravitational load (Bitar et al., 2007; Cheema, 
Ananta et al., 2010). The first strategy in effect doubles the volume that can be expelled 
from a hydrogel under a set load. Further compaction could be achieved by increasing 
this load, however, it has previously been shown that increased stress levels have both 
immediate and long-term negative effects on viability of encapsulated cells (Bitar et al., 
2007; Cheema, Ananta et al., 2010). Therefore the compression of collagen hydrogels is 
limited both by physical and biological effects.  
 
It should be noted that the mechanical strength of normal collagen rich connective 
tissues is not only dependent on fibril density, but also fibril diameter (Cheema et al., 
2007), fibril orientation, and the presence of other ECM proteins (i.e. fibronectin, 
elastin, proteoglycans). And relying solely on improving the mechanical properties by 
increasing the collagen density not only has implications for cell viability, mass transfer 
of nutrients, but also for other aspects that could influence the performance of a TE 
scaffold. For instance cell behaviour can be influenced through the transduction of 
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mechanical signals from surface receptors through the cytoskeleton to the nucleus 
(Wang et al., 2009). It has been shown for instance that proliferation in collagen 
hydrogels increase with higher mechanical stiffness of the substrate (Hadjipanayi et al., 
2009). Additionally, invasion of an tissue engineered implant by endothelial cells can be 
greatly reduced with decreasing pore size (Sahota et al., 2003) with significant 
implications for vascularisation and integration of the implant into the underlying 
wound bed. Lastly, the in vivo degradation rate of a collagen hydrogel has previously 
been shown to decrease with collagen density (Helary et al., 2010) with compressed 
collagen sheets persisting up to 5 weeks (Mudera et al., 2007). This is important as it 
would determine the biological activity of an implant as the integrity of the cell carrying 
component determines how long cells will remain at the site of interest.  
 
The previously promising advantages of using collagen hydrogels in combination with 
the compression technique involved the ability to rapidly provide cells with a 3D 
context, creating living tissue equivalents with good cell viability retention and with 
tensile properties approaching those of native tissues in the space of an hour (Brown et 
al., 2005). It is now concluded that there are limitations to the thickness and break force 
of compressed collagen hydrogels that can be achieved by this technique imposed by 
physical as well as biological considerations. The question is then asked how the 
compression technique on collagen hydrogels compares to other rapid strategies for the 
creation of tissue equivalents with appropriate handling properties that allow for in vivo 
application. 
  
Other, cell-independent means, to improve the mechanical stiffness of the non-
crosslinked, tightly entangled fiber network of collagen hydrogels involve introducing 
inter- and intrafibrillar crosslinks through, exposure to aldehydes (e.g. glutaraldehyde 
(Cheung et al., 1985) or aldehyde sugars), enzymatic treatment (e.g. lysyl oxidase 
(Kagan and Li, 2003) and transglutaminase (Piacentini et al., 2000)), non-enzymatic 
glycation (e.g. by reducing sugars such as glucose and ribose (Girton et al., 1999)) and 
photo-polymerisation using UVA light either alone (Weadock et al., 2004) or with 
riboflavin (which induced by UVA forms free crosslinking radicals) (Ahearne et al., 
2008). 
 
Although these methods are effective in increasing mechanical stiffness, some 
approaches are either too cytotoxic (glutaraldehyde, UVA (Weadock et al., 2004), and 
 149 
free radicals released from UVA / riboflavin (Ahearne et al., 2008)), too time-
consuming (30 mM ribose requires a 3-week incubation period for a 2-fold increase in 
ultimate stress (Girton et al., 1999)), or too costly and impractical for bulk changes in 
mechanical properties (e.g. lysyl oxidase and transglutaminase). Recently, genipin 
(derived from the fruit of Gardenia Jasminoides) has been described to crosslink 
collagen hydrogels (Shreiber et al., 2005) with little cytotoxicity at concentrations less 
than 1 mM, showing a 2-fold increase in storage modulus in 4 hours time. The speed of 
cross-linking can be increased with higher concentrations but above 5 mM a significant 
reduction in cell viability is observed. 
 
As opposed to fabricating and seeding scaffolds in sequence, encapsulating cells during 
scaffold formation (Nicodemus and Bryant, 2008) afford the ability to provide the site 
of interest with an adequate number of cells in a relevant 3D environment within an 
instant. The importance of a 3D cell environment was previously illustrated by the 
finding that a 3D substrate directly affects the distribution of anchored ECM receptors 
over the cell membrane thereby not only influencing cell morphology (Beningo et al., 
2004) but also cell activity. The latter is further illustrated by the finding that in 
fibroblasts in 3D culture VEGF mRNA expression was 22-fold higher than when 
cultured in a monolayer (Pinney et al., 2000). 
 
Cell encapsulation in hydrogels involves mixing a cell suspension with a liquid 
hydrogel precursor solution which is subsequently crosslinked into a network. Only a 
few materials are suitable for cell encapsulation as the scaffold fabrication process 
needs to be cytocompatible. Two main categories can be distinguished (Nicodemus and 
Bryant, 2008): (1) biopolymer hydrogels (i.e. collagen, fibrin, alginate) and (2) 
synthetic based hydrogels (i.e. purely synthetic, i.e. poly(ethylene glycol), with or 
without incorporated biological signals and derivatised biopolymers). 
 
Collagen hydrogels were one of the first materials used for cell encapsulation (Elsdale 
and Bard, 1972; Bell et al., 1979). Other natural materials suitable for cell encapsulation 
are fibrin (Rowe et al., 2007), alginate (Bent et al., 2001) and chitosan. Fibrin hydrogels 
are prepared by mixing fibrinogen with thrombin. The latter catalyses the release of 
fibrinopeptides (A and B) and the subsequent self-assembly of the fibrin hydrogel 
(Blombäck and Bark, 2004). Alginate hydrogels are prepared by ionic crosslinking of 
precursors with calcium sulphate (CaSO4) (Bent et al., 2001). Chitosan, a natural 
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polysaccharide obtained by deacetylation of chitin, is water soluble under dilute acid 
conditions (pH < 6) and forms a physically crosslinked hydrogel at a pH exceeding 6.2 
(Chenite et al., 2000). 
 
As opposed to alginate and chitosan, collagen and fibrin naturally contain essential cell 
recognition sites (i.e. the integrin ligand RGD tripeptide) important for cell attachement, 
survival, and function (Ruoslahti and Pierschbacher, 1987). Fibrin, however, has the 
disadvantage that it is rapidly degraded by plasminogen and MMPs which may be 
secreted by the cells they contain (Ahmed et al., 2007). Alginate is biocompatible and 
non-immunogenic (Alsberg et al., 2001) but cannot be degraded enzymatically in 
mammals (Lansdown and Payne, 1994) and slowly dissolves in vivo at neutral pH as the 
divalent crosslinking cations are lost. Lastly, chitosan lacks mechanical strength and 
also has a tendency to dissolve. 
 
It is apparent that the mechanical and chemical properties of natural materials are 
difficult to control and are subject to biological variation. Currently synthetic based 
hydrogels are explored to address these issues. These hydrogels are formed by (1) 
radical chain polymerisation, (2) step-growth polymerisation, or (3) mixed-mode 
polymerisation. 
 
Radical chain polymerisation occurs in the order of seconds to several minutes. An 
initiator is decomposed into free radicals (possibly by an initiating signal) in the 
presence of monomers (synthetic, e.g. poly(ethylene glycol); or natural, e.g. fibrinogen 
(Almany and Seliktar, 2005), chitosan (Ono et al., 1999; Hong et al., 2006), alginate 
(Yeh et al., 2006), hyaluronic acid (Yeh et al., 2006; Kim et al., 2007), chondroitin 
sulphate (Li et al., 2003b)) which generally have been modified to contain two or more 
functional (i.e. crosslinkable) groups (i.e. methacrylate (Li et al., 2003b; Yeh et al., 
2006), azide (Ono et al., 1999)). A free radical will bind a monomer forming a new 
radical which will then bind another monomer resulting in the generation of a polymer 
chain. The initiation of the chain polymerisation can be brought about by thermal 
(Temenoff et al., 2004), redox (Hong et al., 2006), or photo-initiating (Ono et al., 1999; 
Li et al., 2003b; Yeh et al., 2006) systems.  
 
Radical polymerisation allows for greater control of the mechanical properties and 
degradation of the resulting hydrogels by modifying the number of functional groups, 
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the duration of the initiating signal (e.g. UV-exposure) (Ahearne et al., 2008), and the 
concentration of the initiator (Hong et al., 2007) and precursors (Burdick et al., 2005). 
However, greater mechanical stiffness is generally accompanied with higher 
cytotoxicity from UV-exposure (Yeh et al., 2006), toxic by-products (Li et al., 2003b) 
and free radicals (Hong et al., 2007) reduce cell survival in a dose dependent manner. 
 
A second strategy for encapsulating cells, one which does not require (potentially 
cytotoxic) initiators involves step-polymerization and crosslinking of water-soluble 
multifunctional nucleophilic (i.e. electron rich) precursors. An example is hyaluronic 
acid which has been conjugated with (crosslinkable) thiol groups. The air oxidation of 
these thiols to disulfides allows for the formation of HA-based hydrogels under 
physiological conditions (Shu et al., 2002). This process which can take minutes to 
hours can be accelerated by the use of Michael-type addition reaction (Metters and 
Hubbell, 2005) which involves the reaction between multifunctional unsaturated (or 
electrophilic, i.e. electron deficient) precursors (e.g. acrylated poly(ethylene glycol)) 
and multifunctional nucleophile precursors (e.g. thiolates). 
 
A third strategy for the fabrication of synthetic hydrogels is the mixed-mode 
polymerisation (Rydholm et al., 2005) which involves both radical chain and step-
growth polymerisation reactions of multifunctional, acrylated and thiolated precursors. 
The step-growth reaction involves the linkage between an acrylate and a thiol group and 
the chain polymerisation involves the reaction between two acrylates. 
 
The use of biological precursors such as collagen or fibrin has the advantage over the 
use of purely synthetic precursors in that these biological materials have cell adhesion 
motifs (Ruoslahti and Pierschbacher, 1987) and confer to the hydrogel a cell-mediated 
degradability (Rowe et al., 2007). Synthetic hydrogels, however, suffer from the 
disadvantage that the resorption rate does not necessarily match the rate of matrix 
deposition by the cells and the materials are not always degraded by the cells’ natural 
mechanisms as they generally degrade by simple hydrolysis (Nicodemus and Bryant, 
2008). To make synthetic hydrogels more biomimetic cell binding moieties can be 
introduced by the hybridisation with fibrinogen (Almany and Seliktar, 2005) and 
collagen (Doillon et al., 1995) precursor molecules or grafting of the synthetic 
precursors with cell binding motifs (Burdick and Anseth, 2002). These techniques have 
already resulted in transparent, biomimetic synthetic scaffolds with sufficient suture 
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retention strength that they could be sutured into corneal defects (Rafat et al., 2008; 
Deng et al., 2010). These experimental constructs have, however, not yet been tested for 
their suitability for cell encapsulation and long term support of embedded cells. 
 
An emerging cell encapsulation strategy involves natural or synthetic peptides or 
proteins that self-assemble into hydrogels made of complex nano-scale structures 
(Rajagopal and Schneider, 2004; Williams et al., 2010). Depending on the 
hydrophobicity, hydrophilicity and charge of the side groups of the amino acid sequence 
the peptides or proteins assemble into various nano-structures (e.g. β-sheets and β-
hairpins) through a great number and a variety of weak non-covalent interactions (e.g. 
hydrogen bonding, electrostatic interactions, hydrophobic interactions and van der 
Waals interactions). Although these hydrogels are stable they are mechanically weak 
and require cells to strengthen the matrix through the deposition of ECM (Kisiday et al., 
2002). 
 
4.2 Hybrid constructs 
 
The combination of cell encapsulating hydrogels with prefabricated scaffolds, such as 
presented here, is an attractive one, as the strategy prevents considerations of 
mechanical strength compromising those concerning cytocompatibility. In the present 
study thin sheets of living, suturable dermal-like tissue were created in the space of an 
hour by polymerising and cell seeding a monomeric collagen solution (after inoculation 
with dermal fibroblasts) around a synthetic, degradable polymer mesh and mechanically 
compressing (in an unconfined configuration; Figure 14) the resulting hybrid material to 
improve the integration between the collagen hydrogel and the mesh (Ananta et al., 
2009). This technique was tested with two different slow degrading polyester meshes: 
(1) a weft knitted mesh made of a newly developed PLACL (a 97:3 copolymer of poly-
L-lactic acid and ε-caprolactone; Figure 13) (Ananta et al., 2009) and (2) a 
commercially available warp knitted mesh made of Vicryl (a 90:10 copolymer of 
glycolic acid and lactic acid, polyglycolic acid, PLGA; Figure 40b).  
 
The hybrid construct in the present study was designed as a permanent tissue substitute 
which is why was chosen for a degradable material to act as the mechanical backbone. 
Biodegradable synthetic polymers offer a number of advantages as scaffolding material 
over naturally derived materials. As they are chemically synthesized, they can be 
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reproducibly manufactured on a large-scale and it is possible to control their mechanical 
and physical properties over a wide range using harsh solvents and/or reactants as long 
as the final product is cell friendly. For instance, the degradation rate and UTS of 
synthetic polymers can be tailored by varying the molecular weight or by co-
polymerisation with other synthetic polymers (Holland et al., 1987). 
 
Synthetic polymers can be separated in two main groups, namely plastics and 
elastomers (McKeen, 2008). Plastics are categorised into two main groups depending on 
their response to heat: thermosetting polymers (or thermosets) and thermosoftening 
plastics (or thermoplastics). A thermosetting polymer is a prepolymer in a soft solid or 
viscous state that changes irreversibly into an infusible, insoluble polymer network by 
curing (i.e hardening of the material through the introduction of covalent crosslinks by 
heat, chemical reactions or irradiation). A thermoplastic polymer in contrast is in a 
liquid state at its melting temperature and changes reversibly into a solid below this 
temperature. Elastomers (or elastic polymers) can elastically deform up to 200% strain 
and can also be prepared as thermosets and thermoplastics.  
 
The biodegradable synthetic polymers most studied are thermoplastic and the main 
classes are, polyesters (e.g. poly(α-hydroxy acids), polyorthoesters, polyanhydrides, 
polyphosphazenes, polyurethanes, poly (propylene fumarate), and poly (anhydrides) 
(Gunatillake and Adhikari, 2003; Yang and El Haj, 2006).  
 
Synthetic polymers are generally fabricated into porous three-dimensional shapes (i.e. 
sponges/foams) by the removal of predispersed compounds (e.g. gas, water, salts) from 
a solidifying polymeric solution (Tateishi et al., 2002), such as solvent casting and 
porogen (or particulate) leaching (Mikos et al., 1994), liquid-liquid phase separation 
(i.e. phase separation of a polymer solution with subsequent removal of the solvent 
phase) (Schugens et al., 1996), emulsification/freeze-drying (i.e. water is used as the 
porogen) (Whang et al., 1995), and gas foaming (i.e. gas is used as the porogen) 
(Mooney et al., 1996). These scaffold fabrication techniques are labour intensive, use 
potentially cytotoxic porogens or conditions, and require extended culture time or 
dynamic cell seeding techniques (Godbey et al., 2004) to achieve a homogeneous cell 
distribution. 
For the purpose of this study a textile mesh was chosen as the porous and flat scaffold-
architecture would accommodate the collagen compression technique. The fibres of 
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textiles are generally manufactured by one of four main techniques: (1) melt spinning 
(Ananta et al., 2009), (2) dry spinning, (3) wet spinning (Ellis and Chaudhuri, 2007), 
and (4) electrospinning (Scott et al., 2007). The first three methods are essentially the 
same where fibres are drawn out from a polymer solution (or from a polymer melt) 
extruded through a spinneret (Tuzlakoglu and Reis, 2009). Electrospinning uses an 
electric field to draw fibres from a polymer melt or solution allowing for the creation of 
thin nano-structures (Scott et al., 2007). A draw-back of melt spinning is that the heat 
reduces the molecular weight of the polymer and thereby increases the degradation rate. 
 
Regardless of their manufacture, the fibres can be processed into 3D mesh like 
structures with either knitted, woven or nonwoven patterns (Tuzlakoglu and Reis, 
2009). The main advantage of knitted and nonwoven over woven structures is that they 
do not unravel when cut. An added disadvantage of the woven structure is that it makes 
meshes more prone to rolling (Cooper et al., 1991) leading to difficulty in handling. 
 
The PLACL mesh tested in the present study is a newly developed synthetic material 
which is expected to degrade over a period of 6 to 12 months through simple hydrolysis 
into caproic and lactic acid (Pitt et al., 1981) which depending on the degradation rate 
could negatively affect cell viability through lowering of the surrounding pH (Sung et 
al., 2004). Qualitative findings in the present study indicate that after a 7-day in vitro 
culture period no significant levels of toxic degradation products had formed as cells 
embedded in the basal collagen component did not appear to move away from the mesh 
and no increased reduction in cell viability was found in regions close to the PLACL 
material (Figure 44). 
 
In the in vitro testing phase a subset of the PLACL-CCHH were found to 
macroscopically contract in size and roll up when exposed to aqueous media at 37°C 
and did so even when not coated with cell seeded compressed collagen hydrogels 
(Figure 46). The cell independent mechanism behind this is unclear but from a study on 
another synthetic polyester poly(ethylene terephthalate) (PET) (Knox et al., 1981) a 
cause can be proposed. PET like PLACL and other thermoplastics, is semicrystalline, 
because it does not crystallise easily upon cooling as the polymer chains have to form 
highly ordered structures from their entangled state in order to become crystalline. What 
generally occurs is some crystallisation in certain regions of the polymers resulting in 
polymers with crystalline regions and amorphous regions, thus termed semicrystalline 
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polymers. It is speculated here that an aqueous medium induces a relaxation of stretched 
amorphous polymer chains in the melt spun filaments resulting in a longitudinal (rather 
than transverse, Figure 46i, j) shrinkage of the yarns (with a decrease in porosity, Figure 
47a) and an increase in crystallisation (resulting in an apparent increase in stiffness). 
One of the main functions of a TE scaffold is to maintain a functional space in which 
tissue regeneration can take place. Because of its inability to retain its shape and size 
dimensions the PLACL-mesh was considered unsuitable for in vivo applications. 
 
The second material tested with the hybridisation technique was the PLGA (Vicryl) 
mesh which is well characterised. The PLGA material is commonly used as a resorbable 
suture and the mesh form is found particularly useful for hernia repair (Luijendijk et al., 
2000). It degrades through non-enzymatic hydrolysis (Gorham et al., 1987) into lactic 
acid and glycolic acid which are ultimately eliminated from the body in the form of CO2 
and H2O (Yooa et al., 2005). In vivo testing (Conn Jr et al., 1974) showed that the 
material is completely degraded and absorbed after 60 days with minimal acute or 
chronic inflammatory reaction. Cells seeded directly onto the material showed more 
than 90% viability retention after a 4-day in vitro culture period (Vacanti et al., 1988) 
and cells have over a 5-day in vitro culture period been shown to proliferate on the 
material (Chen et al., 2005). Previous studies have reported that PLGA (Vicryl) meshes 
would roll up in culture when (unilaterally) seeded with cells (Cooper et al., 1991). 
This, however, was not found in the present study, possibly due to the stabilising effects 
of the compressed collagen sheets. 
 
Vicryl meshes have previously been used to improve the suturability of tissue 
engineered constructs. For instance air dried collagen membranes (25 µm thick) 
prepared from shredded limed bovine hide (Gorham et al., 1984) were previously 
enhanced by the incorporation with this mesh (Gorham et al., 1987) extending in vitro 
break strength retention of the mesh possibly due to the retardation of hydrolysis by the 
collagen coating. These constructs were able to successfully seal full thickness bladder 
defects in a lapine model (Monsour et al., 1987) and full thickness oesophagal defects 
in a porcine model (Carachi et al., 1989). These hybrid constructs were in both studies 
eventually replaced by epithelialised, new connective tissue. As opposed to the present 
technique, this strategy does not allow for cell encapsulation. 
A commercially available biological dressing Dermagraft (Advanced Tissue Sciences, 
CA, USA) is created by seeding human neonatal fibroblasts onto the Vicryl mesh which 
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is then cultured for 2 to 3 weeks to achieve confluence of cells and ECM within the 
pores of the mesh (Cooper et al., 1991). As previously mentioned the strategy of cell 
seeding on a prefabricated scaffold is time consuming as it relies on cell activity to 
achieve sufficient cell numbers and to provide a relevant 3D context. This problem is 
compounded by the small surface area available for cell attachment (Mansbridge et al., 
1998) and the fact that synthetic degradable polymers, such as PLGA, commonly have a 
hydrophobic surface chemistry which does not facilitate cell attachment (Ng et al., 
2001; Chen et al., 2005; Vaquette et al., 2008). 
  
To address this issue, collagen micro-sponges were introduced within the interstices of 
the Vicryl mesh through freeze-drying of an acidic collagen solution followed by a 
cross-linking step with gluteraldehyde vapour (Chen et al., 2000). This extended the 
surface area with a more suitable substrate for cell attachment. These PLGA-collagen 
sponge hybrid constructs were 200 µm thick and could be used to create tissues up to 8 
mm thick by way of lamination or rolling (Chen et al., 2003a). This hybrid material has 
been used for 3D in vitro cultures of chondrocytes (Chen et al., 2003b), smooth muscle 
cells and urothelial cells (Nakanishi et al., 2003), fibroblasts (Chen et al., 2005), 
pancreatic b-cells (Kawazoe et al., 2009) for the engineering of cartilage, skin and 
pancreatic like tissues. 
 
These studies suggest that the PLGA-CCHH constructs presented here could be used for 
similar applications but with significantly shorter culture periods. Even though the 
introduction of micro-sponges resulted in a 5-fold increase in cell seeding efficiency and 
a 3-fold increase in proliferation (Chen et al., 2005), the hybrid constructs still required 
2 weeks of in vitro culture before use in vivo. In contrast, the cell encapsulation 
technique allows for seeding of a large number of cells with optimal efficiency and with 
95% retention of pre-compression (Brown et al., 2005) and 92% retention of post-
compression cell viability (Figure 41). 
 
Decreasing or removing a pre-implantation in vitro culture period has significant 
implications, as the PLGA biodegradable polymeric material degrades in a humid 
environment (Gorham et al., 1987). A lengthy in vitro incubation period shortens the 
time that the polymeric support will remain structurally functional in vivo and it has 
been shown that the in vivo persistence of these PLGA-cell derived matrix hybrid sheets 
was shortened from 4-8 weeks (MacDonald et al., 1992; Meddings et al., 1993) to 2-4 
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weeks (Chen et al., 2005). It is shown here that using encapsulation in a collagen 
hydrogel of both cells and mesh addresses this issue and results in a suturable living 
connective tissue within the space of an hour as opposed to weeks. 
 
Encapsulation of a synthetic degradable mesh in cell seeded collagen hydrogel has 
previously been tested with polyglycolic acid (PGA) (Miki et al., 1999) and PLGA 
(Vicryl) (Nakanishi et al., 2003) to reconstruct oesophageal and bladder tissue 
respectively. In both studies the collagen hydrogels were not compacted, either by 
embedded cells or through mechanical loading, which in the first study (Miki et al., 
1999) resulted in a partial delamination of the collagen hydrogel from the mesh and in 
the second study (Nakanishi et al., 2003) in the failure of the formation of a urothelium 
by subsequently seeded urothelial cells. Although comparison is difficult, the present 
findings suggest that the collagen hydrogel compression technique prevents 
delamination (Figure 41) and the formation of a substrate sufficiently stiff to support the 
formation of an epithelium (Figure 48). 
 
4.3 Implantation study 
 
In the present study a co-culture of allogeneic keratinocytes and fibroblasts maintained 
on the PLGA-CCHH were transplanted into a rabbit model of an acute full thickness 
skin defect. Fibroblast seeded compressed collagen sheets have previously been tested 
for this purpose (Hu et al., 2010), however, the handling properties of the resulting skin 
equivalents were considered inadequate for in vivo implantation. The present findings 
show that the addition of the PLGA mesh improved handling with the retention of the 
ability to form a stratified epidermis by keratinocytes grown on the apical surface of the 
PLGA-CCHH. This indicated that the diffusion of nutrients from the basal surface to 
the apical surface of the construct was not impaired during culture at the air-liquid 
interface. This is also of importance in vivo as the construct features no vasculature.  
 
Constructs that featured a near confluent epithelial monolayer (fabrication time 5 hours) 
and those that featured a stratified epithelium (fabrication time 3 weeks) were compared 
to test if the wound healing benefit (in terms of improved outcome parameters) 
warranted an extended in vitro culture period. No permanent engraftment of the 
implants was found, but in the first week post-wounding the co-culture constructs with a 
stratified epidermis did show a 4-fold higher percentage wound closure (Figure 68) and 
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an 8-fold higher number of blood vessels in the wound bed compared to untreated 
wounds (Figure 70). The constructs with a monolayer epidermis showed similar trends, 
but these were not statistically significant. 
 
4.3.1 Epidermal closure 
 
The cultured PLGA-CCHHs carrying a differentiated and stratified keratinocytes 
stimulated epidermal closure (Figure 68). It has previously been shown that the 
application of keratinocytes directly to the wound can aid in epidermal closure (McAree 
et al., 1993) with allogeneic keratinocytes performing equally well to autologous 
keratinocytes in burn and ulcer patients (Hefton et al., 1983; Phillips et al., 1990). They 
increase the rate of epithelialisation in a dose dependent manner (Butler et al., 1999) by 
the release of growth factors and by physically contributing to the epidermal regenerate. 
 
Commercially available cell therapies (Epicel, Epidex, Myskin) (Bottcher-Haberzeth et 
al., 2010; Brusselaers et al., 2010) generally involve the harvest of autologous 
keratinocytes from patients which are grown into confluent stratified sheets (cultured 
epidermal autografts; CEA) in the presence of murine fibroblasts before they are 
transplanted. Disadvantages associated with their use are their slow preparation time, 
variable engraftment rate, inefficiency against wound contraction, poor handling 
properties due to their fragile nature, and high production costs. 
 
The addition of a dermal component (Horch et al., 2000; Jones et al., 2003), such as the 
one presented here, as a transport vehicle for these keratinocyte sheets addresses a large 
number of these issues, as epidermal sheets can be transplanted before they are 
confluent which would shorten the in vitro production time, and the presence of a 
dermal equivalent has shown to prevent wound contraction and improve the take of 
keratinocyte sheets.  
 
Although a dermal component allows the transplantation of subconfluent keratinocytes, 
the findings show that the skin equivalents cultured for two weeks at the air/liquid 
interface to form aconfluent, stratified epidermis showed a higher percentage wound 
closure than the UCs (featuring a subconfluent monolayer epidermis). It has previously 
been shown in a porcine (autologous) model of a full-thickness skin defect that the rate 
of epidermal regeneration and the thickness of the epidermal regenerate is directly 
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related to the number of transplanted dividing keratinocytes (Butler et al., 1999) 
suggesting that differentiated keratinocytes do not contribute significantly. In addition, 
fibroblasts are also able to promote the proliferation and differentiation of keratinocytes 
in a dose dependent manner (Coulomb et al., 1989; el-Ghalbzouri et al., 2002) and 
show a synergistic effect on epidermal regeneration when transplanted together with 
keratinocytes (Svensjo et al., 2002). These reports suggest that the increase in wound 
closure by epidermal regeneration between UCs and CCs could primarily be the result 
of the increase in fibroblast and keratinocyte number and not by the differentiation of 
the keratinocytes. It is therefore speculated that a skin equivalent equally effective as the 
cultured construct here can be prepared without an in vitro culture period by increasing 
the density of fibroblasts and (basal) keratinocytes. Although the number of fibroblasts 
that could potentially be encapsulated in a collagen hydrogel volume of fibroblasts is 
virtually unlimited the number of keratinocytes that can be seeded is limited by the 
surface are of the dermal equivalent. Fibrin encapsulation of keratinocytes is an already 
established technique for the delivery of growth factors (Acevedo et al., 2010). 
Therefore, as a suggestion for future work, it would be interesting to test if a dermal 
equivalent with an increased number of fibroblasts and keratinocytes encapsulated in 
the collagen component would produce similar results as those described here for the 
CCs. 
 
4.3.2 Inflammatory response 
 
In adult mammals injury is inevitably followed by an inflammatory response which 
helps to remove any factors (i.e. microbial contamination and necrotic tissue) that delay 
wound healing (tissue formation and remodelling) and helps induce tissue formation 
(fibroplasia and angiogenesis) (Szpaderska and DiPietro, 2005; Eming et al., 2007). 
Despite its positive effects on wound repair prolongation of inflammation can cause a 
delay in healing and excessive scarring. 
 
The advantage of the use of allogeneic cells over autologous cells in TE is that they are 
readily available and prevent additional operative procedures for subjects receiving the 
cells. However, in contrast to autologous cells, allogeneic cells increase inflammation in 
a dose dependent manner (Figure 55), prolonging the presence of myofibroblasts and 
delaying collagen maturation (Lamme et al., 2002). It has, however, been shown that 
serial passages (Theobald et al., 1993) results in the loss of HLA-DR antigens and 
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major histocompatibility (MHC) class II antigen presenting cells, such as Langerhans 
cells allowing allogeneic cell lines to be transplanted across major histocompatibility 
barriers. 
 
Similar concerns with regards to immunogenicity can be raised against the use of 
xenogeneic (rat tail) collagen. Although the conservation of the triple helical region of 
collagen across species (Fietzek and Kuhn, 1976) has often been used as an argument 
for the safety of exogenous (allogeneic, xenogeneic) collagen (Lynn et al., 2004) 
previous studies have shown that rabbits can produce (both low and high) titer, species-
specific antibodies against acid solubilised rat (tail, skin) collagen (WATSON et al., 
1954; Michaeli et al., 1969). In the present study, however, no differences in leukocyte 
response were found between untreated wounds and those treated with ACs. These 
findings are agreement with those of a study in which compressed rat-tail collagen 
constructs were implanted in rabbits (Mudera et al., 2007) suggesting that in this model 
antigenicity against the material is not a concern. 
 
4.3.3 Angiogenesis  
 
In the first week wounds treated with the CCs showed a statistically signifcant 8-fold 
higher number of blood vessels and a (significant) 3-fold greater blood vessel cross 
sectional area than wounds that were not treated with cell seeded implants. 
 
The formation of new blood vessels (sprouting) from preexisting vessels (i.e. 
angiogenesis) is essential for wound healing (Tonnesen et al., 2000). The importance of 
this has previously been underlined by clinical studies with Dermagraft showing that the 
application of higher cell numbers are correlated with an increased therapeutic effect 
(Mansbridge et al., 1998) and that increased wound closure is mediated, in part, through 
the stimulation of blood vessel formation within the wound (Krishnamoorthy et al., 
2003). The transplantation of keratinocytes and fibroblast can directly stimulate 
angiogenesis by the production of VEGF (Brown et al., 1992; Mansbridge et al., 1998; 
Cheema et al., 2008). Previous work from our lab has shown that the angiogenic 
potential of compressed collagen hydrogels can be simply and rapidly improved by 
increasing the seeding density of fibroblasts. At sufficient levels the cells will create a 
consumption driven hypoxic environment which induces vascular endothelial growth 
factor (VEGF) gene (Cheema et al., 2008), and protein expression (Hadjipanayi et al., 
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2010) which has shown to stimulate blood vessel formation both in vitro and in vivo. 
This illustrates the relative ease and flexibility with which the therapeutic effect can be 
tailored in this system. 
 
4.3.4 Wound contraction 
 
Although there was no permanent engraftment of the skin equivalents the treated 
wounds showed 55% wound contraction compared to the 84% of untreated wounds and 
to the 12% of FTSGs grafted wounds, 5 weeks post-injury (Figure 52). 
 
The physiology of wound healing in animals such as rabbits and guinea pigs is different 
from humans as their skin, where it overlies the panniculus carnosus, is mobile in 
relation to the underlying tissue (BILLINGHAM and MEDAWAR, 1955). In the early 
phases of wound healing, defects in these regions largely and spontaneously close 
(Watts et al., 1958) due to the migratory action of fibroblasts (Grinnell et al., 2006) 
moving out from the wound margins pulling them inward over the underlying wound 
bed. Continuous undercutting of the margins from the wound bed inhibits this process 
(Watts et al., 1958) allowing new connective tissue to be formed more extensively. This 
appears to mimic the human condition where the panniculus carnosus is mostly absent 
and the skin is less mobile. 
 
A previous study in pigs suggests that in humans as in animals with mobile skin, 
granulation tissue formation in the early phases of wound healing does not significantly 
contribute to wound contraction (Gross et al., 1995). At later stages, however, if the 
defect persists and a sufficient amount of granulation tissue has been allowed to form a 
further reduction of the wound size will occur through myofibroblast mediated 
contraction of the matrix under mechanical stimulation (Grinnell, 2000). In vitro studies 
suggest that the mechanical stress appears to be crucial for maintaining this late 
contraction process as apoptosis is initiated upon stress removal (Grinnell et al., 1999; 
Hadjipanayi et al., 2009). These findings were confirmed in vivo experiments in which 
the granulation tissue was released from the wound margins (Carlson et al., 2003) or the 
wound was splinted (Carlson and Thompson, 2004). 
 
Mechanical stress is an important modulator of granulation tissue proliferation and scar 
contracture could therefore very well be the end result of unfavourable mechanical 
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effects working on the site of injury which in the immobile skin can result in major 
body deformation and loss of joint motion. Although the present constructs appear to 
have an influence on early spontaneous contraction their ejection from the wound makes 




Therefore, in the first week there was partial take of the ACs, but all skin equivalents 
showed progressive desiccation with ultimately no permanent engraftment of either the 
AC or cell-seeded skin equivalents. By week 3, grafts were invariably undermined by 
epidermal regeneration ejecting the constructs from the wounds. 
 
In the early phases the immobilisation of the construct within the wound bed is essential 
for engraftment and is provided by the (PLGA/Vicryl) sutures and the structural 
integrity of the (PLGA/Vicryl) mesh. As PLGA degrades in a humid environment 
(Gorham et al., 1987) a pre-implantation in vitro culture period decreases in vivo 
persistence with reports showing a decrease in persistence from 4-8 weeks (MacDonald 
et al., 1992; Meddings et al., 1993) to 2-4 weeks (Chen et al., 2005). Similar to 
previous reports about Dermagraft which is also a PLGA-collagen hybrid cultured for a 
2-week period (Hansbrough et al., 1992) the CCs in the present study showed no tearing 
during suturing, although over the implantation period the loss of CCs was greater and 
occurred earlier than UCs (Table 2).  
 
Vascularisation is in part driven by the release of angiogenic factors from the 
transplanted cells (Cheema et al., 2008) and their survival is therefore important to carry 
out this function. Although an increased angiogenic response was found in the wound 
bed (Figure 70) it fell short of involving the implant (Figure 51). It is considered here 
that the progressive desiccation of the constructs after the removal of the dressing (at 
day 3) could have resulted in the premature cessation in the release of angiogenic 
factors. Compressed collagen hydrogels (0.7 ml/cm²) have been shown to be susceptible 
to dehydration with complete loss of viability after only 60 seconds (Brown et al., 
2005). In addition, the failure of the implant to vascularise could in part be the result of 
the high fibril density of the compressed collagen component which could have further 
increased due the compacting effect of dehydration. It has previously been shown that 
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the pore size is an important determinant of how readily endothelial cells can invade an 
implant (Sahota et al., 2003).  
 
Now although the CCs featured a differentiated stratified epidermis with a stratum 
corneum (the functional barrier layer) this did not prevent the skin equivalents from 
dehydration. It has previously shown that even though an in vitro reconstructed 
epidermis structurally mimics native tissue it does not do so functionally (Fartasch and 
Ponec, 1994). One commercially available skin substitute, Integra, addresses this by 
featuring a silicone elastomer cured to the underlying dermal component (Yannas et al., 
1981). A second stage surgical intervention, however, is required to reconstruct the 
epidermis after the dermal component is vascularised. 
 
Another factor that could have contributed to the failure of these skin equivalents to 
engraft is the inflammatory response to the embedded allogeneic cells. As opposed to 
the present study performed in an immunocompetent animal model, vascularisation of 
PLGA-(cell derived) collagen hybrids in full thickness skin defects has been shown in 
immune compromised animals (Cooper et al., 1991; Chen et al., 2005). It was found 
here that ACs, which did not increase inflammation, showed partial vascularisation and 
integration into the underlying wound bed (Figure 51). The point is further illustrated by 
Apligraf, a collagen based construct seeded with allogeneic (human) cells (Bell et al., 
1979; Wilkins et al., 2004), which showed integration (and reduced wound contraction) 
in wounds of immune deficient (rat) subjects (Bell et al., 1981a) but not in immune 
competent (human) subjects (Griffiths et al., 2004).  
 
Therefore, equal to current (allogeneic) cell seeded products (i.e. Apligraf and 
Dermagraft) which exert a therapeutic effect through multiple applications, the current 
cell-seeded experimental skin equivalents do not show integration into the wound bed 
of an immunocompetent recipient. 
 
4.3.6 Granulation tissue formation 
 
In the first 48 hours after injury the migration from adjacent fascia and dermis 
contribute primarily to the population of fibroblasts responsible for the production and 
remodelling of collagen within the granulation tissue after which time local proliferation 
becomes more important (Spyrou et al., 1998). Transplanted autologous fibroblasts (in a 
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porcine model) have previously been shown to improve collagen maturation in full 
thickness skin defects in a dose dependent manner (Lamme et al., 2000). Additionally, 
in a rabbit model it was found that the transplantation of a (non-autologous) fibroblast 
suspension accelerated the increase in wound strength (Sandulache et al., 2003) 
compared to no treatment. Compared to autologous fibroblast treatment collagen 
maturation is slower with allogeneic cells (Lamme et al., 2002) possibly due to the 
associated inflammatory response. In the present study, however, wounds treated with 
(allogeneic) cells resulted in increase in collagen maturation compared to wounds left 
untreated or treated with ACs (Figure 63). 
 
It should be noted the present findings were obtained using linearly polarised light 
microscopy on picrosirius red stained tissue sections. And although picrosirius red (the 
method used here) has been used in various studies to quantify collagen in various 
studies (Pickering and Boughner, 1991; Rich and Whittaker, 2005; Cuttle et al., 2005), 
there is evidence to suggest that the electrostatic binding of Sirius red to collagen is not 
stoichiometric (Puchtler et al., 1988), implying that the enhancing properties are not 
proportionate to the actual amount of collagen present. Also questions have been raised 
about the specificity of the dye (Kiraly et al., 1997) and the evaluation of unstained 
sections using polarised light microscopy in combination with digital imaging has been 
advocated. Finally, it has been shown that it is difficult to visualise all of the collagen at 
each instance when linearly polarised light is used (Whittaker et al., 1994) because 
(parts of) collagen fibres aligned parallel to the transmission axis of either the polariser 
or analyser (Figure 27) appear dark leading to an underestimation of the actual collagen 
content. In contrast, circularly polarised light allows the visualisation of every portion 
of every fibre. It can be argued that all tissue sections were processed, visualised and 
analysed according to the same protocol and under constant conditions which would 
permit inter-sample comparison, but further analysis is required to confirm this. 
Therefore the validity of the finding that CCs improve collagen maturation has to be 
questioned at present. 
 
4.3.7 Comparison with commercially available skin equivalents 
 
The dermal equivalent in the present study (i.e. the compressed collagen hydrogel 
hyridised with Vicryl) is similar in composition to Dermagraft (Cooper et al., 1991) 
which is fabricated by seeding and maintaining fibroblasts on a Vicryl mesh. The main 
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difference is that the extracellular matrix in Dermagraft is not exogenously provided but 
produced by the seeded cells necessitating a 2 to 3 week in vitro culture period to 
achieve sufficient tissue formation for a therapeutic effect (Cooper et al., 1991). The 
product is currently FDA approved for the treatment of venous (Krishnamoorthy et al., 
2003; Omar et al., 2004), neuropathic and diabetic ulcers (Marston et al., 2003).  
 
Although Dermagraft does not contain keratinocytes it is more effective than 
conventional treatments of chronic (persisting longer than 6 months) venous 
(Krishnamoorthy et al., 2003; Omar et al., 2004), neuropathic and diabetic ulcers 
(Marston et al., 2003) and the product is FDA-approved for these applications. The 
material ‘takes’ in (immune-compromised) animal wounds, but integration in human 
(immuno-competent) subjects has not been reported and Dermagraft requires multiple 
applications to achieve a clinical effect. Dermagraft with a monolayer epidermis has 
been tested in athymic mice (Hansbrough et al., 1993). Take was significantly reduced 
as grafts were prone to mechanical dislodgement, possibly due to the hydrolytic 
degradation of the PLGA material over the extended culture time that was required to 
form the epidermis (of 4-6 days over the 2-3 week ). Although this is less of a concern 
for biological dressings, Dermagraft is currently still only applied clinically without an 
epidermis. 
 
It should be mentioned that Dermagraft is not to be confused with Dermagraft-TC 
(Dermagraft Transient Cover, currently marketed as TransCyte) which is fabricated by 
culturing allogeneic human neonatal fibroblasts 17 days on Biobrane (Bertek 
Pharmaceuticals Inc., WV, USA) a semi-permeable polymer (silicone) membrane with 
partially embedded woven monofilament nylon mesh onto which porcine collagen 
peptides are chemically bound to form a hydrophilic surface (Hansbrough et al., 1994). 
The product is devitalised by freezing and the cell produced ECM contains fibronectin, 
type I collagen, proteoglycans and growth factors. The product is a temporary cover for 
partial thickness burns and is spontaneously ejected by healing wounds. It has shown to, 
decrease hospital stay compared to conventional treatment (silvazine) (Amani et al., 
2006), prevent frequent and painful dressing changes, autografting, and decreases the 
time to wound closure compared to alternative treatments (Biobrane alone, silvazine) 
(Kumar et al., 2004) 
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Other dermal substitutes worth mentioning are Alloderm (Lifecell Corporation, NJ, 
USA) and Integra (Integra Life Sciences Corp, NJ, USA). Both these acellular products 
permanently engraft in clinical acute wounds unlike the presented experimental skin 
equivalents and currently available cell-seeded TE dressings (i.e. Apligraf, Dermagraft, 
OrCel). 
 
Alloderm is produced from human cadaver skin by the tonic removal of epidermis with 
NaCl and decellularisation with sodium dodecyl sulphate (a detergent) of the dermal 
component. Clinical studies have shown it to be useful as a dermal substitute in full 
thickness burns without signs of rejection, showing revascularisation, cellular 
repopulation, incorporation into the wound and cosmetic results similar to intermediate 
thickness skin grafts (Wainwright et al., 1996). 
 
Integra (Yannas et al., 1981) is the first FDA-approved skin substitute (acellular) 
consisting of a suturable, semi-permeable silicone elastomer (polysiloxane, Dow 
Corning Liquid Silastic Medical Adhesive Type A) cured to an underlying dermal 
component made of a degradable crosslinked (vacuum dehydration and gluteraldehyde) 
coprecipitation of bovine collagen and (8%) chondroitin 6-sulfate (a shark cartilage 
derived glycosaminoglycan). Integra is used to reconstruct the skin in a two stage 
procedure in surgically excised burn injuries (Burke et al., 1981; Heimbach et al., 2003) 
or in excised benign or malignant lesions (Prystowsky et al., 2000). After it has 
integrated, generally 2-3 weeks after implantation the silicone membrane is removed 
and the neodermis is grafted with a split thickness skin graft. Histologically the dermal 
matrix disappears after one month (Stern et al., 1990) and only elicits a small transient 
immune response (Michaeli and McPherson, 1990). Graft take is similar to allografts, 
worse than autografts, but cosmetically superior over meshed autografts (Heimbach et 
al., 1988) and the reconstructed skin has elastic properties matching that of normal skin 
(Nguyen et al., 2010). 
 
The cultured skin equivalent featuring a stratified epidermis (i.e. CCs) histologically 
mimics Apligraf (Organogenesis Inc., MA and Novartis Pharmaceutical Corp., NJ, US) 
(Wilkins et al., 2004). This commercially available skin equivalent consists of a bovine 
collagen (type I) hydrogel seeded with allogeneic human neonatal foreskin fibroblasts 
(Bell et al., 1979) and keratinocytes (Bell et al., 1981a). The mechanical properties of 
the dermal component are improved by allowing collagen to contract for 6 days after 
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which keratinocytes are seeded and cultured for 4 days under submerged conditions and 
terminally differentiated into a stratified epidermis for an additional 7 days at the 
air/liquid interface. Apligraf is currently FDA approved for the treatment of venous leg 
(Falanga et al., 1998) and diabetic foot ulcers (Veves et al., 2001). 
 
Apligraf is more effective than conventional treatment (i.e. compression therapy and 
saline-moistened gauze, respectively) in achieving wound closure in chronic (lasting 
longer than 6 months) non-healing venous leg (Falanga et al., 1998) and diabetic foot 
ulcers (Veves et al., 2001) and is FDA-approved for the treatment of these conditions. 
As previously mentioned, Apligraf does not persist in human acute full thickness skin 
defects (cells remain in the wound up to 4 weeks) (Griffiths et al., 2004) and requires 
multiple applications for it to be effective. It is noteworthy that Organogenesis is 
currently in late stage development of a next generation allogeneic skin equivalent, 
VCTO1, which similar to Apligraf with the only difference being that the dermal matrix 
will be human fibroblast derived making its components all human.  
 
The skin equivalent featuring a monolayer epidermis is histologically similar to OrCel 
(Forticell Bioscience, Inc., formerly Ortec International, Inc., NY, US) (Eisenberg and 
Llewelyn, 1998), which is currently under investigation for the treatment of chronic 
wounds. The product is currently FDA-approved for the treatment of split-thickness 
skin graft donor sites (Still et al., 2003) and for use in the surgical release of hand 
syndactyly secondary to epidermolysis bullosa (Eisenberg and Llewelyn, 1998). This 
commercially available skin equivalent is fabricated by seeding allogeneic fibroblasts 
into a preformed lyophilised bovine collagen (type I) sponge which is cultured for 2 
days, inverted and seeded with keratinocytes on its non-porous side and cultured for an 
additional 7-14 days (Bell et al., 1981b) to form a confluent monolayer epidermis. 
 
Compared to current techniques, the compression of fibroblast seeded collagen 
hydrogels with an encapsulated synthetic degradable mesh can significantly shorten the 
culture period required to fabricate a living dermal or skin equivalent with adequate 
handling and wound healing properties. As set out in Table 3 the time advantage of 
almost one week is quite significant when the UCs with a monolayer epidermis and the 
cultured skin equivalent with a stratified epidermis are compared to their commercially 
available equivalents (Dermagraft, OrCel and Apligraf). Additionally, the method is 
independent of cell activity and is therefore amenable to automation. These two 
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characteristics could results in the fabrication of biological dressings more reproducible 
and cost-effective than currently available products. 
 
     
Histology 
   
 Dermagraft® OrCel® UC Apligraf® CC 
Epidermal n/a 7 days 4 hours 14 days 14 days 
Dermal 2 - 3 weeks 2 days 1 hours 6 days 1 hour 
Total 2 - 3 weeks 9 days 5 hours 20 days 14 days 
 
Table 3 – Comparison of the fabrication times for the experimental skin 
equivalents (UC, uncultured constructs; CC, cultured constructs) and currently, 
commercially available, living, biological dressings (Dermagraft, OrCel, Apligraf). 
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1. The expulsion of the interstitial fluid from a collagen hydrogel mechanically 
compressed under a constant force results in a mass transfer dependent and 
anisotropic increase in collagen fibril density in the direction of fluid flow and with 
a maximum at the hydrogel surface through which fluid leaves. This increase 
directly and negatively affects the hydraulic permeability of this FLS, progressively 
resisting the outflow of the fluid content. 
 
2. The break strength (or suturability) of a fully (i.e. strained to over 98%) compressed 
collagen hydrogel can be improved by increasing the pre-compression volume. It is 
hypothesised, however, that the mass transfer dependent decrease in hydraulic 
permeability poses a physical limitation on the maximum volume (per unit area) of 
collagen hydrogel that can be adequately compacted and therefore on the maximum 
break strength that can be achieved by this method without significantly affecting 
cell viability. 
 
3. The compression (to over 98% strain) of a fibroblast seeded collagen hydrogel (1.4 
ml/cm²) with an encapsulated synthetic degradable polymer mesh results in the 
creation of a suturable, living dermal equivalent without significantly compromising 
cell survival. The 1 hour fabrication time is significantly less than the 2-3 weeks 
required to produce Dermagraft®, a commercially available biological dressing 
equivalent to the experimental dermal equivalent and currently FDA approved for 
the treatment of diabetic foot ulcers.  
 
4. The experimental dermal equivalent could be used as a substrate for the formation 
of a monolayer and stratified epidermis for the production of skin equivalents. These 
findings results show that the fabricated dressings stimulate wound closure and the 
generation of blood vessels suggesting their potential utility in the treatment of 
lower limb ulcerations. As such it compares favourably with regards to the culture 
time of substrates used for the fabrication of currently commercially available skin 
equivalents (i.e. OrCel® and Apligraf®) which take 2 to 6 days. This implies a 20 to 
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40% reduction in overall fabrication time which could  help  reduce  the  high costs 
associated with  the  use of  this type of tissue  engineered dressing.  
 
5.2 Future work 
 
An interesting question to answer is why in clinical practice none of the currently 
available tissue engineered, living skin equivalents integrate or persist within the wound 
bed. At present, products as these only act as delivery devices of growth factors, 
cytokines and ECM to the site of injury and do not act as tissue substitutes. The present 
experimental skin equivalents could be used as a model with the data presented here as 
a basis for further research. 
 
From a tissue engineering perspective the compression induced structural heterogeneity 
described here, could be useful for the creation of a skin substitute featuring an 
integrated and stiff, water-impermeable epidermal component (the compacted FLS) and 
an uncompacted dermal component in which different cell lines (e.g. fibroblasts, 
endothelial cells) could be embedded with high cell viability retention. It is proposed 
that the epidermal component at a certain collagen density could prevent dessication of 
both the graft and the wound by decreasing the transfer of water. The physical 
properties of the largely uncompacted dermal component would allow for, higher 
interfacial contact with the wound bed, high permeability to oxygen and nutrients, and 
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